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ABSTRACT
The trans-differentiation of injury-activated fibroblasts to myofibroblasts is a
process that provides contractile strength for wound closure. Persistent myofibroblast
differentiation, however, is associated with fibrotic pathologies such as organ fibrosis,
vascular remodeling, and atherosclerotic plaque formation. Myofibroblasts acquire a
contractile phenotype with biochemical properties characteristic of both smooth muscle
cells and stromal fibroblasts. The cyto-contractile protein, smooth muscle "-actin
(SM"A) is a biomarker of myofibroblast differentiation. Expression of the SM"A gene,
ACTA2, is regulated by cis-acting elements and transcription factors that activate or
repress the ACTA2 promoter.
Purine-rich element binding proteins A (Pur") and B (Pur!) are sequencespecific, single-stranded DNA (ssDNA)/RNA-binding proteins that act as transcriptional
repressors of ACTA2 expression. Both Pur proteins interact with the purine-rich strand of
a cryptic muscle-CAT (MCAT) enhancer motif in 5’-flanking region of the ACTA2
promoter. Despite significant sequence homology with Pur", Pur! was identified as the
dominant repressor of ACTA2 expression in mouse embryonic fibroblasts and vascular
smooth muscle cells by virtue of gain-of function and loss-of-function analyses in
cultured cells. Biophysical studies indicated that Pur! reversibly self-associates in
solution to form a homodimer. Quantitative DNA-binding assays revealed that Pur!
interacts with the purine-rich strand of the ACTA2 MCAT motif via a cooperative,
multisite binding mechanism to form a high-affinity 2:1 Pur!-ssDNA complex.
In this dissertation, a combination of computational, biochemical, and cell-based
approaches were employed to elucidate the molecular basis of Pur! repressor interaction
with the ACTA2 gene. Limited proteolysis of recombinant mouse Pur! in the presence
and absence of the purine-rich strand of the ACTA2 MCAT element led to the
identification of a core ssDNA-binding region that retains the ability to dimerize in
solution. Knockdown of endogenous Pur! in mouse embryonic fibroblasts via RNA
interference induced SM"A expression and conversion to a myofibroblast-like
phenotype. To map the specific structural domains in the core region of Pur! that account
for its unique ACTA2 repressor and ssDNA-binding functions, computational homology
models of the Pur! monomer and dimer were generated based on the x-ray crystal
structure of an intramolecular subdomain of Drosophila melanogaster Pur". Empirical
biochemical and cell-based analyses of rationally-designed Pur! truncation proteins
revealed that the assembled Pur! homodimer is composed of three separate purine-rich
ssDNA-binding subdomains. Evaluation of the effects of anionic detergent and high-salt
on the binding of Pur! to ssDNA implicated the involvement of hydrophobic and
electrostatic interactions in mediating high-affinity nucleoprotein complex formation.
This inference was validated by site-directed mutagenesis experiments, which identified
several basic amino acid residues required for the ACTA2 repressor activity of Pur!.
Collectively, the findings described herein establish the structural and chemical basis for
the cooperative interaction of Pur! with the ACTA2 MCAT enhancer and for Pur!dependent suppression of myofibroblast differentiation.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW
Tissue remodeling is a normal physiological process that occurs during wound
healing following injury. Chronic remodeling, however, plays a significant role in the
progression of pathological fibrotic diseases such as hypertrophic scarring, organ fibrosis,
and dysfunctional vascular remodeling contributing to atherosclerosis and restenosis. A
long-standing goal in the field has been to understand the molecular processes that
contribute to pathological tissue remodeling and fibrotic disease. The myofibroblast is a
specialized cell type that emerges during wound healing and plays a fundamental role in
tissue remodeling by synthesizing extra cellular matrix (ECM) components and providing
contractile force for wound closure. It is well accepted that the formation of these unique
cells relies on trans-differentiation of non-contractile resident fibroblasts to form smooth
muscle cell (SMC)-like myofibroblasts with a contractile phenotype. An understanding of
the molecular mechanisms that regulate trans-differentiation of fibroblasts in vascular
remodeling, wound healing, and tissue repair may elucidate therapeutic strategies for
treating diseases associated with persistent tissue remodeling. The phenotype of SMCs
and growth-activated fibroblasts correlates with the relative expression level of
contractile protein smooth muscle "-actin (SM"A). The gene encoding SM"A, ACTA2,
is regulated by a network of transcriptional activators and repressors. Purine-rich element
binding proteins A (Pur") and B (Pur!) are transcriptional repressors of the SM"A gene,
ACTA2, and have been implicated in regulation of stromal cell phenotype. The following
literature review will summarize experimental studies that have shaped our current
understanding of Pur proteins, their involvement in molecular pathways that regulate
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smooth muscle "-actin expression, and ultimately trans-differentiation of fibroblasts to
myofibroblasts. Elucidation of the molecular mechanisms that control myofibroblast
differentiation may have significant implications in human health and in the development
of therapeutic strategies for treating fibrotic disease.

1.1 TISSUE REPAIR AND FIBROSIS
Wound healing is a complex process that restores tissue continuity subsequent to
injury. Remodeling of connective tissue during normal wound healing involves a twostep process whereby fibroblasts acquire a contractile and reparative phenotype. Tissue
injury disrupts the composition and organization of the ECM in healthy tissues and
causes resident cells to experience a loss in stress shielding from environmental
mechanical tension (1, 2). The initial stage of wound healing, epithelialization, relies on
an increase in growth factors surrounding the site of injury and triggers local fibroblast
cells to migrate into the site of damaged tissue. Prior to injury, cells have very few actinassociated contacts with the ECM or other cells but activated fibroblasts acquire a
migratory phenotype during epithelialization and are characterized by de novo acquisition
of contractile bundles, stress fibers, and focal adhesions consisting of cytoplasmic actins
(3, 4). These activated fibroblasts have been termed proto-myofibroblasts (4). The second
step of wound healing involves the formation and contraction of granulation tissue.
Increased mechanical stress as a result of continued remodeling on the ECM triggers
proto-myofibroblasts to differentiate into myofibroblasts. This transition is marked by an
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increase in SM"A expression which enhances the contractility of myofibroblasts and
leads to the formation and contraction of granulation tissue (5). The final stage of wound
healing results in restoration of tissue continuity, minimization of wound size, and scar
formation. The scar is composed of connective tissue, ECM constituents, and blood
vessels deposited during tissue repair (6). After epithelialization occurs, myofibroblasts
undergo apoptosis resulting in diminished SM"A expression, lower myofibroblast
population, and a reduction of granulation tissue within the scar (7).
Although transient myofibroblast differentiation plays a critical role in restoration
of healthy connective tissue during wound healing, persistent myofibroblast activation
can lead to chronic pathological fibrosis. Continual myofibroblast contraction and
excessive secretion of ECM is referred to as “endless healing” (6). Endless healing leads
to serious pathologies associated with numerous fibrocontractive diseases that often result
in severe complications such as organ dysfunction or hypertrophic scarring. Hypertrophic
scarring is a consequence of deficiency in apoptotic removal of myofibroblasts and an
excessive build-up of collagen matrix. Tissue deformation in hypertrophic scarring is
common in healing burn wounds, fibrotic scleroderma, and Dupuytren’s disease (8).
Organ dysfunction of the heart (9, 10), kidney (11), or liver (12) can result from chronic
differentiation of myofibroblasts and excessive production of ECM proteins (9, 12, 13).
Severe airway myofibroblast remodeling in the lung, has been observed in idiopathic
pulmonary fibrosis, bronchopulmonary dysplasia, alveolar fibrosis, and interstitial
pneumonitis (14-17). Additionally, dysfunctional myofibroblast remodeling creates a
favorable microenvironment for epithelial tumor cells in a stromal reaction that enhances
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cancer progression (14, 15, 18, 19). Myofibroblasts have also been identified in vein graft
remodeling, coronary transplant, and systemic and pulmonary hypertension.
Vascular fibroblasts that acquire a myofibroblast-like phenotype play a significant
role in atherosclerotic plaque formation and persistent vascular remodeling (20). Fibrosis
within the arterial intima results in persistent secretion of cytokines and proteolytic
enzymes induced by inflammation. This negative remodeling is associated with highgrade stenosis in cardiovascular disease. Increased synthesis of SM"A, collagen matrix,
and stress fibers is likely to contribute to the pathological constrictive remodeling
associated with nonstented arteries. A porcine model revealed extensive proliferation of
adventitial fibroblasts and ECM production in response to a dissecting medial injury (2123). The origin of adventitial fibroblasts in vascular remodeling is widely debated.
Proliferating adventitial fibroblasts labeled with bromodeoxyuridine traced migration of
these cells from the adventitia to the media suggesting that these myofibroblast-like
adventitial cells have the ability to translocate from the site of origin and contribute to
vascular remodeling (21, 23). Although these results cannot exclude the possibility of
mislabeled medial SMCs, another study observed the migration of labeled perivascular
fibroblasts into the arterial intima following the introduction of a saphenous vein graft
(24). These results suggest that vascular fibroblasts have the capacity to differentiate into
myofibroblasts and participate in cellular remodeling of vessels.
In addition to fibroblasts, several reports indicate that there may be alternative
cellular precursors that modulate into myofibroblasts (25). Myofibroblast progenitor cells
including Hepatic Stellate Cells (HSCs) in liver fibrosis (12, 26, 27) and bone marrow
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(BM)-derived fibrocytes in kidney (9, 12, 25, 28), liver (12), and pulmonary fibrosis (17,
28, 29) are thought to be alternative sources for myofibroblast differentiation.
Additionally, cancer invasion depends on a stromal reaction that requires myofibroblast
formation from endothelial and epithelial cells (19). Importantly, myofibroblasts in blood
vessels may be derived from vascular SMCs. Of particular interest is the dedifferentiation
of medial SMCs to form myofibroblasts during the development of atherosclerotic
plaques and restenoic lesions (30). Medial SMCs, adventitial fibroblasts, and bonemarrow derived cells have all been implicated in the progression of atherosclerotic plaque
fibrosis (20, 31, 32). Chronic inflammation of the arterial intima results in accumulation
of inflammatory cells and ECM which triggers translocation of SMCs to the
atherosclerotic plaque (33). Recent studies have suggested that SMCs may dedifferentiate
to form myofibroblasts in response to the progression of coronary atherosclerotic and
restenoic lesion formation (30). During the progression of vascular disease, studies have
noted a decrease in markers of differentiated SMCs such as smoothelin and smooth
muscle myosin heavy chain in the media and intima of human coronary arteries while
retaining the common SM"A biomarker (34, 35). To date, myofibroblasts have been
detected in most fibrotic pathologies suggesting that they play a key role in disease
progression.

1.2 MYOFIBROBLASTS
Myofibroblasts were first identified in the granulation tissue of dermal wounds by
Gabbiani et al in 1971 (36). Electron microscopy images of granulation tissue detected a
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cell type with characteristics of both a SMC and fibroblast. Chemical and immunologic
experiments showed that fibroblasts at the site of wound healing have morphological
features of a contractile cell and generate a contractile apparatus composed of thick fibril
bundles. Due to the fibroblastic and SMC characteristics, this intermediate modified celltype was termed myofibroblast. Since their identification, myofibroblasts have been
identified in nearly all physiological conditions involving fibrosis and tissue remodeling
(12). They are essential for generating contractile force during wound healing and
pathological fibrosis.
Myofibroblasts are a unique cell type that form when fibroblasts or other
progenitor cells differentiate and acquire SMC-like features in response to tissue injury.
The myofibroblast is a phenotypically modulated cell type that exhibits properties of both
fibroblasts and SMCs (36). The contractile apparatus is a key morphological feature of
myofibroblasts and contains contractile proteins including non-muscle myosin and actin
microfilament bundles (37-39). The intracellular actin bundles are linked to extracellular
fibronectin fibrils through a fibronexus adhesion complex (37, 40, 41). The formation of
this mechano-transduction system allows for transmission of extracellular mechanical
effectors to influence intracellular signals. The force produced by intracellular stress
fibers is also transmitted to the ECM through this transduction system (37, 42, 43).
Notably, the contractile proteins expressed during the fibroblast to myofibroblast transdifferentiation reflect the phenotype of the cell. Phenotypic modulation of fibroblasts into
proto-myofibroblasts is characterized by the appearance of stress fibers consisting of
cytoplasmic !- and $-actin (4). These actin forms are absent in differentiated
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myofibroblasts and replaced by the SM"A containing stress fibers (44). Unlike SMCs,
myofibroblasts do not have a notable expression of smooth muscle myosin heavy chain,
desmin, h-caldesmon, and smoothelin. Although the identification of a single marker of
SMC and myofibroblast differentiation is impractical due to the diverse number of
pathways involved in differentiation, there is a direct correlation between SM"A
expression and the phenotype of myofibroblasts and SMCs (35).
Expression of SM"A in myofibroblasts is regulated by a combination of factors.
Although numerous serum growth factors including epidermal growth factor (EGF),
insulin, and platelet-derived growth factor (PDGF)-BB are associated with injuryactivation of SM"A expression, transforming growth factor !1 (TGF!1) is considered
the most critical activator of SM"A expression during proto-myofibroblast to
myofibroblast differentiation. Inflammatory cells at the site of injury release cytokines
which trigger resident cells to synthesize ED-A fibronectin (45) and ECM leading to
localized expression of active TGF!1 (4, 46). Cells at the site of injury secrete latent
TGF!1 (L-TGF!1) associated with a latency peptide (LAP) and form a complex with the
latent TGF!1 binding protein-1 (LTBP-1). TGF!1 becomes activated by proteases
released from resident epithelial cells, vascular endothelial cells, and immune cells that
have taken residence in the ECM. During this step, TGF!1 undergoes conformational
changes to take on an active form. Active TGF!1 binds to the transmembrane TGF!1
receptors and upregulates fibronectin and collagen expression (47). This critical step
results in de-repression of ACTA2 and activation of smooth muscle "-actin (SM"A)
expression.
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1.3 SMOOTH MUSCLE "-ACTIN
The mammalian actin family encompasses six isoforms of muscle and nonmuscle actin. Actin is a highly conserved eukaryotic protein that is 95% homologous with
sites of sequence variation localized to the last 10-20 amino acids of the N-terminal tail
(48). The SM"A isoform is a tissue-specific, muscle isoform that is ubiquitously
expressed in stromal cell types and plays an important role in the cytoskeletal network,
cell shape, cell differentiation, and mechanotransduction of biochemical signals (49-53).
SM"A was originally identified in smooth muscle cells and occupies nearly
40% of the total protein in vascular SMCs (54, 55). Sequence comparison of multiple
actin isoforms revealed a unique N-terminal sequence, Ac-EEED, of SM"A (48), which
led to the development of a monoclonal antibody that specifically recognizes the unique
N-terminal epitope of SM"A (56). This antibody provided a method for measuring
SM"A expression in granulation tissue. Since the development of this antibody, SM"A
has been identified as a key component of the cytoskeleton required for transmission of
contractile strength during SMC and myofibroblast differentiation in wound healing,
pathological organ fibrosis, and persistent vascular remodeling (57-60). Consequently,
SM"A is a prominent biomarker for myofibroblast differentiation.
Generation of a SM"A gene knockout mouse suggested that SM"A-null mice
have a normal survival rate and exhibit normal feeding and reproductive behaviors (61).
However, SM"A is essential for vessel dilation (61), establishing a migratory phenotype
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in myofibroblasts, and facilitating wound closure (4). Furthermore, the monoclonal
antibodies that recognize the N-terminal epitope of SM"A prevented polymerization of
SM"A (48, 62) and incubation of this peptide with fibroblast cells resulted in a decrease
in contractile tension exhibited by myofibroblasts in vitro (58).
The dynamic and tissue specific expression of SM"A results in phenotypic
modulation of myocytes (62), vascular SMCs, and myofibroblasts (63). A distinct
correlation between cellular phenotype of myofibroblasts and the level of SM"A
expression has prompted scientists to evaluate the regulatory mechanisms that control the
transcriptional regulation of SM"A gene expression.
!

1.4 TRANSCRIPTIONAL REGULATION OF THE SM"A GENE
Expression of the mammalian SM"A gene, ACTA2, is regulated by a complex
network of cis-elements and trans-acting factors that facilitate promoter activation and
repression. This intricate system involving numerous transcriptional regulatory proteins
and their cognate binding sites provide the molecular framework for efficient phenotypic
modulation of SM"A expression in stromal cell types (64). As stated previously,
activation of SM"A gene transcription is triggered by a key agonist TGF!1 that has been
activated by cytokines secreted by injured epithelial, endothelial, and immune cells that
have migrated to the site of inflammation. Biomechanical stress induced by wound
healing, ischemia, reperfusion and thrombosis, leads to de-repression of the ACTA2
promoter thereby triggering the TGF!1 auto-regulatory signaling pathway, SM"A
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expression, and myofibroblast differentiation (65). This section will review literature
pertaining to the regulatory proteins and the cognate binding sites involved in ACTA2
promoter activation and repression in myofibroblast cells with a focus on studies
pertaining to the purine-rich element binding protein (Pur) family of transcriptional
repressors.
Interaction of active TGF!1 with the receptor II kinase complex induces
phosphorylation of Smad2 and Smad3 transcription factors which associate with Smad4
and migrate from the cytosol into the nucleus where they interact with regulatory DNA
sequences and transcription factors to enhance ACTA2 expression (66, 67). The TGF!1dependent activation pathway also de-represses a 200 base pair (bp) region of the ACTA2
5’-flanking region by eliminating repressor-DNA interactions (68-70) and excluding
transcriptional repressor proteins from the nucleus. Sequence alignment studies have led
to the identification of cis-regulatory elements that are highly conserved in promoter
sequences of the human (71) and mouse (72) ACTA2 gene and contribute to activation of
ACTA2. The ACTA2 promoter contains numerous cis-regulatory elements that have been
identified within the 5’-flanking region of the ACTA2 gene. Most studies evaluating the
impact of these regulatory sequences on ACTA2 activation were performed in aortic
smooth muscle cells, AKR-2B mouse embryo fibroblast cells (MEFs), or BC3H1
myogenic cells. Cis-regulatory elements that were identified include the promoter
element (PE), bp -195 to -164, a TGF!-1 control element (TCE), bp -53 to -43, a TGF!-1
hypersensitivity region (THR), bp -176 to -145, CArG elements, bp -120 to -111 and -70
to -61, and an Sp1/3 binding sequence (SPUR), bp -59 to -28, and muscle-CAT (MCAT)
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enhancer elements, bp -319 to -313, -182 to -176, and +3491 to +3496. For a
diagrammatic view of the ACTA2 promoter, cis-elements, and associated transcription
factors see Figure 1-1. In particular, the SPUR, CArG, and MCAT elements are key
sequences for ACTA2 activation.
The SPUR element is located within the guanine and cytosine-rich TCE and THR
elements of the ACTA2 promoter and contributes to ACTA2 activation (73). Sp Kruppellike proteins are transcriptional activators of ACTA2 that interact with GC-rich
(GGGGCGGGG) or GT-rich (GGTGTGGGG) sequences through a zinc-finger domain
(74, 75). While both proteins activate ACTA2 expression, studies have identified
additional roles for Sp1 in regulation of TGF!1-associated transcription and repression of
smooth muscle myosin heavy chain (SM-MHC) and SM22" in fibroblasts (73, 76-78).
Therefore, the interaction of Sp1/3 with SPUR sequences encoded in the THR and TCE
elements of ACTA2 contribute to dedifferentiation of vascular SMCs and transdifferentiation of fibroblasts to myofibroblasts.
Multiple CArG elements, CC(A/T)6GG, are located within the 5’-flanking region
of the ACTA2 promoter but their involvement in activation of SM"A expression during
myofibroblast differentiation is currently under debate. Although several studies have
predicted minimal involvement (79), a recent study showed that a CArG element in the
first intron of the promoter activated SM"A expression in myofibroblasts (80). CArG
element sequences were formerly identified in the 5’-flanking region of the "-cardiac
actin promoter (81, 82). Similar sequences were also identified within other musclespecific genes and the serum response element (SRE) of early response genes including
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c-fos, skeletal "-actin, and SM"A after serum stimulation (83-86). Serum response factor
(SRF) activates the ACTA2 gene by interacting with CArG boxes, also referred to as the
serum response element (SRE). Activation of genes encoding CArG boxes requires
association of SRF with the coactivator, myocardin, the master regulator of SM"A gene
expression (45, 87). Serum stimulation triggers activation of SM"A gene expression by
prompting the translocation of cytoplasmic SRF into the nucleus where it forms a
nucleoprotein complex with myocardin and CArG elements and triggers SM"A gene
activation.
MCAT enhancer elements and their cognate transcriptional activator, TEF-1, play
a significant role in genetic regulation of muscle-specific genes. MCAT elements were
first identified in the chicken cardiac troponin T promoter and are muscle-specific (88).
Recent studies have shown that MCAT sequence elements are frequently located within
the promoter region of cardiac, skeletal, and smooth muscle genes (89). The consensus
sequence of the MCAT sequence element, 5’-CATTCCT-3’, was identified by selection
binding site assays (90). MCAT elements are specific binding sites for members of the
transcriptional enhancer factor family of activators (91, 92). The four members of the
TEF family, including TEF-1 (92), RTEF-1 (93-97), ETF (94, 98), and DTEF-1 (96, 99,
100), exhibit a conserved TEA DNA binding domain. TEF proteins preferentially bind
the double-stranded MCAT element and lack the capacity to bind to the ssDNA
conformation (101). The MCAT enhancer element is crucial for ACTA2 activation and
RTEF-1 and DTEF-1 are thought to be the dominant inducible activators of ACTA2 in
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!
Figure 1- 1. Transcriptional regulation of ACTA2 by a complex network of transcriptional
regulatory factors. Activation of the ACTA2 promoter is facilitated by assembly of
activator proteins on cis-regulatory elements proximal to the transcriptional start site.
ACTA2 expression is activated upon binding of Sp1/3 proteins to the THR and SPUR
(TCE) elements, association of multimeric SRF:myocardin complexes to CArG elements
and association of TEF-1 with the cryptic MCAT enhancer motif. ACTA2 repression is
facilitated by interaction of sequence-specific, ssDNA-binding proteins Pur", Pur!, and
MSY1 with repressor binding sites proximal to the MCAT enhancer motif. Pur protein
dimers may associate as homodimers or heterodimers of Pur" and Pur!. Pur proteins also
mediate repression by binding to Sp1/3 proteins at the SPUR site to diminish activation.
!
!
!
!
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myofibroblasts (102). Furthermore, the MCAT enhancer element is crucial for ACTA2
activation (101, 103).
The discovery of a cryptic MCAT enhancer element in ACTA2 led to the
identification of a repressor sequence immediately 3’ of the MCAT element. Initially, cell
based reporter gene assays were used to assess a 1.1 kb sequence located at the 5’flanking region of the transcription start site from the 13 kb ACTA2 gene (72). Sequence
comparisons and cell based assays with reporter constructs of the ACTA2 5’-flanking
region led to the detection of a 373-bp sequence that contained a promoter region
(between bp -150 and -191) in the 5’-flanking region of ACTA2 proximal to the
transcriptional start site. Original studies found that bp -191 and -150 contained sequence
elements that were required for transcriptional activation of ACTA2 (104, 105). These
studies also identified a 33-bp sequence (corresponding to bp -224 to -191) that plays a
role in repressing ACTA2 transcription. Deletion or replacement of this element with a
different sequence resulted in the enhancement of ACTA2 transcription in fibroblasts.
These data suggested that the 33-bp sequence contains a cis-acting negative control
element (104, 105). Interestingly, further analysis of this repressive sequence led to the
identification of an activation sequence, CATTCCT (corresponding to bp -181 to -175),
within the 3’ flanking region of this repressive element. The activation sequence had
previously been described as an inverted muscle-CAT (MCAT) activation element (68,
70).
Although two MCAT motifs were identified in the ACTA2 promoter (bp -182
through -176 and -320 through -314) and confirmed to govern ACTA2 activation, only the
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proximal MCAT element (bp -182 through -176) possessed the ability to repress and
activate ACTA2 (68, 103). Furthermore, Cogan et al evaluated the functional properties of
the proximal MCAT element and flanking repressor sequence by mutating nucleotides
within the purine-rich proximal MCAT enhancer element in the -195 to -164 bp region.
These mutations inhibited binding of RTEF-1 to the proximal MCAT enhancer element
confirming that the enhancer element is important for RTEF-1 mediated ACTA2
activation (68).
In addition to identifying the interaction between TEF-1 and the inverted MCAT
consensus sequence, Cogan et al identified two sequence-specific, ssDNA-binding
proteins, dubbed vascular actin single-stranded binding factors 1 and 2 (VACssBF1 and
VACssBF2), that interact with ssDNA sequence elements surrounding the MCAT
enhancer (68). Nucleotide mutations within the MCAT enhancer abolished (R)TEF-1
binding but had no effect on VACssBF protein binding. Moreover, mutations that
diminished VACssBF2 did not alter transcriptional activation of ACTA2 (68, 70, 102).
These results indicated that binding sites for VACssBF proteins are proximal to the TEF1 binding site and located within a unique asymmetric polypurine/polypyrimidine
(pur/pyr) tract. Deletion of the (pur/pyr) tract surrounding the MCAT enhancer resulted
in transcriptional activation of ACTA2 suggesting that pur/pyr sites confer transcriptional
repression (70). Mutational analysis of the TEF-1 binding site and proximal sequences
showed that VACssBF1 specifically interacts with the pyrimidine-rich strand while
VACssBF2 exhibited specificity for the purine-rich strand. These results indicated that
these trans-acting repressors may regulate transcriptional activation by altering the
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conformation of the MCAT enhancer region by stabilizing ssDNA conformation to
prevent binding of TEF-1, which specifically recognizes the double-stranded MCAT
motif.
Interaction of VACssBF1 and 2 with opposing strands of the double stranded
MCAT enhancer motif (-194 to -165) prevents binding of TEF-1. To establish a
biochemical basis for ssDNA site specificity and repressive capabilities of VACssBF1
and VACssBF2, studies by Kelm et al evaluated binding of VACssBF proteins to MCAT
enhancer elements located within a proximal element and a coding element of ACTA2
(106). An intragenic sequence located 3’ proximally to intron 2 in the coding element
(CE) of the ACTA2 gene encodes a GGAATG TEF-1 binding site identical to that found
in the promoter element (PE). Both VACssBF proteins and TEF-1 showed highly specific
interaction with the MCAT enhancer element located within the PE whereas only
VACssBF2 interacts with the purine-rich strand of the MCAT enhancer within the CE.
Cell-based promoter-reporter assays showed that substitution of the PE motif for the CE
led to repression of transcriptional activity. Mutations within the CE of the chimeric
promoter prevented VACssBF2 binding and de-repressed the promoter. Furthermore,
transcription was rescued upon introduction of VACssBF2 mutations. Together these
data suggested that VACssBF2 possesses ssDNA-binding activity independent of
VACssBF1 and that VACssBF2 may disrupt the dsDNA conformation of the MCAT
enhancer element to prevent binding of inducible activators. UV-crosslinking and
electrophoretic mobility assays revealed that VACssBF1 is composed of a single ~52
kDa polypeptide with specificity for the pyrimidine-rich strand of the repressor element.
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Evaluation of the molecular weight and DNA-binding site screening identified
VACssBF1 as MSY1 (mouse YB-1), a member of the Y-box family of DNA/RNAbinding proteins. Southwestern blots and electrophoretic mobility of VACssBF2, on the
other hand, displayed three molecular weight species consisting of a higher molecular
weight species at 115 kDa and a doublet with bands around 44 kDa and 46 kDa. These
results indicated that VACssBF2 consists of multiple peptides or is multimeric complex
of two different proteins. Finally, interaction of VACssBF2 with the CE represses the
transcriptional enhancer independent of VACssBF1 and the dsDNA transcriptional
activator. The VACssBF2 exon recognition element was used to screen a mouse lung
cDNA expression library. Two cDNA clones encoding purine rich element binding
proteins A (Pur") and B (Pur!) were isolated (107).
The human Y-box binding protein 1 (YB-1) and Pur" were originally identified
as transcriptional regulatory proteins in other cellular contexts. YB-1 is a DNA-binding
protein that interacts with the pyrimidine-rich strand of a Y-box sequence of the human
DRA promoter within the major histocompatibility complex II gene (108, 109). This
confirmed the observation that VACssBF1 exhibited a strong preference for pyrimidinerich DNA. Pur" (or HeLa Pur Factor) had been formerly identified as a protein that
bound to an origin of DNA replication in the 5’-flanking region of the c-myc gene in
HeLa cell nuclear extracts. This observation confirmed that Pur" specifically recognizes
purine-rich ssDNA. Pur!, on the other hand, had no aforementioned function (110).
Based on the data presented, it was predicted that recombinant Pur", Pur!, and
MSY-1 form multimers that specifically interact with the PE MCAT enhancer element to
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prevent interaction of TEF-1 with the MCAT enhancer. To test this, cell-based
transfection assays were carried out with promoter-reporter constructs containing
mutations that prevent binding of Pur", Pur!, or MSY1 to evaluate expression of the
reporter gene (101). This study revealed that deletion of nucleotides (111) -194 through 192 lead to a significant decrease in Pur protein binding and thereby reduced the effective
repression of the MCAT enhancer located in the PE of the ACTA2 promoter. These
results indicate that Pur" and Pur! have the capacity to prevent TEF-1 interaction with
the MCAT enhancer leading to repression of ACTA2 transcription.
Together these studies indicate that Pur protein mediated ACTA2 repression
requires the nucleoprotein assembly of ssDNA-binding repressors at the cryptic MCAT
enhancer motif to prevent ACTA2 activation by TEF-1. Pur" and Pur! interact with the
purine-rich sense strand of the MCAT element as either homo- or heterodimers while
MSY-1 binds to the pyrimidine-rich anti-sense strand of the MCAT element. The
ssDNA-binding repressors may facilitate strand separation of the duplex DNA as a
mechanism to deter TEF-1 binding since TEF-1 specifically binds dsDNA. A mutational
analysis was used to map nucleotides that mediate Pur protein binding within the cryptic
MCAT enhancer of ACTA2. Cell based promoter-reporter assays were carried out with
promoter-reporter constructs harboring mutations within the ACTA2 MCAT enhancer
sequence to identify mutations that are essential for Pur protein mediated repression. A
truncated construct, VSMP4 (spanning nts -191 to +48), exhibited unrestricted MCATdependent enhancer activity. However, extension of the 5’-flanking region through the
addition of just four nts (-195 to -192) was sufficient to reduce ACTA2 enhancer-
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promoter activity to basal levels indicating that the extended promoter created a better
binding site for repressors (101). Transient transfection assays with promoter-reporter
constructs TV187, TV189, and TV191 indicated that mutation of guanine nucleotides
upstream of the TEF-1 binding MCAT site led to de-repression of the ACTA2 promoterreporter constructs. Additionally, promoter constructs incorporating nucleotide mutations
3’ of the MCAT motif resulted in diminished repression. These results suggested that
there are distinct repressor binding sites located both 3’ and 5’ of the TEF-1 binding site
(68). To more accurately identify specific nts involved in nucleoprotein interaction,
synthetic oligonucleotides containing the same mutations were evaluated in direct
ssDNA-binding assays. Mutation of the sequence between -175 and -172, ACTG, directly
3’ of the MCAT enhancer element resulted in a significant increase in Pur protein
binding. Notably, Pur proteins bound an oligonucleotide encoding nts -196 to -164
(PE32-F) with the highest affinity. Oligonucleotides lacking key purine-rich elements
resulted in a significant loss in Pur protein ssDNA-binding affinity (112). These results
pointed to two sequence elements on the 5’-side, GGGAGC, and the 3’-side, GGAAGA,
of the core MCAT sequence that are essential for high affinity Pur protein interaction.
!
1.4.1 ALTERNATIVE MECHANISMS OF PUR PROTEIN TRANSCRIPTIONAL
REGULATION
In addition to Pur! repression of ACTA2 transcription through interactions with
the cryptic MCAT enhancer, the participation of Pur! in other ACTA2 regulatory
pathways has been noted. The ACTA2 activators, Sp1 and Sp3, interact with the THR
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element and the TCE binding site in the SPUR element to stimulate SM"A expression.
Conversely, interaction of Pur proteins with Sp1 bound to the TCE binding site generates
a nucleoprotein complex that restricts the ability of Sp1 to activate SM"A expression
(73, 76). During TGF!1 mediated ACTA2 activation, repressor proteins Pur" and Pur!
are released from the SPUR element. This de-repression releases the inhibitory complex
formed when Pur proteins interact with Sp1/Sp3 at the TCE element and activates ACTA2
expression in fibroblasts (73, 76).!Although these alternative mechanism of Pur proteindependent ACTA2 regulation will not be discussed at length in this literature review, it is
important to note that structural characterization of Pur" and Pur! will be essential for
understanding the structural elements in each protein that facilitate direct Pur repressor
interaction with specific trans-activators.

1.5 DIVERSE CELLULAR FUNCTIONS FOR PUR PROTEINS
The mammalian Pur protein family consists of four highly homologous proteins;
Pur", Pur!, Pur$A and Pur$B that interact with purine-rich ssDNA and RNA. The two
isoforms of Pur$ result from differences in polyadenylation (113). Although ubiquitously
expressed in metazoans, little is known about the function of the Pur$ isoforms (114).
Pur" is a ubiquitous regulatory factor that participates in numerous cellular processes
whereas Pur! appears to participate in specific regulatory tasks associated with
repression of the ACTA2 gene and modulation of cell differentiation. The functional
properties of Pur proteins in other cellular systems shape our understanding of Pur
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protein function and provide a foundation for evaluating Pur proteins in the context of
SM"A gene expression.

1.5.1 PUR PROTEIN INVOLVEMENT IN REPLICATION PATHWAYS
Human Pur" was originally identified in HeLa cells as a ssDNA-binding factor
that interacted with a purine-rich consensus sequence upstream of the c-myc promoter
during replication (110, 115). Due to the fact that Pur" exhibits specificity for purine-rich
sequences, the consensus binding sequence was originally termed the purine-rich (PUR)
element (110, 115). Competitive electrophoretic mobility assays pointed to a 24mer
ssDNA oligonucleotide derived from the replication origin of c-myc, MF0677 (5’GGAGGTGGTGGAGGGAGAGAAAAG-3’) that exhibited a band shift induced by the
presence of Pur". This Pur"-MF0677 interaction was confirmed by UV-irradiation
crosslinking studies that covalently linked Pur" to MF0677 in HeLa cell nuclear extracts.
Methylation of guanine residues or guanine to adenine mutations analyzed by
footprinting analyses detected guanine specific protein contacts between Pur" and
MF0677. (110). Screening of the GenBank nucleotide sequence database identified
numerous sequences from DNA replication zones homologous with the PUR element.
Specifically, a 16 nt sequence was conserved across 12 ori zone sequences from various
eukaryotic

organisms

and

termed

the

PUR

consensus

sequence

element

(GGNNGAGGGAGARRRR-3’, N is any nucleotide, R is A or G). These findings
suggested that Pur" may play a key role in initiation of DNA replication.
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In a follow up study, Bergmann et al analyzed the ability of Pur" to bind mutants
of the MF0677 oligonucleotide (110, 115). The effect of incremental substitution of
thymine nts for nts within MF0677 was evaluated using competitive binding reactions
resolved by gel shift assays. Competitive binding was retained in an oligonucleotide
(MH0677) that encoded the sequence, GGAGGG, while alteration of this sequence in
oligonucleotide ME0677 resulted in diminished binding capacity. These results suggest
that GGAGGG is the minimal sequence element required for Pur" ssDNA-binding.
Additionally, GGT repeats at the 5’-end of MF0677 appear to be important for protein
contact whereas adenine nts in the 3’-end of MF0677 (MC0677) have little effect on
nucleoprotein complex formation. These results were consistent with methylation
interference studies that pointed to the importance of guanine but not adenine nts in
ssDNA binding.
Pur" has also been reported to play a role in viral genome replication of the JC
polyoma virus (HJCV) as a regulator of the lytic cycle. Pur" and YB-1 exhibit opposing
functions to govern lysogeny of HJCV under the control of the JC tumor antigen. Bandshift assays evaluating binding of Pur", YB-1, and HJCV T-antigen (Tag) indicated that
interaction of Pur" with the viral lytic control element of the HJCV promoter activates
early gene transcription to sustain lysogeny (116). Conversely, YB-1 acts as an antagonist
of Pur" and disrupts the Pur":HJCV promoter nucleoprotein complex by binding to the
opposite strand of the cognate binding site facilitating expression of late genes triggering
the lytic cycle (117). Interestingly, the effect of Pur" binding is reversed in patients
infected with HIV. In this context, late transcriptional activation of the JCV Tat-
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responsive transcriptional control element is mediated by internalization of exogenous
Tat into oligodendroglia followed by association with Pur" (118, 119). Formation of a
Tat/Pur" complex allows for association of the complex with a Pur" binding site
(GGAGGCGGAGGC) within a Tat-responsive JCV element, upTAR (118, 119). This
synergistic activation of the JCV late genes stimulates viral replication without the coinfection of both HJCV and HIV-1 in cells (120, 121).
These studies suggest that Pur" participates in a variety of cellular contexts
involved in genomic replication. Pur" acts as a regulatory factor in these pathways not
only through direct interactions with DNA but also through protein-protein interaction.
Furthermore, initial studies identified a PUR consensus sequence, 5’-GGGAGA-3’,
within the MF0677 sequence that has become a standard oligonucleotide for testing Pur
protein ssDNA-binding (110, 115, 122-124). Although both Pur" and Pur! have the
capacity to interact with the PUR consensus sequence, the sequence only binds one mole
of Pur" or Pur!. As described earlier, the ACTA2-derived MCAT enhancer sequence,
PE32-F, contains two flanking sequences that are essential for high-affinity Pur! ssDNAbinding (112). Both Pur protein binding sites of PE32-F resemble the single consensus
sequence identified in c-myc. These studies indicate that a single PUR consensus site is
sufficient to trigger c-myc replication, but transcriptional repression of the cryptic MCAT
enhancer may require the binding of two Pur proteins to prohibit interaction of TEF-1. A
recent study by Ramsey et al. validated this supposition by reporting that two Pur!
monomers interact with PE32-F in a cooperative manner forming a 2:1 Pur!:PE32-F
nucleoprotein complex with high-affinity (125). Therefore, although the PUR consensus
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element is employed as a standard for evaluating Pur protein binding, in the context of
ACTA2 transcriptional regulation, PE32-F is a more suitable ssDNA probe for testing Pur
protein interaction with the MCAT enhancer region of ACTA2.

1.5.2 PUR PROTEIN INVOLVEMENT IN TRANSCRIPTIONAL REGULATION
Pur" is key transcriptional regulatory factor for many genes. In addition to acting
as a repressor of ACTA2 transcription, the involvement of Pur" in the transcriptional
repression of somatostatin ssCRE and "-myosin has been noted. Additionally, Pur"
participates in regulatory pathways of transcriptional activation. During neuronal
development, Pur" regulates the expression of the myelin basic protein (MBP) gene in
glial cells (126). The proximal promoter of the MBP gene contains a Pur" GC/GA-rich
binding site (dubbed MB1) that is required for Pur" mediated transcriptional activation
of MBP expression (127-130). The expression of MBP varies with different stages of
brain development (129, 130).
The involvement of Pur proteins in regulation of replication and transcription
brings to question the mechanism by which Pur proteins access cognate binding sites. Pur
proteins are sequence-specific transcriptional regulators that preferentially bind singlestranded nucleic acid. Presumably, Pur proteins would have a low affinity for the
supercoiled and duplex genome. Despite the apparent inconsistency between Pur protein
sequence specificity and the duplex conformation of the genome, they achieve access to
ssDNA and regulate gene promoter sequences. Two mechanisms have been proposed that

24

would allow Pur proteins to access the duplex genome (65, 124, 131). First, natural
perturbations within the DNA duplex may be facilitated by non-B-form DNA structures
or other transcription factors that facilitate localized dsDNA melting. The formation of
secondary structure in nucleic acids is common at transcriptionally active sites. Non-Bform duplex DNA structures such as Z-DNA, G-quadruplexes, and cruciforms are
frequently identified within gene promoter regions (132, 133). In fact, Strauch et al.
proposed a cruciform stem-loop structure for the MCAT/THR cis-elements of the ACTA2
promoter (65). Additionally, non B-form DNA secondary structures are commonly
identified in asymmetric duplex DNA sequences such as the pur/pyr asymmetry
surrounding the cryptic MCAT enhancer motif (134, 135). Pur proteins exhibit a
preference for purine-rich stretches of ssDNA supporting the idea that localized melting
of complementary strands of genomic DNA may contribute to Pur protein induced helix
destabilization.
The second mechanism that has been proposed for Pur protein helix
destabilization is one by which Pur proteins facilitate duplex DNA unwinding. In support
of this hypothesis, multiple studies have reported interaction of Pur" with dsDNA
probes. A report by Wortman et al. indicated that Pur" has the ability to unwind DNA
duplexes of various lengths in an ATP independent manner (124). The interaction of
Pur" with supercoiled pUC19 plasmids produced distinct bands indicative of unwinding
of the DNA duplex (124, 131). The banding pattern observed in these electrophoretic
mobility shift assays (EMSAs) was comparable to that achieved after treatment of
supercoiled plasmids with topoisomerases. A similar pattern was observed when
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experiments were performed with a pUC19 plasmid containing the c-myc-associated
replication origin. These results indicate that interaction of Pur" with the pUC19 plasmid
may lead to an increase in twist or writhe to facilitate DNA backbone opening around the
Pur" binding site.

1.5.3 PUR PROTEIN INVOLVEMENT IN PROTEIN-PROTEIN
INTERACTIONS
Pur" also participates in protein-protein interactions that are critical for gene
replication and transcription. As mentioned previously, interaction between the HJCV Tantigen and Pur" regulates lytic cycle gene expression. Furthermore, the HIV-1 Tat
protein interacts with Pur" to facilitate JCV late gene activation (119, 136). Pur" also
plays a critical role in cell cycle control by forming protein-protein complexes with key
cell cycle regulatory proteins. Overexpression of Pur" in an NIH-3T3 cell line arrests the
cell cycle at the G1/S check point phases (137). Pur" has been shown to interact with the
retinoblastoma protein (pRb) tumor suppressor via a psycho motif located in the Cterminus of Pur" (115, 138).
In addition, the formation of transcriptional repressor complexes at sequences
composed of GGN repeats (N is any nucleotide) often depends on protein-protein
interactions between multiple transcription factors including Pur" and Pur!. For
example, a multimeric complex of Pur!, Pur", and Sp3 has been shown to repress !myosin heavy chain (!MyHC) expression in skeletal muscle (139). Formation of
multimeric protein complexes as a mode for controlling intracellular processes is distinct
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from other modes of genomic regulation since it does not require the association of Pur
proteins with cis-regulatory elements. This indicates that Pur proteins possess structural
elements that mediate protein-protein interaction as well as ssDNA-binding to specific
sequences within genomic DNA. Furthermore, recent studies indicate that Pur! possesses
the capability to reversibly self-associate in the absence of nucleic acid and to assemble
onto the MCAT enhancer motif of the ACTA2 gene via a cooperative binding mechanism
(125).

1.5.4 PUR PROTEIN INVOLVEMENT IN mRNA TRANSPORT
Pur proteins have been documented to interact with specific mRNAs as a
mechanism for regulating expression of mRNA transcripts at a translational level. Both
Pur" and Pur! have been reported to repress the cytoplasmic translation of the mRNA
transcript encoding cardiac "-myosin heavy chain ("-MHC) (140, 141). Pur proteins
also interact with other mRNA targets to facilitate translational regulation, nuclear
export, and cytoplasmic transfer involved in neuronal development (142).
Neuronal development requires transport of RNA:protein complexes (RNPs)
along dendritic microtubules for localized translation of mRNAs. Several RNA
transcripts including microtubule associated protein (MAP) and RNA polymerase IIItranscribed RNA (BC1 RNA) have been identified in the neuronal postsynaptic
compartments. Both Pur" and Pur! have been identified in nucleoprotein complex with
BC1 RNA as BC1 RNP and act as a connection between BC1 RNA and the microtubule
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that transports the complex and distributes it throughout neuronal dendrites (143). A Pur"
deficient transgenic mouse (PURA-/-) generated by inactivation of the PURA gene led to
the defective brain development and perinatal lethality (142). The neurological
complications associated with abolishment of Pur" expression are likely to be associated
with the lack of Pur" available to transport mRNA to developing dendrites.
As described above, Pur proteins participate in numerous cellular processes
including replication, transcriptional regulation, multi-protein complex formation, and
mRNA binding to regulate at the translational level as well as transport of mRNA
transcripts. Despite ~70% identity between Pur" and Pur!, Pur" appears to be
considerably more ubiquitous and contribute to numerous cellular pathways. The role of
the Pur! isoform, on the other hand, is as a dominant repressor of ACTA2 and other genes
encoding muscle-specific isoforms of actin and myosin.

1.6 STRUCTURAL CHARACTERIZATION OF PUR PROTEINS
Until recently, published data on the structural make-up of Pur! was limited to
the primary sequence, secondary structural predictions, and quaternary structure (107,
144, 145). This section will review the structural characteristics of Pur proteins identified
in early studies and elaborate on recent developments that inform our current
understanding of Pur protein structure and function. Finally, differences between the Pur
isoforms and limitations of the current data on Pur protein structure will be discussed.
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1.6.1 PRIMARY STRUCTURE OF PUR PROTEINS
A clone of Pur" was isolated and the primary sequence was determined by
Bergmann et al (110). These experiments suggested that the cDNA-deduced amino acid
sequence of Pur" was unique in comparison to all other proteins that had been sequenced
at that time. To date, the primary sequences of Pur proteins from numerous organisms
have been identified by gene cloning and DNA sequence analysis. Alignment of the
primary amino acid sequence of Pur! and Pur" from various vertebrate species reveals a
high sequence homology across organisms (Figure 1-2). The high homology across Pur
proteins indicates that Pur" and Pur! probably share a common ancestral gene that
underwent duplication and divergence resulting in the existence of Pur protein paralogs.
Mouse Pur" and Pur! are approximately 70% identical due to the high sequence
conservation of the central core region of each protein are essential for Pur protein
function. The presence of glycine-rich amino acid sequences within the central modular
region and near the C-terminus are unique features of the Pur! paralog. Polyglycine
sequences have been implicated in helix destabilization of other DNA-binding proteins
such as FBP in the c-myc promoter (146). Consequently, these glycine-rich stretches may
impart unique functional properties to Pur!. The Pur protein sequence is composed of a
modular central domain surrounded by glycine-rich N- and C-termini. The central region
is highly conserved in all Pur paralogs and is made up of alternating sequence motifs that
fall into one of two classes and possess a high level of sequence homology. Class one
repeats are made up of basic and aromatic amino acid residues (mostly Phe and Tyr). On
the other hand, class II repeats consist of amino acid stretches rich in leucine and acidic
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amino acids (Figure 1-3). This modular distribution of amino acids has led to the
prediction that basic amino acids in the class I motif may mediate electrostatic
interactions with the negatively charged phosphate backbone of nucleic acids and
aromatic residues might participate in base-stacking interactions. Additionally, a unique
sequence, dubbed the psycho motif, is located at the C-terminal end of the central domain
and is composed of Pro-Ser-Tyr with a downstream Cys residue (138). The psycho motif
is similar to sequence motifs found in cell cycle regulatory proteins and mediates
interaction with the transcription factors pRb and E2F-1 and the large T-antigen of the
simian virus 40 (SV40) (122, 131). It was suggested that this psycho motif might form an
amphipathic helix (110). The psycho motif is essential for Pur" interaction with pRb
(122). Finally, the C-termini of Pur" and Pur! are markedly different. The Pur! Cterminus is rich in glutamate (E) and glycine (G) residues but the Pur" C-terminus
contains a polyglutamine (Q) sequence that replaces glycine residues found in Pur!.
A collection of data from multiple studies evaluating the effect of Pur protein
deletion mutants on single-stranded nucleic acid binding provides insight into the
function of Pur protein sequence elements and their role in sequence-specific ssDNAbinding to purine nts. The core region of human Pur" containing all Pur repeats (amino
acids 65-191) is critical for association with the c-myc origin of replication (124), the
HJCV control element (116), the MBP promoter sequence (130), and somatostatin and
tyrosine hydroxylase cAMP response elements (CREs)
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Figure 1- 2. Primary sequence alignment of Pur" and Pur! from different species.
Alignment of the primary sequence of Homo sapiens (Human), Mus musculus (Mouse),
Rattus norvegicus (Rat), and Drosophila melanogaster (Fruit Fly) Pur" and Pur!. Amino
acid sequences were aligned and obtained using the UniProt database (147). The three
regions of high sequence homology (dark gray) are separated by amino acid stretches of
low sequence conservation (light grey).
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!
Figure 1- 3.The primary structure of Pur" and Pur! is composed of three PUR repeats
flanked by N- and C-terminal tails. Both PUR repeat I and PUR repeat II consist of one
module composed of basic and aromatic amino acid residues (dark blue) and a portion of
the module containing leucine and acidic amino acid residues (dark red). Instead of an
acidic/leucine-rich module (red), the PUR III repeat contains a psycho motif (purple).
The Pur! sequence contains intervening glycine-rich sequences that are not found in
Pur".!
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!
(148). Deletion of the C-terminal tail of Pur" (amino acids (aa) 215-322) impairs dsDNA
binding (124). In addition, elimination of the C-terminus (aa 264-324) of Pur! diminishes
the capacity of Pur! to repress activation of an ACTA2-derived MCAT enhancer element
(149) and prevents protein-protein interactions of Pur! with Pur" and co-repressor
MSY1 (69). These results suggest that the core sequence of Pur proteins is essential for
interaction with nucleic acids and the C-terminal tail plays a regulatory role in DNA
binding.
More recently, an x-ray crystal structure of Drosophila melanogaster (61) Pur"
amino acids 40 through 185 prompted re-evaluation of the original domain assignments
and the proposal of a new scheme to identify modular sequence elements in Pur proteins
based on the PUR domains delineated by the crystal structure. In this schematic, the
central sequence is composed of three PUR repeats. PUR repeats I and II are each
composed of one class I repeat and a segment of one class II module while Pur repeat III
consists of one class I module and the psycho motif (150).

1.6.2 SECONDARY STRUCTURE OF PUR PROTEINS
In the absence of higher order structural data, predictions regarding Pur protein
secondary structural elements were made using protein structure prediction webservers
(151). These programs were used to determine the propensity of protein sequences to
form secondary structural elements such as "-helix, !-strand, random coil, or other
secondary structural elements. Based on the sequence of Pur!, programs predicted that
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each PUR repeat consists of three or four !-sheets and one "-helix (Figure 1-4). The
PUR III repeat containing the psycho motif is predicted to encode an extended " -helix.
A recently solved x-ray crystal structure of Dm Pur" residues 40-185 confirmed these
secondary structural predictions for the first two PUR repeats (150). The structure
revealed that each PUR repeat consists of a C-terminal "-helix and four-antiparallel !sheets. PUR repeats I and II are linked by a short random coil and form a PUR
subdomain with a !!!!"-!!!!" topology. The high resolution structure of the PUR
repeat III has yet to be established.

1.6.3 TERTIARY STRUCTURE OF PUR PROTEINS
For many years, the tertiary structure of Pur proteins was limited to speculation
based on the primary sequence.! Graebsch et al. sought to identify the key sequences
elements conserved in Pur" proteins (150, 152). Using homology detection, they
identified a bacterial protein that consisted of a single PUR repeat, which self-associated
with another PUR repeat to form an intermolecular PUR domain (152). The recently
solved x-ray crystal structure of Dm Pur" residues 40-185 spanning PUR repeats I and II
constituted a monomeric PUR subdomain (150). The structure revealed that PUR repeats
I and II interact to form a PUR subdomain with each PUR repeat consisting of a Cterminal alpha helix and four antiparallel !-strands. PUR repeats I and II are linked by a
short random coil and form a PUR subdomain with a !!!!"-!!!!" topology that fold
with

34

Figure 1- 4. Secondary structural predictions based on the Pur! amino acid sequence
indicate a repetitive sequence of !-strands (yellow arrow) and "-helices (pink) separated
by a random coil (black line). The secondary structural predictions were obtained using
PsiPred (151). The mouse Pur! sequence was obtained from UniProt (147).
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hydrophobic residues buried at the interface between the two PUR repeats. A surface
conservation plot of Pur" I-II indicates a high level of conservation localized around the
!-sheet side while the "-helix side was void of conserved residues. Additionally,
electrostatic surface maps revealed localization of positively charged residues around the
!-sheets, whereas the "-helices displayed a slightly negative charge. The regions of
positively charged residues represent potential binding sites for negatively charged
nucleic acids. Pur" I-II retained the ability to associate with the PUR consensus element
(150).
The PUR domain is structurally homologous to the whirly-class nucleic-acid
binding fold. Other whirly-domain containing proteins with the !!!!"-!!!!" topology
include RNA-binding proteins, mitochondrial RNA-binding protein (MRP)-2 and MRP-1
(153), and a DNA-binding protein, P24 (154). Superposition of whirly domains from
Pur" with those from P24, MRP-1 and -2, revealed a common overall topology. The
PUR whirly-like domains exhibited longer random coil loop regions and a slightly tilted
!-sheet orientation relative to MRP2. Although most whirly domain-containing proteins
exhibit a tetrameric quaternary structure whereby protein-protein contacts form between
"-helices, no protein-protein contact was observed in the Pur" I-II crystal lattice (150).

1.6.4 QUATERNARY STRUCTURE OF PUR PROTEINS
The quaternary structure of Pur! has been elucidated by hydrodynamic and
thermodynamic techniques. To evaluate the quaternary structure of solution-phase
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recombinant Pur!, Ramsey et al. used dynamic light scattering coupled to size exclusion
chromatography (SEC) to show that Pur! has the capacity to self-associate and form a
concentration dependent homodimer in the absence of nucleic acid (145). Dynamic light
scattering experiments and resolution of the hydrodynamic radius indicated that Pur!
takes on an asymmetric, non-spherical shape. Further results using analytical
ultracentrifugation showed that Pur!, free of nucleic acid, exists in a reversible
equilibrium between the monomeric and dimeric state with a dissociation constant of ~1
µM. The concentration dependent reversible nature of Pur! dimerization may play a
significant role in nucleic acid binding and ultimately modulation of ACTA2 expression.
Further studies analyzing the mechanism and energetics involved in Pur!
assembly on the purine-rich strand of the cryptic MCAT enhancer element of the ACTA2
promoter revealed the formation of a high affinity nucleoprotein complex with a 2:1
(Pur!:PE32-F) stoichiometry (125). Results of quantitative band shift and DNase I
footprinting assays were consistent with a model in which Pur! monomers interact in a
sequential and cooperative manner with two non-identical sites to form the 2:1
protein:ssDNA complex. The apparent affinity of the Pur! for PE32-F was determined to
be approximately 0.3 nM.

1.6.5 POINT MUTATIONS OF INDIVIDUAL PUR PROTEIN AMINO ACIDS
Several studies have identified amino acid residues in the Pur proteins that
mediate nucleoprotein interaction. An initial study by Wortman et al. identified point
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mutations that significantly diminished ssDNA binding in mouse and human Pur" (124).
Mutation of basic residues in the PUR I-II subdomain of Pur", R71E and R110E, greatly
diminished Pur" ssDNA-binding. Knapp et al. generated the corresponding mutations in
the Pur! isoform and evaluated the effect of these mutations on repression of ACTA2,
functional ssDNA-binding, and protein folding (144). Although these mutations
generated a Pur! protein defective in ssDNA interaction, the mutations also resulted in
destabilization of the secondary, tertiary, and quaternary structure of Pur!. Studies
revealed the formation of oligomeric complexes with a lower percent of helical secondary
structural elements suggesting that the loss in nucleic acid binding was likely due to a
loss in structural stability.
As stated above, Pur proteins play a role in nuclear RNA export and formation of
mRNP transport granules in neuronal cells. A recent study by Aumiller et al. evaluated
the localization of Dm Pur" during oogenesis, a cellular process that requires transport of
mRNP granules (142). Co-immunoprecipitation experiments showed that Pur" interacts
with many different RNAs and plays an important role in oocyte mRNA transport
between the nucleus and cytoplasm via the oocyte mRNA transport system. In addition,
this study identified three amino acids in Pur" that are critical for mRNA binding.
Mutation of residues R80A/R158A/R229A abolished single-stranded nucleic acid
binding but did not impact conformational stability or dimerization of Pur". These results
suggested that amino acid residues R80, R158, and R229 are critical for contacting
single-stranded nucleic acids and forming a nucleoprotein complex in the context of
mRNP formation.
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In summary, the level of SM"A expression directly correlates with myofibroblast
phenotype and modulation of myofibroblast differentiation. Pur! is the dominant
transcriptional repressor of SM"A expression in muscle-specific cell types. Therefore,
elucidation of the mechanism by which Pur! associates with the purine-rich strand of the
MCAT enhancer element of ACTA2 is essential for understanding the factors that govern
SM"A expression. Determination of a structural basis for ssDNA-binding of Pur! to the
MCAT enhancer may point to potential therapeutic strategies for treating fibrotic disease.
Although Pur" and Pur! possess 70% sequence identity, numerous studies
indicate that these Pur protein isoforms exhibit distinct functional properties. First, Pur"
is ubiquitously involved in replication, transcriptional repression, transcriptional
activation, formation of multimeric protein complexes, and mRNA transport, whereas
Pur! is almost exclusively involved in transcriptional repression of muscle-related genes.
Furthermore, dimerization of two Pur" monomers requires an RNA molecule (155) while
self-association of Pur! monomers occurs in the absence of nucleic acid (145). This
mechanistic difference in Pur protein self-assembly may be due to the fact that Pur! and
Pur" have distinct functional properties. In addition, Pur! has been identified as the
dominant repressor of ACTA2 activation in myofibroblasts, vascular SMCs, and
cardiomyocytes (112, 144). The expression of Pur! and Pur$ in the Pur" knockout mouse
(PURA-/-) did not rescue postnatal brain development (156). These observations along
with Pur protein gain-of-function studies indicating that structural and functional
characteristics are not equivalent in all Pur paralogs (112, 149) point to key structural and
functional differences between the Pur! and Pur" homologs. These studies highlight the
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importance of studying the independent structural features associated with each Pur
protein.
Duplex DNA helix destabilization resulting in the formation of locally unwound
ssDNA sites in asymmetric pur/pyr tracts in the 5’-ACTA2 promoter has warranted
investigation into the ssDNA-binding mechanism of Pur proteins (157). Nucleoprotein
complex formation at PUR elements has identified both homo- and heterodimers of Pur
proteins (69). Recent studies have indicated that Pur! employs a cooperative binding
mechanism to interact with the MCAT enhancer motif. The elements that facilitate Pur
proteins nucleoprotein complex formation with the PUR elements require further
investigation. In this study, we establish a structural basis for Pur! mediated ACTA2
repression and cooperative ssDNA-binding to the ACTA2-derived MCAT enhancer
element sequence.
Pur! plays an important role in regulation of ACTA2 gene transcription. Higher
order structural data regarding the organization of Pur! is limited to the primary
sequence, secondary structure predictions, and quaternary structure. Herein, we have
evaluated the structural elements of Pur! that confer site-specific ssDNA-binding to the
cryptic MCAT enhancer motif. The first aim was to characterize the physical and
functional roles of the intra- and intermolecular domains of Pur! in ACTA2 repression
and site-specific ssDNA-binding. As a second aim, we sought to identify amino acid
residues that confer specificity and high-affinity binding of Pur! to ssDNA target sites
within the ACTA2 promoter. We propose that Pur! is composed of a core ssDNA-binding
domain with a tripartite organization that forms intra- and intermolecular subdomains that
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mediate nucleoprotein formation and facilitate ACTA2 repression. Furthermore, we have
found that these subdomains contain basic amino acid residues that mediate ACTA2
repression in MEFs. The elucidation of structural elements that facilitate nucleoprotein
complex formation between Pur! and the MCAT enhancer sequences will improve our
understanding of the structural mechanism by which Pur! mediates SM"A gene
repression. These findings may have therapeutic implications for regulating
myofibroblast phenotype and fibrotic disease.
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ABSTRACT
Pur! is a single-stranded nucleic acid-binding protein implicated in the injuryinduced repression of genes encoding certain muscle-restricted isoforms of actin and
myosin expressed in the heart, skeletal muscle, and vasculature. To better understand
how the modular arrangement of the primary sequence of Pur! affects the higher order
structure and function of the protein, purified recombinant Pur! was subjected to partial
proteolysis in an attempt to identify a well-folded truncation protein that retained purinerich single-stranded DNA-binding activity. Limited tryptic digestion of Pur! liberated a
core ~30 kDa fragment corresponding to residues 29-305 as determined by epitope
mapping and mass spectrometry. Size exclusion chromatography indicated that the
isolated core fragment retains the ability to self-associate while circular dichroism
analysis confirmed that the Pur! core domain is stably folded in the absence of glycinerich N- and C-terminal sequences. Comparative DNA-binding assays revealed that the
isolated core domain interacts with purine-rich cis-elements from the smooth muscle "actin gene with similar specificity but increased affinity compared to full-length Pur!.
These findings suggest that the highly conserved modular repeats of Pur! fold to form a
core functional domain, which mediates the specific and high affinity binding of the
protein to single-stranded DNA.
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INTRODUCTION
Purine-rich element binding protein B (Pur!) is a member of a small but highly
conserved family of nucleic acid-binding proteins whose signature biochemical feature is
preferential interaction with purine-rich single-stranded DNA (ssDNA) or RNA
sequences (1). The founding and most widely studied member of this family, Pur", is
involved in many aspects of nucleic acid homeostasis including the regulation of DNA
replication, DNA repair, gene transcription, RNA transport, and mRNA translation (2,3).
With respect to gene expression, an ensemble of reports have implicated both Pur" and
Pur! in the repression of genes encoding smooth, cardiac, and skeletal muscle-associated
isoforms of actin and/or myosin in stress-activated fibroblasts, smooth muscle cells,
cardiomyocytes, and skeletal myoblasts (4-7). The key biochemical finding shared by
these muscle-related studies is the sequence- and strand-specific interaction of Pur" and
Pur! with GGN repeat-containing cis-elements. In the case of the gene encoding smooth
muscle "-actin (SM"A), Pur" and Pur! appear to repress transcription by ssDNAbinding and protein-protein interaction mechanisms that limit access of trans-activators
to canonical double-stranded DNA (dsDNA) target sites in the SM"A 5´-flanking region
(4,5,8).
Despite the fact that Pur" and Pur! are highly homologous (9) and exhibit
comparable ssDNA-binding properties in vitro (10), these proteins are not entirely
redundant in terms of their transcriptional regulatory properties toward specific muscle
genes in different cell types. For example, Pur! displays substantially more repressor
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activity toward the SM"A promoter than Pur" when over-expressed in cultured vascular
smooth

muscle

cells

(11).

Moreover,

gene

knockdown

and

chromatin

immunoprecipitation analyses have pointed to endogenously-expressed Pur! as the more
crucial player in SM"A gene repression in mouse embryonic fibroblasts (12,13). A
unique role for Pur! in actin and myosin isoform class switching has also been suggested
in the context of cardiac transplant remodeling, heart failure, and skeletal muscle
performance (14-16). Biochemical explanations for the seemingly dominant repressor
activity of Pur! have included its preferred binding to certain trans-activators (12) and its
ability to interact cooperatively with multiple ssDNA-binding sites (17).
Published data on the molecular architecture of Pur! is currently limited to aspects of
primary, secondary, and quaternary structure (9,13,18). The primary sequence of Pur! is
characterized by alternating basic/aromatic class I and acidic/leucine-rich class II
modules which are highly conserved in Pur" (9) and all other known members of the Pur
protein family in mammals (1,3). The recently solved x-ray crystal structure of residues
40 to 185 of Drosophila melanogaster (56) Pur" has revealed that the first and second
class I and II modules fold into two homologous PUR repeats each with !!!!" topology
(19). Moreover, intramolecular interaction between the "-helices of the two PUR repeats
forms a ssDNA-binding domain resembling the Whirly class of nucleic acid-binding
proteins (19). The case for Pur! adopting a similar core structure is supported by
sequence homology (9) and site-directed mutagenesis studies indicating that certain
amino acids within this region are critical to the conformational stability and functional
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activity of the protein (13). However, Pur! does possess some unique features including
two internal glycine/proline-rich stretches, which interrupt the second PUR repeat, and
other distinguishing sequence elements near the N- or C-terminal regions of the protein,
which may serve to modulate its ssDNA-binding function (10,11). In this study, we
utilized limited proteolysis to probe the structure of recombinant mouse Pur! in solution
and to identify a well-folded core domain that mediates specific and high affinity binding
of Pur! to ssDNA.
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MATERIAL AND METHODS
Recombinant Pur! purification. Full-length mouse Pur! was expressed in E. coli as
an N-terminal 6%His-tagged fusion protein and purified by metal chelate affinity and
calibrated size exclusion chromatography (SEC) (18). Protein purity was assessed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing
conditions and staining with Coomassie& Brilliant Blue R-250. Absence of nucleic acid
in NHis-Pur! preparations was confirmed by determining the A260/A280 ratio. Protein
concentration was calculated based on theoretical molar extinction coefficient for NHisPur! at 280 nm of 20,400 M 1 cm 1.
#

#

Proteolytic resistance assay. Limited digestion reactions were initiated by the
addition of either sequencing- or proteomics-grade trypsin (Roche Applied Science or
Sigma-Aldrich) to 3.0 or 5.0 µM solutions of NHis-Pur! at 4°C in buffer consisting of 50
mM sodium phosphate pH 7.5, 300 mM NaCl, 0.5 mM EDTA, and 10 mM !mercaptoethanol (!-ME). Pur! to enzyme mass ratios were tested at 10:1 and 25:1.
Aliquots were removed at 0, 15, 30, 60, 90, or 120 min time points, supplemented with
1% w/v SDS and 5% v/v !-ME, and heated at 95oC for 5 min. Protein fragments were
separated by SDS-PAGE (12% or 10% mini-gel) and visualized by Coomassie& Brilliant
Blue R-250 staining. Alternatively, fragments were transferred to a polyvinylidine
fluoride (PVDF) membrane (Immobilon'-P, Millipore) and probed with polyclonal
antibodies against selected Pur! sequences (4), a monoclonal antibody against the Nterminal RGS(H)6 tag (Qiagen), or biotinylated ssDNA (Supplementary Methods).
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Prestained markers (New England Biolabs or Invitrogen) were used as molecular weight
standards on western and southwestern blots. Wide range SigmaMarker' standards
(Sigma-Aldrich) were used on stained gels.
Purification of the Pur! core tryptic fragment. A 1 mg/ml solution of NHis-Pur!
was combined with proteomics grade trypsin at a protein to enzyme ratio of 500:1. After
incubating for 6 h on ice, N"-tosyl-lysine-chloromethylketone and benzamidine were
sequentially added to a final concentration of 0.1 mM and 10 mM, respectively. Insoluble
material was removed by centrifugation at 2,500 % g for 5 min and the soluble digest was
applied to a small column packed with ~2 ml heparin-agarose (Sigma-Aldrich)
equilibrated with 20 mM Tris-Cl pH 7.4, 300 mM NaCl, 0.5 mM EDTA, 0.1 mM
benzamidine, 0.1 mM phenylmethanesulfonylfluoride, and 10 mM !-ME. Bound protein
was eluted by applying a linear gradient of 0.3 M to 2.0 M NaCl in column equilibration
buffer. Individual fractions were analyzed by SDS-PAGE to identify those enriched in
the core fragment. The concentration of the core fragment in pooled fractions was
calculated assuming a molar extinction coefficient at 280 nm of 20,400 M 1 cm 1.
#

#

Circular dichroism spectroscopy. Purified NHis-Pur! or the core fragment were
dialyzed into buffers consisting of 10 mM Tris-Cl pH 7.5, 150 mM NaCl, 0.5 mM
EDTA, 0.5 mM DTT or 50 mM Tris-Cl pH 7.5, 300 mM NaCl, 0.5 mM EDTA, 0.5 mM
TCEP. Data were collected on a Jasco model 815 spectrometer using a 1 mm cuvette at
25ºC. Multiple wavelength scans (typically 8) were collected between 260 and 195 or
197 nm at 1 nm intervals. Recorded CD spectra in millidegrees were averaged, corrected
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for buffer, and then converted into mean residue ellipticity in deg cm2 dmol 1 using the
#

formula,
[!] = !obs / (c · l · n)
in which !obs is observed ellipticity in millidegrees, c is the molar protein concentration, l
is the path length of the cuvette in millimeters, and n corresponds to the number of amino
acid

residues.

CD

data

were

analyzed

using

the

K2d

algorithm

(http://www.embl.de/~andrade/k2d/) (20).
Intact protein mass spectrometry. Intact proteins were reduced, alkylated using
iodoacetamide, and then dialyzed against 50 mM ammonium bicarbonate. Ten µg of each
protein was dried separately using a lyophilizer. Protein was resuspended in 5 µl of 50%
acetonitrile (ACN), 2.5% formic acid (FA) and then an additional 15 µl of 2.5% ACN,
2.5% FA for a final concentration of 14.4% ACN, 2.5% FA. Five µl was loaded, using a
MicroAS autosampler and Surveryor Pump Plus HPLC (Thermo Electron), on to a nanoESI microcapillary column with an internal diameter of 100 µm and packed with 12 cm
of reverse-phase C4 resin. HPLC solvent A was 2.5% ACN, 0.15% FA. HPLC solvent B
was 99.85% ACN, 0.15% FA. After a 15 min isocratic loading in solvent A, proteins
were eluted into a LTQ-orbitrap (Thermo Electron) hybrid mass spectrometer using a
20%-80% ACN gradient. Mass measurements were made in the orbitrap at 30,000
resolution.
DNA-binding assays. An enzyme-linked immunosorbent assay (ELISA) was
conducted using synthetic biotinylated ssDNA probes (Table S1) immobilized on
StreptaWells (Roche Applied Science) at a concentration of 0.5 nM as previously
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described (13). Briefly, ssDNA-coated wells were incubated overnight with 1.0 nM
solutions of full-length NHis-Pur" or the core fragment in binding buffer consisting of 20
mM Hepes pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 1.0 µg/ml dT32 with
0.2% w/v BSA and 0.05% v/v Tween& 20. Nucleoprotein complexes were detected by
sequentially washing and then incubating the wells with 1) 1.0 µg/ml primary rabbit
polyclonal antibody recognizing the Pur! 210-229 epitope (4), 2) 1:8000 dilution of
secondary horseradish peroxidase-coupled goat anti-rabbit antibody (Santa Cruz
Biotechnology, Inc.), and 3) ABTS chromogenic substrate solution (Millipore).
A competitive colorimetric DNA-binding assay was performed using microtiter wells
coated with 20 nM NHis-Pur! plus 5.0 µg/ml BSA carrier as previously described (13].
Briefly, Pur!-coated wells were incubated with 0.5 nM biotinylated PE32-F ssDNA in
the presence of selected concentrations of fluid-phase competitor (either full-length
NHis-Pur! or the core fragment) diluted in binding buffer. After overnight incubation at
25ºC, wells were sequentially washed and incubated with solutions containing
ExtrAvidin&-peroxidase diluted 1:2000 followed by ABTS chromogenic substrate
(Millipore). In both the direct ELISA and competitive DNA-binding approaches, the
peroxidase substrate reaction was quenched by the addition of an equal volume of 1%
SDS. Absorbance values at 405 nm were obtained with a 96 well plate reader (Molecular
Devices).
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RESULTS
Identification of a trypsin-resistant core domain in recombinant Pur!. To assess
the extent of protein asymmetry and existence of tertiary folding within Pur!, purified
recombinant NHis-Pur! was subjected to limited trypsin digestion at a concentration in
which the protein would be predicted to be mostly dimeric (18). The proteolytic products
were then resolved by SDS-PAGE under reducing conditions and visualized by staining
with Coomassie Blue (Fig. 2-1A). At early time points, four prominent bands were
observed that included full-length NHis-Pur! and three closely spaced products of trypsin
digestion. Prolonged incubation with trypsin up to 2 hours reduced the number of
resolved bands to a single major fragment of Mr ~32 kDa (~30 kDa when taking into
account the well documented anomalous electrophoretic mobility of Pur! (4,18)).
Importantly, a fragment of identical size was also generated in more dilute solutions of
Pur! suggesting that a protease-resistant domain is intrinsic to the monomeric form of the
protein as well (Fig. 2-1C).
Primary structure of the Pur! core tryptic fragment. Tryptic digests of Pur! at
various time points were probed by western blotting with antibodies specific for the Nterminal 6%His tag or Pur! peptide sequences spanning amino acids 302-324 or two
internal regions from 42-69 and 210-229 (Fig. 2-1B). Epitope mapping revealed that the
core fragment present at the 90 min and 2 h time points nominally contained Pur!
sequences from residues 42-69 and 220-229 but was missing the 6%His N-terminus and
some C-terminal residues. Southwestern blotting confirmed that the core tryptic fragment
retains the ability to bind ssDNA (Fig. 2-1D). Because tryptic cleavage at R10 and R28
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would theoretically produce peptides with N-terminal polyglycine stretches of 9 and 8
residues, we elected to perform targeted LC-MS/MS analysis (as opposed to Edman
sequencing) of the core ~30 kDa fragment in comparison to the full-length protein after
further in-gel tryptic digestion in order to map the N- and C-terminal boundary peptides
of the core fragment. As predicted, a prominent tryptic fragment corresponding to
GGGGGGGGPGGEQETQELASK was identified consistent with the N-terminus
beginning at G29 (Fig. S2-1A and Table S2-2). Other identified peptides indicated that
the likely C-terminus of the core fragment extends just beyond the psycho motif to
residue 305 (Fig. S1B and Table S2-2). To validate this conclusion, we also analyzed
full-length NHis-Pur! and the core fragment via intact protein ESI-LC-MS and found
that the molecular mass of the core fragment does indeed correspond to residues 29305/306 (Fig. 2-2).
Quaternary structure and folding of the Pur! core tryptic fragment. The purified
core fragment was subjected to calibrated SEC to determine whether the protein exists as
a monomer or dimer at concentrations in the micromolar range. As is evident from the
elution profile, the Pur! core fragment overlaps with BSA (~66 kDa), which is consistent
with a dimer (Fig. 2-3A). The relative broadness of the peak, however, is suggestive of a
reversible monomer-dimer equilibrium just as previously documented for the full-length
protein (18). Comparative analysis of full-length NHis-Pur! and the core fragment by CD
spectrometry indicated that the core fragment is stably folded (Fig. 2-3B). The modest
increase in negative ellipticity between 210 and 222 nm seen with the Pur! core implies a
somewhat larger proportion of !-strand and "-helix elements owing to loss of putative
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Figure 2- 1. Identification of a core trypsin-resistant domain in Pur!. (A) Recombinant
NHis-Pur! at 3.0 µM was combined with trypsin at 10:1 mass ratio. Aliquots were
removed at the indicated time points. Proteolytic fragments were separated by 12% SDSPAGE under reducing conditions and visualized by staining with Coomassie& Brilliant
Blue. (B) Tryptic digestion mixtures were separated by 10% SDS-PAGE and protein
fragments were either stained with Coomassie& Brilliant Blue (Coo Blue) or transferred
to a PVDF membrane for immunoblotting with antibodies recognizing the NHis tag or
Pur! epitopes B42-69, B210-229, or B302-324. (C) NHis-Pur! at 9.0 nM was incubated
with trypsin at a 1:10 mass ratio. Aliquots were removed at the indicated time points and
subjected to reducing SDS-PAGE and western blotting using a primary antibody
recognizing the 210-229 epitope. (D) A tryptic digest of NHis-Pur! was subjected to
southwestern blotting with a SM"A-derived probe. The arrow in panels A, C, and D
identifies the core ~30 kDa fragment liberated by trypsin digestion.
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random coil-forming N- and C-terminal sequences. Although this feature was observed in
both low and high salt buffers, the high glycine content of full-length NHis-Pur! (22%)
precluded the computational acquisition of statistically valid numerical values of
secondary structure (21).
DNA-binding properties of the Pur! core trypsin-resistant fragment. Since
qualitative southwestern blotting demonstrated the capacity of the core fragment to
interact with ssDNA (Fig. 2-1D), we next studied the ssDNA-binding affinity and
specificity of the isolated Pur! core domain in comparison to the full-length protein. A
colorimetric, microtiter well-based competition assay was first employed to establish the
relative affinity of the core fragment for the SM"A-derived PE32-F element in solution.
As shown in Fig 4A, the competition curve for the core fragment is shifted to the left
relative to the full-length protein implying a slightly higher binding affinity for the
biotinylated PE32-F probe. In support of this contention, the calculated IC50 values for
the full-length protein and the core fragment were 1.3 and 0.5 nM, respectively. These
values are consistent with previous estimates of the macroscopic binding affinity of Pur!
for this sequence element based on quantitative band-shift and footprinting assays (17).
An ELISA-based assay was used to assess the DNA-binding specificity of the core
fragment in comparison to the full-length protein using SM"A-derived cis-element
probes in both single-stranded and double-stranded configuration (12,13). These assays
were conducted with limiting amounts of purified protein (1.0 nM) and biotinylated DNA
(0.5 nM) to restrict the analysis to high affinity nucleoprotein interactions. As shown in

72

Figure 2- 2. Intact protein nano-ESI LC-MS spectra of NHis-Pur" and the core tryptic
fragment. A basic deconvolution of the acquired spectra for full-length NHis-Pur! (A)
and the core fragment (B) was performed using ProMass (version 25.0.1) using an input
m/z range of 500-1,550 and an output m/z range of 20,000-40,000. The insets show the
deconvoluted masses for the proteins based on the composite isotopic envelopes. The
spectra are labeled to denote the measured and theoretical (boxed) m/z values for a range
of charge states. Note for the Pur" core fragment, tryptic digestion could lead to a ragged
carboxyl-terminus with or without the protein containing Arg306. This is reflected in the
overlapping isotopic envelopes and deconvoluted masses exhibiting mass differences of
approximately the mass of arginine (156.1 daltons). The observed and calculated masses
for full-length and core Pur" with their respective methionines variably oxidized are
indicated above their respective spectra.
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Figure 2- 3. Structural analysis of the Pur" core tryptic fragment via SEC and CD
spectrometry. (A) A 1.5 x 98-cm column packed with Sephacryl S200 HR resin was
calibrated with six different molecular weight standards (!). Resolved peaks
corresponding to BSA (66 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), and
cytochrome c (12.4 kDa) are highlighted. In a separate run, the elution of purified Pur"
core fragment (0.5 mg loaded) was monitored at 280 nm ("). Inset, SDS-PAGE analysis
of purified Pur! proteins. (B) CD scans of full-length NHis-Pur! and the core tryptic
fragment were obtained in high salt buffer. The spectrum of the core fragment is
consistent with loss of putative N- and C-terminal random coil-forming sequences.
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Fig. 4B, the isolated core domain preferentially interacts with purine-rich sense (forward)
strands of the PE32 and SPUR32 elements. With respect to the PE32 sequence,
individual or combined mutation of the high affinity 3´ and 5´ binding sites and low
affinity internal site (17), reduced the interaction of full-length NHis-Pur! and the core
tryptic fragment in an analogous fashion (Fig. 2-4C). To ascertain whether the presence
of DNA would affect the susceptibility of the full-length protein to proteolysis, limited
tryptic digestion was carried out with solutions containing either polydeoxythymidylate
(dT32) as a nonspecific control or PE32-F. As shown in Fig. 2-4D, although the core
fragment was generated in both instances, the presence of equimolar amounts of PE32-F
protected the core from complete digestion. These results reinforce the conclusion that
the 29-305 region of Pur! constitutes the core ssDNA-binding domain of the protein.
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Figure 2- 4. Assessment of the ssDNA-binding affinity and specificity of the Pur! core
tryptic fragment. (A) A competition assay was conducted with 0.5 nM PE32-bF in the
presence of a fixed amount of solid-phase NHis-Pur! and varying amounts of fluid-phase
NHis-Pur! (!) or the core fragment ("). Data points were fit to a four parameter
logistic curve using SigmaPlot 9.0 (Systat Software, Inc.). (B, C) ELISAs were
performed to compare the binding of NHis-Pur! and the core fragment to StreptaWellimmobilized DNA probes corresponding to wild-type (B) or mutated (C) SM"A ciselements and a telomeric repeat, (TTAGGG)4. (D) Limited tryptic digestion of NHisPur! at 5.0 µM was carried out in the presence of equimolar dT32 (lanes 2-8) or PE32-F
(lanes 9-15). Lane 1 contains SigmaMarker' proteins. Arrow shows the core fragment.
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DISCUSSION
In an earlier study, we speculated that Pur! may possess some degree of intrinsic
structural asymmetry based on hydrodynamic analyses indicating that the Pur! dimer is
elongated (18). Limited proteolysis coupled with the biochemical characterization of
peptide fragments resistant to digestion is a classic approach used to identify dimerization
regions and/or potential sources of structural asymmetry in DNA-binding proteins
(22,23). Taking into account the modular arrangement of predicted secondary structural
elements in Pur! (Fig. S2-2) and the necessity of all corresponding class I and class II
repeats for ssDNA-binding function (11), we hypothesized that these elements might fold
in such a way as to protect the central domain of the protein from digestion by trypsin
while leaving the putatively more flexible N- and C-termini exposed. Results of our
limited proteolysis experiments validated this prediction by identifying a trypsinresistant, core ssDNA-binding domain extending from residues 29-305. Interestingly, this
domain contains the minimal ssDNA/RNA-binding region (residues 37-263) mapped by
deletion mutagenesis (11) plus the so-called psycho motif, which is predicted to be "helical (Fig. S2-2). Functionally, the Pur! core tryptic fragment mirrors the full-length
protein in terms of ssDNA-binding specificity but shows a modestly higher binding
affinity presumably due to the absence of an acidic C-terminal tail (Fig. S2-2). This
finding differs from previous results obtained with the 37-263 mutant, which exhibited
much weaker ssDNA-binding affinity (11). Hence, these new data point to a critical role
for residues 264-305 in facilitating high affinity binding of Pur! to ssDNA.
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These findings are particularly intriguing when considered in conjunction with results
of small angle-x-ray scattering measurements and SEC analysis of a Dm Pur" construct
containing PUR repeats I-III (19). Dm Pur" I-III, which is analogous to the Pur! core
domain described herein, appears to dimerize by virtue of intermolecular interaction
between the PUR III repeats (i.e. the third basic/aromatic repeat plus the psycho motif)
from each monomer. As a consequence, dimeric Pur" adopts an elongated Z-like
configuration composed of a central intermolecular PUR domain and two flanking
intramolecular PUR domains (19). If this type of structure is also adopted by the dimeric
form of Pur!, then the role of putative "-helix forming residues 264-305 may be to
ensure stable self-association of the protein when tethered to ssDNA. Importantly, this
type of structural arrangement fits nicely with the cooperative multisite binding
mechanism proposed for Pur! interaction with the PE32-F element in the SM"A gene
promoter (17). Multisite contact via individual PUR domains is an attractive model to
explain why Pur! interacts preferentially with cis-elements containing repeats of
consensus and non-consensus PUR elements such as those present in the promoter
regions of genes encoding SM"A, "-myosin heavy chain, and !-myosin heavy chain (57).
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SUPPLEMENTARY MATERIALS
METHODS

In-gel digestion, mass spectrometry (MS), and data analysis. Cubed gel bands of
full-length NHis-Pur! or the Pur! core fragment were rinsed with water, destained with
50% acetonitrile (ACN)/50% ammonium bicarbonate, dehydrated with 100% ACN, and
subjected to in-gel digestion with 6 ng/µl sequencing grade modified trypsin (Promega)
in 50 mM ammonium bicarbonate for 2 h at 37ºC. Peptides were extracted once with
50% ACN, 2.5% formic acid (FA); and once with 100% ACN. Dried peptides were
resuspended in 2.5% ACN, 2.5% FA and loaded using a Micro AS autosampler (Thermo
Electron) and a Surveyor MS Pump Plus (Thermo Electron) onto a nano-electrospray
microcapillary column packed with 15 cm of reverse phase MagicC18 material (5 #m,
200Å, Michrom Bioresources, Inc.). Elution was performed with a 5-35% ACN (0.15 %
FA) gradient over 41 min, after a 14 min isocratic loading at 2.5% ACN, 0.15% FA.
Solvent A was 2.5% ACN, 0.15% FA and Solvent B was 99.85% ACN, 0.15% FA. Mass
spectra were acquired in a LTQ-XL linear ion trap mass spectrometer (Thermo Electron).
Throughout the entire run a sequence of nine scan events was repeated: 1. Precursor
survey (MS1) scan (390-1600 m/z). 2. Data-dependent MS/MS scan performed on the
most intense ion from the survey scan. 3-9. Targeted MS/MS scans on the following m/z
(+/- 1.5) values (note that the corresponding peptide and charge state are indicated for
each targeted m/z value which is the peptide average mass/z of the indicated peptide):
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610.96 (GGGGGGGGPGGEQETQELASK, 3+), 856.94 (YADEM*KEIQERQR, 2+);
571.63

(YADEM*KEIQERQR,

(YADEM*KEIQER,

3+);

3+);

720.76

714.79

(YADEM*KEIQER,

2+);

476.86

(GGGGGGGGGPGGFQPAPR,

2+);

480.84

(GGGGGGGGGPGGFQPAPR, 3+). M* indicates an oxidized methionine. These
targeted values were chosen as they correspond to the predicted tryptic peptides at the
termini of full-length Pur! or the core fragment. Mass spectral data were searched against
a full-length mouse Pur! protein database using Turbo SEQUEST (Thermo Electron,
Version 27, Revision 12) requiring no enzyme specificity, and a 2 Da precursor mass
tolerance. Differential modification of 16.0 Da on methionine residues was permitted.
Southwestern blotting. Proteolytic fragments generated during limited trypsin
digestion were separated by SDS-PAGE on a 10% mini-gel and then electroblotted onto
PVDF membrane. The membrane was blocked in 2% w/v bovine serum albumin (BSA)
dissolved in 25 mM Tris-Cl pH 7.5, 150 mM NaCl, and 0.05% v/v Tween& 20 (TBST)
for 16 h at 4oC. Blocking buffer was removed and the membrane was then gently mixed
at room temperature with a 5 ml solution of 10 nM ssDNA probe (PE32-bF, Table S1)
diluted in 0.2% w/v BSA/TBST with 2.0 µg/ml poly[dI-dC] (Roche Applied Science).
After incubating for 2 h, the membrane was washed four times with TBST and a 5 ml
solution of ExtrAvidin&-peroxidase (Sigma-Aldrich) diluted 1:2000 in BSA-TBST
buffer was applied for 1 h. The membrane was washed as above followed by application
of ECL' western blot substrate as directed by the manufacturer (Pierce). The membrane
was covered in plastic wrap and exposed to RXB-blue sensitive x-ray film (IBF-Medix).
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Secondary structure prediction. Software tools available at the Expert Protein
Analysis System (ExPASy) proteomic server of the Swiss Institute of Bioinformatics
were used to predict the presence and arrangement of secondary structural motifs in
mouse Pur! based on primary sequence. The programs and software packages applied
included Jpred, a neural network using multiple sequential network layers [1], SSpro,
one-dimensional recurrent neural network [2], GenTHREADER, a sequence profile
based fold recognition program [3], PROFsec, a profile based neural network [4], Porter,
a bidirectional recurrent neural network with two independent training models [5], and
APSSP2, a neural network and nearest neighbor approach [6].
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SUPPLEMENTARY TABLES AND FIGURES
Table S3- 1. Sequences of 3´-biotinylated oligonucleotides used in this study
__________________________________________________________________
Designation
Sequence (5´(3´)
__________________________________________________________________
SPUR32-bFa

GAAGCGAGTGGGAGGGGATCAGAGCAAGGGGC

SPUR32-bR

GCCCCTTGCTCTGATCCCCTCCCACTCGCTTC

PE32-bFb

GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA

PE32-bR

TCTCTTCCACTGCATTCCTCTGTTCTGCTCCC

PE32-bF-5T7

TTTTTTTGAACAGAGGAATGCAGTGGAAGAGA

PE32-bF-IT7

GGGAGCAGAACAGTTTTTTTCAGTGGAAGAGA

PE32-bF-3T7

GGGAGCAGAACAGAGGAATGCAGTTTTTTTTA

PE32-bF-35T7

TTTTTTTGAACAGAGGAATGCAGTTTTTTTTA

PE32-bF-3I5T7

TTTTTTTGAACAGTTTTTTTCAGTTTTTTTTA

PE32-bF-5IT7

TTTTTTTGAACAGTTTTTTTCAGTGGAAGAGA

PE32-bF-3IT7

GGGAGCAGAACAGTTTTTTTCAGTTTTTTTTA

(TTAGGG)4

TTAGGGTTAGGGTTAGGGTTAGGG

__________________________________________________________________
a

Corresponds to nucleotides #59 to #28 of the mouse SM"A gene.

b

Corresponds to nucleotides #195 to #164 of the mouse SM"A gene.
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Table S3- 2. Boundary peptides identified by targeted LC-MS/MS scans of in-gel
digested full-length NHis-Pur! in comparison to the core 30 kDa fragment

_____________________________________________________________
Sequence (N ( C)
Location
NHis-Pur!
Core fragment
________________________________________________________________________
GGGGGGGGGPGGFQPAPR

N-terminal

+

#

GGGGGGGGPGGEQETQELASK N-terminal

+

+

YADEMKEIQER

C-terminal

+

+

DKLYER

C-terminal

+

+

RGGGSGGGDESEGEEVDED

C-terminal

+

#

GGGSGGGDESEGEEVDED
C-terminal
+
#
________________________________________________________________________
_
+, Peptide detected.
#, Peptide not detected.
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Figure S2- 1. LC-MS/MS analysis of full-length Pur! and the core fragment after in-gel
tryptic digestion. Low energy collision-induced dissociation (CID) MS/MS spectra are
shown for the putative N-terminal (A) and C-terminal (B) boundary peptides of the core
~30 kDa fragment. Asterisks in (A) indicate ions that are explained by water losses off of
b- and y-type ions. Daggers in (A) indicate additional singly- or doubly-charged y- or btype ions. For the N-terminal peptide (A) note the high relative abundance of the y13 ion,
characteristic in this instrumentation of low energy CID fragmentation N-terminal to
proline residues. The N-terminal peptide was found in both doubly-charged (shown) and
triply-charged (not shown) states. (C) Amino acid sequence of full-length NHis-Pur!
showing the location of boundary peptides identified by LC-MS/MS analysis (red) of the
core fragment (italics). Peptides highlighted in blue were only found in preparations of
full-length protein.
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Figure S2- 2. Predicted arrangement of secondary structural elements in Pur!. The
diagram presents a hypothetical map generated by six different secondary structure
prediction algorithms in which arrows stand for "-helices, and open rectangles represent
!-strands. The primary sequence of the protein is shown with basic/aromatic class I
motifs highlighted in blue, acidic/leucine-rich class II motifs in red, psycho motif in
purple, and glycine-rich regions in green. Arrowheads denote the positions of R57 and
R96 in the first class I and class II repeat modules, respectively. In the postulated model,
all three basic/aromatic repeats are composed of three or four !-sheets. In contrast, the
acidic/leucine-rich regions are predicted to be mostly "-helical, except for a disordered
polyglycine stretch in the second class II repeat. The psycho motif is also presumed to be
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predominantly "-helical. The N- and C-terminal regions are predicted to form random
coils. Overall, the proposed model concurs with results of limited tryptic digestion
indicating that Pur! possesses an organized core nucleic-acid binding domain and more
flexible N- and C-termini.
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Abbreviations: SM"A, smooth muscle "-actin; ssDNA, single-stranded DNA; MEF,

mouse embryo fibroblast; MCAT, muscle CAT; Pur/Pyr, polypurine/polypyrimidine;
YB-1, Y-box binding protein 1; AoSMC, aortic outgrowth smooth muscle cell; TGF-!1,
transforming growth factor !1.

93

ABSTRACT
A hallmark of dysfunctional fibroblast to myofibroblast differentiation associated
with fibrotic disorders is persistent expression of ACTA2, the gene encoding the cytocontractile protein smooth muscle "-actin. In this study, a PURB-specific gene
knockdown approach was used in conjunction with biochemical analyses of protein
subdomain structure and function to reveal the mechanism by which purine-rich element
binding protein B (Pur!) restricts ACTA2 expression in mouse embryo fibroblasts
(MEFs). Consistent with the hypothesized role of Pur! as a suppressor of myofibroblast
differentiation, stable short hairpin RNA-mediated knockdown of Pur! in cultured MEFs
promoted changes in cell morphology, actin isoform expression, and cell migration
indicative of conversion to a myofibroblast-like phenotype. Promoter-reporter assays in
transfected Pur! knockdown MEFs confirmed that these changes were attributable, in
part, to de-repression of ACTA2 transcription. To map the domains in Pur! responsible
for ACTA2 repression, several recombinant truncation mutants were generated and
analyzed based on hypothetical, computationally-derived models of the tertiary and
quaternary structure of Pur!. Discrete subdomains mediating sequence- and strandspecific cis-element binding, protein-protein interaction, and inhibition of a composite
ACTA2 enhancer were identified using a combination of biochemical, biophysical, and
cell-based assays. Our results indicate that the Pur! homodimer possesses three separate
but unequal single-stranded DNA-binding modules formed by subdomain-specific interand intramolecular interactions. This structural arrangement suggests that the cooperative
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assembly of the dimeric Pur! repressor on the sense strand of the ACTA2 enhancer is
dictated by the association of each subdomain with distinct purine-rich binding sites
within the enhancer.
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INTRODUCTION
The myofibroblast is a unique cell type that exhibits an ensemble of phenotypic
properties typical of a collagenous matrix-producing fibroblast and a contractile smooth
muscle cell (1). In the body, pre-formed myofibroblasts play an important structural role
in certain developing and adult tissues and organs (1, 2). On the other hand, emergent
myofibroblasts are critical to the formation and remodeling of granulation tissue during
wound healing as they provide the contractile machinery and mechanical strength
necessary for wound closure (3-5). While transient differentiation of resident connective
tissue fibroblasts to myofibroblasts is a normal physiological response to tissue injury,
persistent myofibroblast activation is associated with hypertrophic scarring, pathologic
organ fibrosis, aberrant vascular remodeling, and dysfunctional stromal responses to
neoplasia (6-9). Consequently, an improved understanding of the molecular mechanisms
underlying myofibroblast trans-differentiation may reveal novel drug targets to limit
scarring, fibrosis, and tumor progression.
Among the markers of myofibroblast conversion, expression of ACTA2, the gene
encoding smooth muscle "-actin (SM"A)3 is recognized as one of the key determinants
of the transition to a contractile phenotype (10-12). Based largely on comparing ACTA2
reporter gene activity in myogenic versus non-myogenic cell lines, early reports
suggested that activation of ACTA2 transcription in fibroblasts is mediated by serumderived, growth factor-dependent signaling leading to induction of an otherwise repressed
5) enhancer-promoter (13-15). Later studies revealed that the 5) flanking region of
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ACTA2 contains a variety of discrete but functionally-interacting cis-elements that serve
as binding sites for certain muscle-associated, growth factor-inducible, or basal transactivators found in ACTA2-expressing fibroblasts (16-19). In particular, combinatorial
interactions between a transcription enhancer factor 1 (TEF1)-binding muscle CAT
(MCAT) motif, two serum response factor (SRF)-interacting CArG boxes, and several
specificity protein 1 and 3 (Sp1/3)-binding GC-rich elements are necessary to drive high
level ACTA2 transcription in differentiating myofibroblasts (17, 20). Conversely, in
undifferentiated fibroblasts, the activity of a composite MCAT/CArG/GC box enhancer
is apparently suppressed by several single-stranded DNA (ssDNA)-binding repressors
that interact with the opposing strands of an asymmetric polypurine/polypyrimidine-rich
(Pur/Pyr) tract containing the core MCAT motif (15, 21). Cell-based promoter
mutagenesis studies in conjunction with nucleoprotein interaction analyses with doublestranded and single-stranded probes led to the identification of purine-rich element
binding proteins A and B (Pur" and Pur!) and Y-box binding protein 1 (YB-1) as the key
factors in strand-specific Pur/Pyr tract recognition and repression of the composite
ACTA2 enhancer (17, 22).
Pur" and Pur! are members of a small family of nucleic acid-binding proteins that
interact with purine-rich ssDNA or RNA sequences homologous to the so-called PUR
element originally described in eukaryotic gene flanking regions and origins of DNA
replication (23-25). Despite the fact that Pur" and Pur! share ~70% sequence identity
and exhibit similar ssDNA-binding and helix-destabilizing properties in vitro (26-28),
comparative gain-of-function and loss-of-function analyses conducted in transiently-
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transfected fibroblasts and vascular smooth muscle cells point to Pur! as the dominant
repressor of ACTA2 in these cell types (29, 30). In keeping with its general biological role
as a potent repressor of genes that encode contractile proteins, Pur! has also been
reported to negatively-regulate MYH6 and MYH7 in cardiac and skeletal myocytes (3133). More recent studies suggest that Pur! repressor expression in muscle cells is tightly
controlled at the post-transcriptional level by certain muscle-restricted microRNAs to
ensure appropriate myofiber composition for sustained cardiac and skeletal muscle
performance in response to stress (34, 35).
Apart from hydrodynamic analyses revealing that Pur! can reversibly self-associate
to form an elongated homodimer in the absence of ssDNA (36), comparatively little is
known about the higher order structural domains in either the Pur! monomer or dimer
that confer specific and high-affinity interaction with purine-rich elements in ACTA2 or
any other target gene. A previous report demonstrated that Pur! interacts in a sequential
and cooperative manner with the sense strand of the MCAT-containing Pur/Pyr element
from mouse ACTA2 to form a high affinity 2:1 Pur!:ssDNA complex (37). While the
primary structure of Pur! is similar to Pur" in terms of the presence of three distinct
regions of internal homology (dubbed PUR repeats I, II, and III) (38), Pur! contains
several unique intervening sequences with high glycine and proline content that may
affect the structural and functional properties of the protein (26). Importantly, the x-ray
crystal structure of a truncated version of Drosophila melanogaster (56) Pur" (amino
acids 40-185) revealed a monomeric Whirly fold-like DNA-binding domain formed by
the intramolecular interaction of the first two PUR repeat sequences (39). On the other
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hand, we recently identified a core tryptic fragment of Pur! (amino acids 29-305) that
contains all three PUR repeats, self-associates in the absence of nucleic acid, and retains
the ability to interact with the purine-rich strand of the ACTA2-derived MCAT element
with high-affinity and specificity (40). In this study, the putative biological role of Pur!
in suppressing ACTA2 expression and restricting myofibroblast cyto-differentiation was
first validated via a stable gene knockdown approach. In silico modeling of protein
structure coupled with empirical analyses of protein function were then used to delineate
the relevant domains in Pur! that mediate ACTA2-specific nucleoprotein interaction and
repression of the composite MCAT/CArG/GC box enhancer.

MATERIALS AND METHODS
Cell culture and extraction. AKR-2B MEF cell lines stably-transduced with
lentiviral vectors encoding a PURB transcript-specific short hairpin RNA (shRNA) or a
scrambled control RNA were generated as described in (30). Subcloned cell lines were
propagated in McCoys 5A medium (Gibco'/Invitrogen) containing 5% heat-inactivated
fetal bovine serum (FBS) and 10 µg/ml blasticidin in a humidified 5% CO2 incubator and
studied at passage number 5 to 15. Phase contrast images of live cells were obtained on a
Zeiss Axiovert model 200 inverted microscope equipped with an AxioCam MRm digital
camera. Assays used to compare the growth and migratory properties of derived cell lines
are detailed in Supporting Information. In timed growth factor-treatment experiments,
cells were seeded at a fixed density and then switched to serum-free MCDB-402 medium

99

(JRH Biosciences) for 36 to 48 h. Cells were then treated for 24 h with either 10% FBS
or 2.5 ng/ml recombinant human transforming growth factor !1 (TGF-!1) (R & D
Systems) diluted in MCDB-402 medium. Confluent monolayers of growth factorstimulated cells were washed three times with ice-cold phosphate buffered saline (PBS)
and then extracted with 1% Reporter Gene Assay Lysis Buffer (Roche Applied Science)
supplemented with protease inhibitors 0.5 mM phenylmethanesulfonyl fluoride and 1
µg/ml each of pepstatin A, leupeptin, and aprotinin. Soluble lysates and cell remnants
were collected by centrifugation at 15,800 % g for 10 min at 4°C. Total protein content in
cleared lysates was measured by BCA' Protein Assay (Thermo Scientific) using bovine
serum albumin (BSA) as a standard. Insoluble pellets were further extracted with a
denaturing solvent consisting of 8 M urea, 100 mM sodium phosphate, 10 mM Tris-Cl
pH 8.0 plus protease inhibitors. Denatured lysates were cleared by centrifugation and
assayed for protein content as described above.
Promoter:reporter

constructs.

Murine

ACTA2

promoter-chloramphenicol

acetyltransferase reporter constructs (pVSMP8-CAT and pVSMP4-CAT) have been
described elsewhere (14, 30, 41). The corresponding ACTA2 promoter-luciferase
reporters were constructed as follows. A ~3.6 kb fragment was released from pVSMP8CAT by sequential treatment with SphI, mung bean nuclease, and BamHI. A ~240 bp
insert was released from pVSMP4-CAT by sequential treatment with SalI, mung bean
nuclease, and BamHI. Restriction fragments were ligated into SmaI/BglII-digested and
alkaline phosphatase-treated pGL3-Basic vector (Promega) to generate pVSMP8-Luc and
pVSMP4-Luc. Following transformation into E. coli HB101 cells, ampicillin-resistant
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clones were selected for propagation and plasmid purification (Roche Applied Science).
The fidelity of plasmid constructs was confirmed by restriction enzyme digestion
followed by automated DNA sequencing performed by the Vermont Cancer Center DNA
Analysis Facility.
Expression vectors. Bacterial and mammalian expression vectors encoding fulllength, N-terminal hexahistidine-tagged mouse Pur! (pQE30-NHis-Pur! and pCI-NHisPur!) were described in previous reports (17, 22). Expression plasmids encoding NHisPur! truncation proteins corresponding to amino acids 41-112 (Pur! I), 125-210 (Pur!
II), 209-303 (Pur! III), 41-210 (Pur! I-II), 125-303 (Pur! II-III), and 41-303 (Pur! I-IIIII) were constructed following a similar strategy outlined in (29) and as further detailed
in Supporting Information.
Monoclonal antibodies. With the exception of antibody screening assays, all other
procedures involved in generating murine and rat monoclonal antibodies (mAbs)
recognizing Pur" and/or Pur! were carried out by a commercial vendor (Green Mountain
Antibodies). These included rodent immunization, fusion of mouse or rat splenocytes
with NS-1 myeloma cells, subcloning of hybridoma cells (2 rounds), and in vitro
production, purification, and isotype/subclass determination of derived mAbs. The
specific antigens used for immunization were keyhole limpet hemocyanin-coupled
peptides corresponding to amino acid sequences B42-69, B302-324, and A291-313 of
mouse Pur! and Pur", respectively (22). Animals were immunized with each individual
peptide or a combination of all three peptides. The relative affinity and specificity of
purified mAbs were evaluated by direct enzyme-linked immunosorbent assay (ELISA)
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using immobilized peptides or full-length NHis-Pur" or NHis-Pur! as described in
Supporting Information and shown in Figure S1.
Computational modeling of protein structure. A homology model of Mus
musculus (Mm) Pur! was generated based on the structure of Drosophila melanogaster
(56) Pur" repeats I-II (amino acids 40-185) using web-based modeling servers and a
bioinformatics approach described previously (38, 39). A pair-wise multiple sequence
alignment of Mm Pur! and Dm Pur" indicating 52% sequence identity was obtained
using ClustalW (42, 43). The sequence alignment was submitted to the HHrepID and
PSIPRED web servers (44, 45) under default parameters to identify repeated sequences
and predict secondary structural elements within Pur! (26). To generate a model
consistent with these results, the FASTA sequence of Mm Pur! was submitted to the ITASSER web server (46, 47) to generate a homology model of Pur! repeats I-II using
Dm Pur" I-II (3K44) as a template (39). On the basis of the internal sequence homology
of the three Pur! repeats, Pur! III was independently predicted by SWISS-MODEL (4850) by threading the sequence of the third Pur! repeat onto the structure of Dm Pur" I-II.
Predicted intermolecular interaction between two Pur! III repeats was modeled by
rotating the Mm Pur! III repeats of two monomers into an extended conformation and
aligning them on Dm Pur" I-II using Coot (51). Energy minimization of the Pur!
homodimeric homology model was completed using CNS version 1.2 (52, 53) to relax
close contacts and to regularize local bond and angle geometry. Computationally-derived
structures were viewed and depicted using PyMOL (54).
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Recombinant protein purification. Full-length NHis-Pur! and selected truncation
proteins were expressed in and isolated from E. coli JM109 cells using chromatographic
methods optimized for each particular recombinant protein as detailed in Supporting
Information. NHis-Pur!-enriched fractions obtained by metal chelate affinity, heparin
affinity, or size exclusion chromatography (SEC) were monitored for purity by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing
conditions and staining with Coomassie& Brilliant Blue R-250. Wide range
SigmaMarker' proteins (Sigma-Aldrich) were used as molecular weight standards. The
protein concentration of pooled fractions was determined by absorbance measurement
using theoretical molar extinction coefficients at 280 nm of 20,400 M 1 cm 1 for full#

#

length NHis-Pur! and NHis-Pur! I-II-III, 7,450 M 1 cm 1 for NHis-Pur! I-II, and 12,950
#

#

M 1 cm 1 for NHis-Pur! III (55). Protein preparations were routinely screened to ensure
#

#

the absence of contaminating nucleic acid as previously described (36). Protein
preparations were also monitored for the presence of nuclease activity by incubating 1.0
µM protein stocks with 2 µg of either pBLCAT3 plasmid or M13mp18 ssDNA (Bayou
Biolabs) for 1 h at 37°C. The integrity of the DNA substrates was then evaluated by
agarose gel electrophoresis. Absence of contaminating nuclease activity in recombinant
Pur! preparations was established based on comparison to DNA substrates treated in
parallel with 10 1 to 10 5 units of DNase I (Invitrogen).
#

#

Calibrated SEC and circular dichroism spectroscopy. The quaternary state of
purified truncation proteins was determined by SEC on a 1.5 % 100 cm Sephacryl& 200
HR column calibrated with molecular weight standards blue dextran, BSA, ovalbumin,
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carbonic anhydrase, cytochrome C, and DNP aspartate (36). The foldedness of
recombinant proteins was assessed by CD spectroscopy. All proteins were analyzed on a
Jasco model 815 spectrometer after dialysis into buffer consisting of 50 mM Tris-Cl pH
7.5, 300 mM NaCl, 0.5 mM EDTA, and 0.5 mM tris(2-carboxyethyl)phosphine
hydrochloride (TCEP). Multiple wavelength scans were recorded at 1 nm intervals from
195 to 280 nm on 5.0 µM protein solutions in a 1 mm cuvette at 25°C. Raw CD data were
analyzed as previously described (40).
Single-stranded

DNA-binding

assays.

Direct

or

competitive

colorimetric

microplate-based assays were conducted with purified proteins and a 3) biotinylated
ssDNA probe corresponding to the purine-rich strand of the murine ACTA2 5)-flanking
sequence from #195 to #164 (PE32-bF) as previously described (40, 56). In the direct
ssDNA-binding format, solid-phase Pur!-PE32-bF complexes were detected by ELISA
using primary rabbit antibodies directed against amino acids 210-229 or 302-324 of
mouse Pur! (22) or the NHis tag (His probe H-15 from Santa Cruz Biotechnology, Inc.
or anti-6-His from Bethyl Laboratories, Inc.). In the competitive binding format, solidphase nucleoprotein complexes were detected with ExtrAvidin&-peroxidase (SigmaAldrich). Log [protein] vs. absorbance datasets were fit to four parameter variable slope
equations to determine EC50 or IC50 values depending on the format of the assay (Prism
5, Version 5.04, Graphpad Software, Inc.).
Protein-protein interaction assay. Protein-protein interaction was assessed in an
ELISA format using microtiter wells (Costar& EIA/RIA 96 well plate, certified high
binding, Corning Inc.) coated with 200 nM NHis-Pur! or selected truncation proteins as
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previously described (30, 56). Nuclear extracts prepared from exponentially growing
AKR-2B MEFs served as a source of protein binding partners of Pur! (57). The primary
antibodies used for detection of solid-phase protein-protein complexes included rabbit
anti-mouse Pur" 291-313 (22), rabbit anti-mouse YB-1 (MSY1) 242-269 (22), and rabbit
anti-mouse TEF1 1-15 (17). Commercial rabbit polyclonal antibodies against SRF (G20), Sp1 (H-225 and PEP-2), and Sp3 (D-20) were from Santa Cruz Biotechnology, Inc.
Transient transfection assay. AKR-2B MEFs were seeded into 6 well plates at 4.0
%104 cells per well in McCoys 5A medium with 5% FBS. Primary mouse aortic
outgrowth smooth muscle cells (AoSMCs) (30) were seeded at 2.5 %104 cells per well in
DMEM with 10% FBS. After an overnight incubation at 37°C in a 5% (MEFs) or 10%
(AoSMCs) CO2 incubator, adherent cells were transfected with 2 µg of total DNA using
jetPEI' reagent (PolyPlus-transfection) at a ratio of 1.5 µl per µg of DNA. Transfection
solutions typically contained 0.9 µg of pVSMP8- or pVSMP4-CAT or luciferase
reporters, 0.1 µg of pSV40-!-Gal control reporter, and 1.0 µg of expression plasmid.
After 48 h incubation at 37°C, cells were washed with PBS and then extracted with 1%
Passive Lysis Buffer (Promega) supplemented with protease inhibitors. Total protein
content was determined by BCA' or Bradford assay and individual reporters were
measured with the use of a CAT or !-Gal ELISA kit (Roche Applied Science),
Luciferase Assay System (Promega), or ortho-nitrophenyl-"-galactoside chromogenic
substrate assay. Numerical datasets were subjected to one-way analysis of variance and
Tukey’s multiple comparison test with significance set at p < 0.05 (Prism 5, Version
5.04, Graphpad Software, Inc.). In some instances, transfected cells were processed by
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sequential extraction using a subcellular protein fractionation kit as directed by the
manufacturer (Thermo Scientific).
Immunoblotting. Samples were prepared for SDS-PAGE by dilution of concentrated
cell lysates into 6% sample preparation buffer (120 mM Tris-Cl pH 6.8, 3% w/v SDS,
30% v/v glycerol, 0.03% w/v bromophenol blue). For less concentrated cell lysates,
soluble protein was precipitated by adding 5 volumes of ice-cold ethanol to 1 volume of
cell lysate and incubating for at least 1 h at #20°C. Precipitated protein was collected by
centrifugation and dissolved in 1% SDS-PAGE loading buffer. Samples were
supplemented with 5% v/v 2-mercaptoethanol, heated for 3-5 min at 100°C, and
subjected to slab gel electrophoresis on 10%, 12% or 15% w/v acrylamide:bisacrylamide
(29:1) mini-gels or 4-20% precast gradient gels (Lonza). Molecular weight standards
were run in parallel on each gel (BenchMark' Prestained Protein Ladder, Invitrogen).
Proteins were then electrotransferred to Immobilon&-P or Immobilon&-PSQ
polyvinylidene difluoride membrane (Millipore) in 25 mM Trizma base, 192 mM
glycine, 20% v/v methanol at 125 V for 90 min at 4°C. Transblots were probed with
selected antibodies as described in (22). Primary and secondary antibodies used are listed
in Supporting Information.

RESULTS
Derivation of Pur! knockdown MEFs. To assess the phenotypic consequence of
Pur! loss-of-function in a multipotent mesenchymal cell type, a lentiviral shRNA
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expression system was used to stably-transduce AKR-2B MEFs owing to their high
steady-state levels of Pur" and Pur! and sensitivity to inducers of myofibroblast
differentiation (20, 22, 58). As shown in Figure 3-1A, specific knockdown of Pur! (faster
migrating band of doublet) was confirmed in two independently-derived blasticidinresistant cell lines by Western blotting with the use of a newly-developed rat monoclonal
antibody directed against a conserved PUR repeat I sequence present in both Pur" and
Pur! (specifically, amino acids 42-69 of Pur!). Importantly, Pur" expression (slower
migrating band of doublet) was not altered in either Pur!-only knockdown cell line (!IB4 and !1-G7) compared to control cells transduced with scrambled RNA (!S-E6). For
the purpose of comparison, extract from a serendipitously-derived cell line deficient in
Pur" expression (!I-F3) was included on the gel to highlight differences in the
electrophoretic mobility of bands corresponding to Pur" and Pur!. To quantify relative
differences in Pur! expression, a functional ELISA was used to measure Pur! ssDNAbinding activity in soluble extracts of each cell line (Figure 3-1B). In keeping with the
results of Western blotting, Pur! ssDNA-binding activity was reduced by 2.5-2.7 fold in
the !I-B4 and !I-G7 cells in comparison to the !S-E6 control cell line. Consistent with a
dominant Pur" loss-of-function phenotype (59), the Pur"-deficient !I-F3 cell line
exhibited a markedly enhanced rate of cell growth relative to Pur!-only knockdown and
scrambled control cell lines and was thus excluded from detailed study (Figure S3-2).
Phenotypic properties of Pur! knockdown MEFs. Analysis of growing MEF cell
lines by light microscopy revealed that Pur!-only knockdown cells adopt a more
elongated spindle-like morphology in comparison to control cells expressing scrambled
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RNA (Figure 3-1C). A similar but less dramatic change in morphology is evident in cells
co-deficient in Pur". These morphological differences were readily apparent in confluent
cell monolayers as well (Figure S3-3). To investigate the physical basis for these changes
in cell shape, the expression of cytoskeletal actin proteins was assessed by
immunoblotting of detergent-soluble and detergent-insoluble lysates prepared from
serum- or TGF-!1-stimulated MEF cell lines. In serum-stimulated cells, the soluble Gform of SM"A was the predominant actin isoform exhibiting enhanced expression in
concert with Pur! knockdown although a slight increase in !-actin expression was
detected as well (Figure 3-2A). Consistent with sensitization to TGF-!1-driven
myofibroblast cyto-differentiation, a corresponding increase in both G- and F-form
SM"A, but not !-actin, was seen in Pur! knockdown MEFs relative to the control cell
line treated with TGF-!1 (Figure 3-2B). Pur! deficiency, however, did not promote
acquisition of a smooth muscle cell-like protein expression pattern as other markers of
smooth muscle differentiation including smooth muscle myosin and SM22"/transgelin
were not detected by immunoblotting of either control or Pur! knockdown MEFs (data
not shown). To determine whether increased expression of SM"A protein correlated with
de-repression of ACTA2 transcription, transient transfection assays were conducted using
a minimal MCAT- and CArG-dependent ACTA2 enhancer-promoter construct. As shown
in Figure 3-2C, ACTA2-driven reporter expression was significantly increased in both
Pur! knockdown cell lines in comparison to control cells implying that loss of Pur!
repressor function is necessary and sufficient to promote ACTA2 expression and
myofibroblast differentiation in MEFs. In keeping with the known motility-restrictive
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Figure 3- 1. Validation of constitutive Pur! knockdown in MEFs. (A) Immunoblotting of
whole cell extracts (10 µg protein/lane) from the indicated MEF cell lines was conducted
with a mAb (rat anti-Pur! 42-69 clone 3C3.6C1) directed against a conserved PUR repeat
I epitope present in both Pur" (slower migrating band) and Pur! (faster migrating band).
The Pur"/! blot was reprobed with a GAPDH mAb to confirm equivalent protein
loading. !I-B4 and !I-G7 (lanes 1 and 3) are two distinct clonal cell lines stably
expressing a Pur! shRNA, while !S-E6 is a control cell line stably expressing a
scrambled RNA (lane 4). For the purpose of comparison, !I-F3 (lane 2) is a
serendipitously isolated cell line deficient in Pur" expression. Lines and numbers on the
left side designate the relative position and size (in kDa) of prestained protein markers.
(B) Quantification of functional Pur! protein in extracts from the indicated MEF cell
lines by ssDNA-binding ELISA. Bars show Pur! expression relative to !S-E6 control
cells (mean ± SEM, n = 4). *, p < 0.05, **, p < 0.01 compared to !S-E6. (C) Phase
contrast micrographs of subconfluent cultures of the indicated MEF cell lines viewed
through a 20% objective.
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Figure 3- 2. Knockdown of Pur! enhances SM"A expression in growth factorstimulated MEFs. (A, B) Immunoblotting of cell extracts prepared from Pur! knockdown
(lanes 1 and 2) and control (lane 3) MEFs stimulated with either serum (A) or TGF-!1
(B) was conducted with mAbs against Pur"/!, SM"A, or !-actin. Pur"/! (10 µg
protein/lane) and G-form actin (0.5 µg protein/lane) were detected in detergent-soluble
cell lysates. F-form actins were detected in detergent-insoluble cell remnants dissolved in
8 M urea (0.2 µg protein loaded/lane). (C) The indicated MEF cell lines were transiently
transfected with a combination of pVSMP4-CAT and pSV-!gal promoter-reporter
constructs. Cell extracts were prepared 48 h later and reporter enzymes were quantified
by ELISA. Bars show the ratio of CAT to !-gal measured in each cell line normalized for
total protein (mean ± SEM).

110

properties of SM"A-containing myofilaments in cultured fibroblasts (60), Pur!
knockdown MEFs also demonstrated a modest reduction in chemotactic migration toward
serum growth factors as measured by Boyden chamber assay (Figure S3-4).
Homology modeling of Pur! tertiary and quaternary structure. To explore the
physical basis for Pur!-mediated repression of ACTA2 transcription, we first set out to
computationally model the higher order structure of Pur! based on 1) sequence homology
with other members of the purine-rich element binding protein family, and 2) the known
x-ray crystal structure of Dm Pur" 40-185. Primary sequence analysis of Mm Pur! using
selected homology detection and structure prediction algorithms indicated that Pur!
possesses the same linear arrangement of PUR repeat modules (designated I, II, III) as
originally described in Pur" (38, 39) (Figure 3-3A). The sequences encoding Mm Pur"
and Mm Pur! were threaded on the x-ray crystal structure of Dm Pur" residues 40-185
(3K44) using SWISS-MODEL to assess the overall homology of the intramolecular PUR
domain formed by PUR repeats I and II of each protein. As expected, the major
differences were restricted to putative loop regions connecting the individual PUR I and
II repeats while the !-strand and "-helix forming sequences were virtually
superimposable (Figure S3-5). To create a hypothetical structure of the full-length Pur!
monomer, PUR repeat III was independently modeled using SWISS-MODEL and the
tertiary structure of the entire protein was constructed on the basis of an I-TASSER
generated template (Figure 3-3B). Like PUR repeats I and II, PUR repeat III is predicted
to possess similar !!!!" topology. However, a putative random coil-forming region
located between PUR repeats II and III may impart some degree of flexibility as to the
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position of PUR repeat III relative to the intramolecular domain formed by PUR repeats I
and II (Figure 3-3C). Consequently, dimerization may occur via formation of an
intermolecular PUR domain composed of two self-associating PUR III repeats from two
Pur! monomers (Figure 3-3D).
Structural analysis of computationally-derived Pur! subdomains. To test the
models in Figure 3-3, a series of cDNAs were engineered to encode NHis-tagged Pur!
truncation proteins corresponding to individual PUR repeat modules (Pur! I, Pur! II,
Pur! III) or selected combinations thereof (Pur! I-II, Pur! II-III, Pur! I-II-III). The utility
of recombinant NHis-Pur! as a reliable experimental surrogate for the native protein
expressed in mammalian cells has been documented in previous studies (29, 37, 56).
Sequence validated bacterial expression plasmids were transformed into E. coli cells and
recombinant truncation proteins were produced for trial purification under both native
and denaturing conditions. While metal chelate affinity enrichment of each Pur!
truncation protein was possible under harsh denaturing conditions (data not shown), only
Pur! I-II-III (residues 41-303), Pur! I-II (residues 41-210), and Pur! III (residues 209303) were amenable to purification in non-denaturing solvents (Figure S3-6) and were
found to exhibit CD spectra consistent with well-folded polypeptides (Figure S3-7).
Hence, it appeared that Pur! I (residues 41-112), Pur! II (residues 125-210), and Pur! IIIII (residues 125-303) were intrinsically unstable and/or mis-folded when expressed in E.
coli. This observation is consistent with the putative requirement for intramolecular
association of PUR repeats I and II or intermolecular association of two PUR III repeats
to form a stably-folded subdomain (Figure 3-3). To confirm the predicted quaternary
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Figure 3- 3. Computational models of Mm Pur! monomer and dimer. (A) The primary
sequence of the 324 amino acid Mm Pur! was analyzed by HHrepID. Predicted regions
corresponding to PUR repeats I, II, and III are highlighted in red, blue, and green,
respectively. Numbers refer to amino acid positions. Intervening elements and N-and Cterminal regions are shown as black lines. (B) Web servers (I-TASSER and SWISSMODEL) were used to generate a homology model of the Pur! monomer. In this
hypothetical model, PUR repeat III (140) is in a closed conformation relative to the
intramolecular PUR domain formed by PUR repeats I (red) and II (blue). (C) A model of
the Pur! monomer in an extended conformation was generated by rotating the PUR
repeat III away from the intramolecular domain formed by PUR repeats I-II. (D) A model
of the Pur! dimer was created by aligning the PUR III repeats of two Pur! monomers in
such a way as to form an intermolecular PUR domain that is predicted to mediate protein
self-association.
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Figure 3- 4. Quaternary structure of isolated Pur! subdomains. (A-C) Calibrated SEC
was conducted on preparations of Pur! I-II-III (A), Pur! I-II (B), and Pur! III (C) at
loading concentrations in excess of 10 µM (open circles). The elution profile of a mixture
of molecular weight standards is shown for comparison (closed circles). Numbers in (A)
indicate the apparent molecular weights of the four globular protein standards used in
generating a standard curve to calculate the size of the Pur! species eluting in the peak
fractions.
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state of each isolated truncation protein, calibrated SEC was performed using loading
concentrations well in excess of the reported Kd for the full-length Pur! dimer (36). As
shown in Figure 3-4A and B, Pur! I-II-III eluted as a ~64 kDa dimer while Pur! I-II
resolved as a ~18 kDa monomer. In agreement with its predicted role in mediating selfassociation, Pur! III eluted as a ~17 kDa dimer (Figure 3-4C).
ACTA2 repressor activity of Pur! subdomains. To assess the functional role of
each putative Pur! subdomain in ACTA2 repression, transient co-transfection assays were
performed in MEFs and primary mouse AoSMCs using a full-length ACTA2 construct
(#1070 to +2582, VSMP8-Luc) as well as a minimal MCAT/CArG/GC box-dependent
enhancer (#146 to +46, VSMP4-Luc) as specific transcriptional targets of Pur! (30). As
shown in Figure 3-5B, full-length Pur! and the core I-II-III construct demonstrated
comparable repressor activity toward both ACTA2 reporters in MEFs. Importantly, Pur!
I-II was the only other truncation protein to exhibit statistically significant repressor
activity. Pur! III alone showed no inhibitory activity while Pur! II-III was only weakly
repressive. In agreement with E. coli expression and purification studies, immunoblotting
of non-denatured MEF lysates indicated stable expression of full-length Pur!, Pur! I-IIIII, Pur! I-II, and Pur! III (Figure 3-5C). However, Pur! I, Pur! II, and Pur! II-III were
either not readily detected or only seen after extracting detergent-insoluble cell remnants
with a denaturing solvent (Figure 3-5D), again pointing to the intrinsic instability and/or
mis-folding of these truncation mutants. Essentially identical results were obtained in cotransfection studies conducted with primary AoSMCs (Figure S3-8) supporting the
conclusion that the relative ACTA2 repressor activity of the stably-expressed truncation
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Figure 3- 5. ACTA2 repressor activity of Pur! truncation proteins expressed in AKR-2B
MEFs. (A) Schematic representation of the full-length (VSMP8-Luc) and truncated
(VSMP4-Luc) ACTA2 promoter-reporter constructs used to assess Pur! repressor
function. PE32 designates the Pur! recognition sequence containing an MCAT motif. (B)
Subconfluent AKR-2B MEFs were transiently co-transfected with ACTA2 luciferase
reporters and expression vectors encoding the indicated Pur! proteins. After 48 h, cell
lysates were prepared and assayed for luciferase activity and total protein. Bars show
total protein-corrected luciferase values normalized to the pCI control (defined as 1) for
each reporter (mean ± SEM, n = 9). ***, p < 0.001 compared to pCI control for VSMP8
(black bars) or VSMP4 (gray bars). (C) Western blotting of detergent-soluble lysates (15
µg protein/lane) of transfected cells was performed with a mAb recognizing the Nterminal His epitope tag present on each Pur! construct. The anti-His tag blot was
reprobed with a GAPDH mAb as a loading control. (D) Western blotting of ureadenatured lysates (15 µg protein/lane) of detergent-insoluble cell remnants was
conducted with the His tag mAb. (C, D) In both immunoblots, lysates were resolved on a
15% polyacrylamide gel. Lines and numbers on the left side designate the relative
position and size (in kDa) of prestained protein markers. FL, full-length.
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proteins is Pur! I-II-III > Pur! I-II >> Pur! II-III or Pur! III. Titration studies conducted
in AKR-2B MEFs using a fixed amount of VSMP8 reporter and varying amounts of
expression plasmid confirmed that Pur! I-II-III and Pur! I-II are quantitatively distinct in
terms of their ACTA2 repressor activity (Figure 3-6).
Cis-element binding properties of Pur! subdomains. To assess whether the
relative ACTA2 repressor activity of each Pur! truncation protein correlated with
differences in the affinity and/or specificity for target sites in the ACTA2 promoter,
colorimetric microplate-based assays were used to compare the ssDNA-binding
properties of Pur! I-II-III, Pur! I-II, and Pur! III to full-length Pur!. The purine-rich
sense strand of the 5) ACTA2 Pur/Pyr element containing a consensus core MCAT motif
(italics) (GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA, PE32-F) was chosen
as a probe because it has multiple interacting binding sites (underlined) that permit
formation of a high-affinity (macroscopic Kd ~ 0.3 nM) 2:1 Pur!:ssDNA complex (37).
Initially, a titration experiment was performed to identify a minimal concentration of 3)
biotinylated PE32-F probe necessary to detect the interaction of each Pur! truncation
protein by ELISA. Surprisingly, stable formation of Pur! I-II nucleoprotein complexes
required a markedly higher concentration of ssDNA implying a significant difference in
binding affinity of the monomeric subdomain relative to full-length Pur!, Pur! I-II-III,
and Pur! III (Figure S3-9A). Titration assays conducted with a limiting concentration of
PE32-bF (0.5 nM) highlighted the striking differences in the apparent ssDNA-binding
affinity of the individual subdomains, Pur! III (EC50 = 1.80 ± 0.74 nM, n = 4) and Pur!
I-II (EC50 > 100 nM), relative to the full-length protein (EC50 = 0.16 ± 0.05 nM, n = 4)
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Figure 3- 6. Relative ACTA2 repressor activity of Pur! truncation proteins expressed in
AKR-2B MEFs. (A) AKR-2B MEFs were transiently co-transfected with a fixed amount
of ACTA2 luciferase reporter (VSMP8) and varying amounts of expression vector
encoding the indicated Pur! proteins. After 48 h, cell lysates were prepared and assayed
for luciferase activity and total protein. Symbols show total protein-corrected luciferase
values normalized to the pCI control (mean ± SEM, n = 6). (B) Immunoblots of
transfected cell lysates (15 µg protein/lane) with a His tag mAb (top panel) followed by a
GAPDH mAb (lower panel). Lines and numbers on the left side designate the relative
position and size (in kDa) of prestained protein markers. FL, full-length.
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and Pur! I-II-III (EC50 = 0.22 ± 0.05 nM, n = 4) (Figure 3-7A and B). Consistent with a
functional distinction between the separated dimerization and intramolecular subdomains,
competition assays revealed that Pur! III (IC50 = 46 ± 15 nM, n = 3) and Pur! I-II (IC50
> 1000 nM) were much less effective than the composite Pur! I-II-III construct (IC50 =
1.0 ± 0.3 nM, n = 5) or the full-length protein (IC50 = 1.2 ± 0.2 nM, n = 5) at inhibiting
the interaction of 0.5 nM PE32-bF with immobilized Pur! (Figure 3-7C). Despite these
substantial differences in apparent ssDNA-binding affinity, the isolated Pur! III and Pur!
I-II subdomains retained similar binding site specificity as demonstrated by their reduced
interaction with mutant versions of PE32-bF containing heptathymidylate substitutions
(T7) in place of 5)or 3) PUR and/or internal MCAT motifs (Figure 3-7D and Figure S39B).
Trans-acting factor binding properties of Pur! subdomains. To ascertain whether
the isolated subdomains exhibited similar protein binding properties as full-length Pur!,
an ELISA-based profiling assay was conducted using nuclear extract of AKR-2B MEFs
as a natural source of potential Pur! interaction partners. Recombinant Pur! proteins
were immobilized on microtiter wells at a saturating coating concentration (200 nM) and
then assayed for their ability to capture specific transcription factors implicated in ACTA2
activation or repression. Consistent with previous findings (30, 56), full-length Pur!
demonstrated preferential interaction with its co-repressor partner MSY1 relative to other
factors screened using this assay format (Figure 3-8). Interestingly, Pur! I-II-III exhibited
an even greater binding capacity for MSY1, while the isolated Pur! I-II and Pur! III
subdomains displayed markedly reduced interaction with MSY1. In contrast, Pur! I-II
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showed a clear preference for interaction with the ACTA2 trans-activator Sp3, while Pur!
III exhibited little or no Sp3 binding activity. Essentially identical results were obtained
using nuclear extract diluted in binding buffer supplemented with reducing agent (Figure
S3-10). This was done to ensure that the differences observed in the binding properties of
individual Pur! truncation proteins were not attributable to anomalous protein oxidation.
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Figure 3- 7. The relative affinity and specificity of Pur! truncation proteins for ssDNA.
(A, B) Varying concentrations of the indicated NHis-Pur! proteins were incubated with
0.5 nM biotinylated mouse ACTA2-derived ssDNA probe (PE32-bF) immobilized on
StreptaWells. (A) Solid-phase nucleoprotein complexes were detected by ELISA using a
primary antibody recognizing the NHis tag. Absorbance values at 405 nm (A405) were
corrected for nonspecific binding by subtracting the signal generated in wells with no
DNA. (B) Solid-phase nucleoprotein complexes were detected by ELISA using a primary
antibody directed against amino acids 210-229 of Pur!. A405 values were corrected for
nonspecific binding and normalized to the absorbance obtained at the maximum
concentration of each protein tested (defined as 1). (C) Varying concentrations of fluidphase Pur! proteins were incubated with a fixed concentration of PE32-bF (0.5 nM) in
microtiter wells pre-coated with full-length Pur! (20 nM). Solid-phase nucleoprotein
complexes were detected by colorimetric assay using an avidin-peroxidase conjugate.
A405 values were normalized to the maximum absorbance obtained in the absence of any
competitor. (A, B, and C) Data points were fit to a four parameter equation to determine
an EC50 (A, B) or IC50 (C) for each protein. A representative experiment is shown in
each panel. (D) A fixed concentration of Pur! protein was incubated with wild type or
mutant ssDNA probes immobilized on StreptaWells. The ratio of Pur! to ssDNA tested
(nM/nM) is indicated in parentheses. Solid-phase nucleoprotein complexes were detected
by ELISA with a primary His tag antibody. A405 values were corrected for nonspecific
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binding and normalized to the absorbance obtained for each protein binding to the wild
type probe (defined as 1). FL, full-length.
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Figure 3- 8. Relative binding of AKR-2B MEF-derived transcription factors to purified
NHis-Pur! proteins. Microtiter wells coated with equivalent concentrations of the
indicated Pur! proteins (200 nM) were incubated with a fixed amount of nuclear protein
(250 µg/ml) diluted in binding buffer. Solid-phase protein-protein complexes were
detected by ELISA using primary rabbit polyclonal antibodies recognizing Pur", MSY1,
TEF1, SRF, Sp3, or Sp1. Absorbance values at 405 nm generated with each transcription
factor antibody were corrected for nonspecific antibody binding to Pur! coated wells in
the absence of nuclear extract. Signal generated in Pur!-coated wells incubated with
nuclear extract and probed with the secondary antibody only (no 1° Aby) is shown as a
background control. FL, full-length.
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DISCUSSION
The transient differentiation of stromal fibroblasts to contractile, SM"A-expressing
myofibroblasts is an essential and tightly-regulated component of the wound healing
process. Conversely, sustained stromal myofibroblast activation is pathologic as it often
promotes aberrant tissue remodeling (61). Because SM"A expression is a biochemical
hallmark of the myofibroblast phenotype, a better understanding of the regulatory factors
that mediate ACTA2 transcription and translation in fibroblasts may reveal novel targets
for therapeutic intervention to limit destructive fibrocontractile remodeling associated
with scarring, fibrosis, and tumor progression. Among the factors implicated in ACTA2
regulation in fibroblasts, Pur" and Pur! are unique in that they apparently repress gene
transcription by forming nucleoprotein complexes with purine-rich ssDNA in such a way
as to block trans-activator recognition of cognate double-stranded binding sites within
the composite MCAT/CArG/GC box enhancer (16, 17, 30, 62).
In view of a growing body of evidence suggesting that Pur! may play a central role in
repressing genes encoding muscle-restricted isoforms of actin and myosin in both
myogenic and non-myogenic cell types (31-35), we initially sought to confirm that
deficiency of Pur! in MEFs would necessarily promote the acquisition of a myofibroblast
phenotype in vitro. To do so, we transduced MEFs using a lentivirus-based shRNA
transgene delivery system to knockdown the expression of Pur! in a specific, stable, and
constitutive manner. Analyses of two independently-derived cell lines showed that a
relatively modest decrease in Pur! expression (~60-70% knockdown) was sufficient to
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switch cells to a myofibroblast-like phenotype as exemplified by characteristic changes in
cell morphology, SM"A expression, TGF-!1 inducibility, and chemotactic migration
(Figures 3-1, 3-2, S3-3 and S3-4). Importantly, these changes occurred in the absence of
any substantive effect on cell growth suggesting that Pur! does not participate in the
direct regulation of cell cycling as has been reported for Pur" (63-68).
To better understand the structural basis for Pur!-mediated repression of ACTA2, we
employed web-based homology modeling servers to generate computational models of
the Pur! monomer and dimer based on the known x-ray crystal structure of Dm Pur"
residues 40-185 (39). As previously described for Pur" (38), the HHrepID web server
identified three regions of internal sequence homology termed PUR repeats I, II, and III
(Figure 3-3). Homology modeling suggested that each PUR repeat is similarly structured
with respect to the arrangement of four !-stands and one "-helix. By analogy to the
tertiary structure of Dm Pur" I-II, Mm Pur! I-II is predicted to fold in such a way as to
form an intramolecular PUR domain with features resembling a Whirly class-like DNAbinding fold (39). Although the PUR III repeat of Pur! is also predicted to adopt !!!!"
topology, the "-helical region is substantially longer than in PUR repeats I and II owing
to the presence of the so-called “psycho” motif spanning residues 264-305 (29). This
sequence is predicted to form an extended amphipathic "-helix, which may facilitate
protein-protein interaction. In one hypothetical model of the Pur! monomer, the PUR III
repeat is depicted as packing against the PUR I-II intramolecular domain (Figure 3-3B).
However, previous hydrodynamic studies showed that full-length Pur! reversibly selfassociates to form an elongated homodimer (36). Therefore, we speculated that the
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glycine-rich sequence spanning residues 210-229 may impart some degree of internal
flexibility allowing the PUR III repeat region to extend away from I-II (Figure 3-3C).
The interaction of two PUR III repeats to form an intermolecular PUR domain would
necessarily give rise to an elongated Pur! homodimer composed of three distinct modules
(Figure 3-3D).
Based on these deduced homology models, we created a set of expression vectors
encoding His-tagged Pur! truncation proteins containing single or selected combinations
of PUR repeats I, II, and III. Trial purifications from E. coli indicated that stable
expression and folding of Pur! requires the formation of intra- and/or intermolecular
subdomains. For example, Pur! I, Pur! II, and Pur! II-III constructs were poorly
expressed and/or only detectable in denatured lysates. Conversely, full-length Pur!, Pur!
I-II-III, Pur! I-II, and Pur! III were each highly expressed and readily purified under
non-denaturing conditions. Moreover, their respective CD spectra were indicative of
well-folded polypeptides. The results of calibrated SEC analysis confirmed the predicted
quaternary state of each purified truncation protein and indicated that PUR repeat III
constitutes the dimerization domain of Pur! (Figure 3-4). These findings are entirely
consistent with the reported quaternary structures of Dm Pur" I-II and Dm Pur" I-II-III
(39). Although the Pur" homodimer has been proposed to adopt a Z-like shape based on
results of small angle-X-ray scattering (39), the exact orientation and relation of the intraand intermolecular subdomains in the Pur! homodimer is currently unknown.
To evaluate the capacity of each Pur! truncation protein to repress ACTA2
transcription, we performed ACTA2-luciferase reporter gene assays in both MEFs and
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AoSMCs. As expected, the relative expression/stability of each Pur! construct in
mammalian cells was similar to that seen in E. coli. Of the truncation proteins expressed,
only the dimerization-competent Pur! I-II-III core construct and the Pur! I-II
intramolecular subdomain were consistently found to repress both the complete and
minimal ACTA2 enhancer-promoter in both cell types (Figures 3-5 and S3-8). However,
while Pur! I-II-III repressed the promoter to the same extent as the full-length protein,
Pur! I-II exhibited ~50% less repressor activity. The intrinsically weaker activity of Pur!
I-II was validated by titration experiments conducted over an extended range of
expression vector concentrations pointing to the necessity of the PUR III repeat for full
repressor function (Figure 3-6). Interestingly, forced expression of the Pur! III
dimerization domain by itself did not affect the ACTA2 enhancer-promoter owing, in part,
to the apparent inability of this construct to enter the nucleus when separated from Pur!
I-II intramolecular domain (Figure S3-11). However, in the context of the full-length
protein and the Pur! I-II-III core construct, we surmise that the PUR repeat III likely
promotes more efficient ACTA2 repression by mediating the formation of a dimeric
repressor capable of multisite ssDNA-binding within the confines of the nucleus.
Previous high resolution structural analyses of the 5)-flanking region of ACTA2
during myofibroblast differentiation revealed that an asymmetric Pur/Pyr tract spanning
nucleotides #210 to #150 is hypersensitive to modification by chemical probes that
preferentially react with unpaired nucleobases (58). This region contains a consensus
MCAT motif and a TGF-!1 response element that appear to function in conjunction with
downstream CArG and GC boxes to mediate high level ACTA2 transcription in
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fibroblasts (16, 17, 20). Consequently, we have chosen to focus our efforts on
characterizing the interaction of Pur! with the MCAT region of the ACTA2 enhancerpromoter due to its high Pur/Pyr asymmetry and apparent propensity to transiently adopt
non B-form structures in vivo (58). In this regard, a prior study from our lab reported that
Pur! interacts with the 32 nt purine-rich strand of the ACTA2 MCAT element (dubbed
PE32-F, #195 to #164) via a cooperative binding mechanism to generate a high-affinity
2:1 Pur!:ssDNA complex (37).
To test the importance of protein dimerization in facilitating the interaction of Pur!
with PE32-F, the relative ssDNA-binding affinity and specificity of full-length Pur! and
the core I-II-III protein were compared to the isolated intra- and intermolecular
subdomains using both direct and competitive ssDNA-binding assays. Because these
microplate-based colorimetric assays were performed under intrinsically non-equilibrium
conditions, it was not possible to determine precise quantitative differences between Pur!
I-II-III and the full-length protein. Despite this technical limitation, the Pur! I-II-III core
construct did appear to bind PE32-F with comparable affinity and specificity to fulllength Pur! under the assay conditions employed (Figure 3-7). Moreover, the
biochemical properties of Pur! I-II-III (residues 41-303) defined in this study are
analogous to those of a His tag-free core tryptic fragment of Pur! (residues 29-305)
described in an earlier report (40). Interestingly, while the Pur! I-II and Pur! III
subdomains each displayed a lower apparent affinity for PE32-F than Pur! I-II-III, the
intermolecular subdomain bound more tightly to ssDNA than the intramolecular
subdomain. The functional non-identity of the isolated Pur! I-II and Pur! III subdomains
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suggests that the native Pur! homodimer contains three separate but unequal ssDNAbinding modules. This structural arrangement reinforces the concept that stable
nucleoprotein complex assembly on the ACTA2 MCAT element likely involves the
recognition of multiple binding sites by Pur! (37). In support of this assertion, mutation
of all three PUR elements in PE32-F was necessary to completely eliminate ssDNAbinding by full-length Pur!, the I-II-III core, and each subdomain (Figure 3-7D).
Another defining attribute of Pur! structure and function uncovered in this report is
that the individual subdomains of Pur! differ in their capacity to interact with certain
transcription factors relevant to ACTA2 regulation in fibroblasts. In particular, the Pur! III intramolecular subdomain was a more avid binder of Sp3 than the Pur! III
intermolecular subdomain (Figure 3-8 and Figure S3-10). As Sp1 and Sp3 are known to
interact with several sequence elements located within the composite MCAT/CArG/GC
box enhancer (20), it is quite possible that the relatively strong repressor activity of Pur!
I-II observed in transfected cells was due, in part, to its ability to bind and sequester Sp3
away from the enhancer. This would also explain why Pur! I-II retained repressor
activity in the face of its relatively weak ssDNA-binding affinity compared to Pur! I-IIIII. On the other hand, all three PUR repeats were required for efficient interaction of
Pur! with MSY1 (mouse YB-1), the co-repressor protein that interacts with the
pyrimidine-rich antisense strand of the ACTA2 Pur/Pyr tract (17, 22). This feature may
account for why Pur! I-II-III was such an effective repressor when expressed in cells as
direct physical interaction between Pur! and MSY1 is probably essential for efficient
assembly of these co-repressors on the Pur/Pyr element and ensuing disruption of the
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core MCAT motif (37). Coordinated binding of MSY1 to the pyrimidine-rich strand may
also serve to potentiate the intrinsic helix-destabilizing activity of Pur! (28). Unraveling
the degree to which Pur! can stably alter the secondary structure of specific cis-elements
in ACTA2 will clearly require a more systematic evaluation of the helix-destabilizing
properties of Pur! and its isolated subdomains based on the biochemical criteria
established for Pur"-mediated melting of duplex DNA (27, 28, 69).
In summary, our findings reveal that Pur! is a potent inhibitor of myofibroblast
differentiation by virtue of its ability to repress ACTA2 transcription via specific proteinssDNA and protein-protein interactions. The functionally relevant unit of Pur! that
mediates ACTA2 repression appears to be the homodimeric form of the protein.
Subdomain-specific inter- and intramolecular interactions account for the formation of
three separate ssDNA-binding modules within the Pur! homodimer. The tripartite
organization of the assembled homodimer readily explains the structural basis for the
cooperative binding of Pur! to multiple purine-rich sites within the MCAT region of the
composite ACTA2 enhancer as well as the preferential association of Pur! with its corepressor partner MSY1/YB-1.

130

REFERENCES
1.

Walker, G. A., Guerrero, I. A., and Leinwand, L. A. (2001) Myofibroblasts:
molecular crossdressers, Curr Top Dev Biol 51, 91-107.

2.

Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., and Brown, R. A. (2002)
Myofibroblasts and mechano-regulation of connective tissue remodelling, Nat
Rev Mol Cell Biol 3, 349-363.

3.

Gabbiani, G., Ryan, G. B., and Majne, G. (1971) Presence of modified fibroblasts
in granulation tissue and their possible role in wound contraction, Experientia 27,
549-550.

4.

Gabbiani, G., Hirschel, B. J., Ryan, G. B., Statkov, P. R., and Majno, G. (1972)
Granulation tissue as a contractile organ. A study of structure and function, J Exp
Med 135, 719-734.

5.

Hinz, B. (2007) Formation and function of the myofibroblast during tissue repair,
J Invest Dermatol 127, 526-537.

6.

Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M. L., and
Gabbiani, G. (2007) The myofibroblast: one function, multiple origins, Am J
Pathol 170, 1807-1816.

7.

De Wever, O., and Mareel, M. (2003) Role of tissue stroma in cancer cell
invasion, J Pathol 200, 429-447.

8.

Zalewski, A., Shi, Y., and Johnson, A. G. (2002) Diverse origin of intimal cells:
smooth muscle cells, myofibroblasts, fibroblasts, and beyond?, Circ Res 91, 652655.

9.

Hao, H., Gabbiani, G., Camenzind, E., Bacchetta, M., Virmani, R., and BochatonPiallat, M. L. (2006) Phenotypic modulation of intima and media smooth muscle
cells in fatal cases of coronary artery lesion, Arterioscler Thromb Vasc Biol 26,
326-332.

10.

Darby, I., Skalli, O., and Gabbiani, G. (1990) Alpha-smooth muscle actin is
transiently expressed by myofibroblasts during experimental wound healing, Lab
Invest 63, 21-29.

131

11.

Wang, J., Zohar, R., and McCulloch, C. A. (2006) Multiple roles of alpha-smooth
muscle actin in mechanotransduction, Exp Cell Res 312, 205-214.

12.

Hinz, B., Celetta, G., Tomasek, J. J., Gabbiani, G., and Chaponnier, C. (2001)
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity,
Mol Biol Cell 12, 2730-2741.

13.

Stoflet, E. S., Schmidt, L. J., Elder, P. K., Korf, G. M., Foster, D. N., Strauch, A.
R., and Getz, M. J. (1992) Activation of a muscle-specific actin gene promoter in
serum-stimulated fibroblasts, Mol Biol Cell 3, 1073-1083.

14.

Foster, D. N., Min, B., Foster, L. K., Stoflet, E. S., Sun, S., Getz, M. J., and
Strauch, A. R. (1992) Positive and negative cis-acting regulatory elements
mediate expression of the mouse vascular smooth muscle alpha-actin gene, J Biol
Chem 267, 11995-12003.

15.

Sun, S., Stoflet, E. S., Cogan, J. G., Strauch, A. R., and Getz, M. J. (1995)
Negative regulation of the vascular smooth muscle alpha-actin gene in fibroblasts
and myoblasts: disruption of enhancer function by sequence-specific singlestranded-DNA-binding proteins, Mol Cell Biol 15, 2429-2436.

16.

Subramanian, S. V., Polikandriotis, J. A., Kelm, R. J., Jr., David, J. J., Orosz, C.
G., and Strauch, A. R. (2004) Induction of vascular smooth muscle alpha-actin
gene transcription in transforming growth factor beta1-activated myofibroblasts
mediated by dynamic interplay between the Pur repressor proteins and Sp1/Smad
coactivators, Mol Biol Cell 15, 4532-4543.

17.

Carlini, L. E., Getz, M. J., Strauch, A. R., and Kelm, R. J., Jr. (2002) Cryptic
MCAT enhancer regulation in fibroblasts and smooth muscle cells. Suppression
of TEF-1 mediated activation by the single-stranded DNA-binding proteins, Pur
alpha, Pur beta, and MSY1, J Biol Chem 277, 8682-8692.

18.

Gan, Q., Yoshida, T., Li, J., and Owens, G. K. (2007) Smooth muscle cells and
myofibroblasts use distinct transcriptional mechanisms for smooth muscle alphaactin expression, Circ Res 101, 883-892.

19.

Sandbo, N., Kregel, S., Taurin, S., Bhorade, S., and Dulin, N. O. (2009) Critical
role of serum response factor in pulmonary myofibroblast differentiation induced
by TGF-beta, Am J Respir Cell Mol Biol 41, 332-338.

20.

Cogan, J. G., Subramanian, S. V., Polikandriotis, J. A., Kelm, R. J., Jr., and
Strauch, A. R. (2002) Vascular smooth muscle alpha-actin gene transcription
during myofibroblast differentiation requires Sp1/3 protein binding proximal to
the MCAT enhancer, J Biol Chem 277, 36433-36442.
132

21.

Cogan, J. G., Sun, S., Stoflet, E. S., Schmidt, L. J., Getz, M. J., and Strauch, A. R.
(1995) Plasticity of vascular smooth muscle alpha-actin gene transcription.
Characterization of multiple, single-, and double-strand specific DNA-binding
proteins in myoblasts and fibroblasts, J Biol Chem 270, 11310-11321.

22.

Kelm, R. J., Jr., Cogan, J. G., Elder, P. K., Strauch, A. R., and Getz, M. J. (1999)
Molecular interactions between single-stranded DNA-binding proteins associated
with an essential MCAT element in the mouse smooth muscle alpha-actin
promoter, J Biol Chem 274, 14238-14245.

23.

Bergemann, A. D., and Johnson, E. M. (1992) The HeLa Pur factor binds singlestranded DNA at a specific element conserved in gene flanking regions and
origins of DNA replication, Mol Cell Biol 12, 1257-1265.

24.

Bergemann, A. D., Ma, Z. W., and Johnson, E. M. (1992) Sequence of cDNA
comprising the human pur gene and sequence-specific single-stranded-DNAbinding properties of the encoded protein, Mol Cell Biol 12, 5673-5682.

25.

Johnson, E. M., Daniel, D. C., and Gordon, J. (2013) The pur protein family:
Genetic and structural features in development and disease, J Cell Physiol 228,
930-937.

26.

Kelm, R. J., Jr., Elder, P. K., Strauch, A. R., and Getz, M. J. (1997) Sequence of
cDNAs encoding components of vascular actin single-stranded DNA-binding
factor 2 establish identity to Puralpha and Purbeta, J Biol Chem 272, 2672726733.

27.

Darbinian, N., Gallia, G. L., and Khalili, K. (2001) Helix-destabilizing properties
of the human single-stranded DNA- and RNA-binding protein Puralpha, J Cell
Biochem 80, 589-595.

28.

Wortman, M. J., Johnson, E. M., and Bergemann, A. D. (2005) Mechanism of
DNA binding and localized strand separation by Pur alpha and comparison with
Pur family member, Pur beta, Biochim Biophys Acta 1743, 64-78.

29.

Kelm, R. J., Jr., Wang, S. X., Polikandriotis, J. A., and Strauch, A. R. (2003)
Structure/function analysis of mouse Purbeta, a single-stranded DNA-binding
repressor of vascular smooth muscle alpha-actin gene transcription, J Biol Chem
278, 38749-38757.

30.

Knapp, A. M., Ramsey, J. E., Wang, S. X., Godburn, K. E., Strauch, A. R., and
Kelm, R. J., Jr. (2006) Nucleoprotein interactions governing cell type-dependent

133

repression of the mouse smooth muscle alpha-actin promoter by single-stranded
DNA-binding proteins Pur alpha and Pur beta, J Biol Chem 281, 7907-7918.
31.

Gupta, M., Sueblinvong, V., Raman, J., Jeevanandam, V., and Gupta, M. P.
(2003) Single-stranded DNA-binding proteins PURalpha and PURbeta bind to a
purine-rich negative regulatory element of the alpha-myosin heavy chain gene and
control transcriptional and translational regulation of the gene expression.
Implications in the repression of alpha-myosin heavy chain during heart failure, J
Biol Chem 278, 44935-44948.

32.

Ji, J., Tsika, G. L., Rindt, H., Schreiber, K. L., McCarthy, J. J., Kelm, R. J., Jr.,
and Tsika, R. (2007) Puralpha and Purbeta collaborate with Sp3 to negatively
regulate beta-myosin heavy chain gene expression during skeletal muscle
inactivity, Mol Cell Biol 27, 1531-1543.

33.

Gupta, M., Sueblinvong, V., and Gupta, M. P. (2007) The single-strand
DNA/RNA-binding protein, Purbeta, regulates serum response factor (SRF)mediated cardiac muscle gene expression, Can J Physiol Pharmacol 85, 349-359.

34.

McCarthy, J. J., Esser, K. A., Peterson, C. A., and Dupont-Versteegden, E. E.
(2009) Evidence of MyomiR network regulation of beta-myosin heavy chain gene
expression during skeletal muscle atrophy, Physiol Genomics 39, 219-226.

35.

van Rooij, E., Quiat, D., Johnson, B. A., Sutherland, L. B., Qi, X., Richardson, J.
A., Kelm, R. J., Jr., and Olson, E. N. (2009) A family of microRNAs encoded by
myosin genes governs myosin expression and muscle performance, Dev Cell 17,
662-673.

36.

Ramsey, J. E., Daugherty, M. A., and Kelm, R. J., Jr. (2007) Hydrodynamic
studies on the quaternary structure of recombinant mouse Purbeta, J Biol Chem
282, 1552-1560.

37.

Ramsey, J. E., and Kelm, R. J., Jr. (2009) Mechanism of strand-specific smooth
muscle alpha-actin enhancer interaction by purine-rich element binding protein B
(Purbeta), Biochemistry 48, 6348-6360.

38.

Graebsch, A., Roche, S., Kostrewa, D., Soding, J., and Niessing, D. (2010) Of bits
and bugs--on the use of bioinformatics and a bacterial crystal structure to solve a
eukaryotic repeat-protein structure, PLoS One 5, e13402.

39.

Graebsch, A., Roche, S., and Niessing, D. (2009) X-ray structure of Pur-alpha
reveals a Whirly-like fold and an unusual nucleic-acid binding surface, Proc Natl
Acad Sci U S A 106, 18521-18526.

134

40.

Rumora, A. E., Steere, A. N., Ramsey, J. E., Knapp, A. M., Ballif, B. A., and
Kelm, R. J., Jr. (2010) Isolation and characterization of the core single-stranded
DNA-binding domain of purine-rich element binding protein B (Purbeta),
Biochem Biophys Res Commun 400, 340-345.

41.

Wang, J., Niu, W., Nikiforov, Y., Naito, S., Chernausek, S., Witte, D., LeRoith,
D., Strauch, A., and Fagin, J. A. (1997) Targeted overexpression of IGF-I evokes
distinct patterns of organ remodeling in smooth muscle cell tissue beds of
transgenic mice, J Clin Invest 100, 1425-1439.

42.

Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A.,
McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., Thompson, J.
D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and Clustal X version 2.0,
Bioinformatics 23, 2947-2948.

43.

Goujon, M., McWilliam, H., Li, W., Valentin, F., Squizzato, S., Paern, J., and
Lopez, R. (2010) A new bioinformatics analysis tools framework at EMBL-EBI,
Nucleic Acids Res 38, W695-699.

44.

Biegert, A., and Soding, J. (2008) De novo identification of highly diverged
protein repeats by probabilistic consistency, Bioinformatics 24, 807-814.

45.

Buchan, D. W., Ward, S. M., Lobley, A. E., Nugent, T. C., Bryson, K., and Jones,
D. T. (2010) Protein annotation and modelling servers at University College
London, Nucleic Acids Res 38, W563-568.

46.

Zhang, Y. (2008) I-TASSER server for protein 3D structure prediction, BMC
Bioinformatics 9, 40.

47.

Roy, A., Kucukural, A., and Zhang, Y. (2010) I-TASSER: a unified platform for
automated protein structure and function prediction, Nat Protoc 5, 725-738.

48.

Arnold, K., Bordoli, L., Kopp, J., and Schwede, T. (2006) The SWISS-MODEL
workspace: a web-based environment for protein structure homology modelling,
Bioinformatics 22, 195-201.

49.

Kiefer, F., Arnold, K., Kunzli, M., Bordoli, L., and Schwede, T. (2009) The
SWISS-MODEL Repository and associated resources, Nucleic Acids Res 37,
D387-392.

50.

Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., and Schwede, T. (2009)
Protein structure homology modeling using SWISS-MODEL workspace, Nat
Protoc 4, 1-13.

135

51.

Emsley, P., Lohkamp, B., Scott, W. G., and Cowtan, K. (2010) Features and
development of Coot, Acta Crystallogr D Biol Crystallogr 66, 486-501.

52.

Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., GrosseKunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R.
J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Crystallography & NMR
system: A new software suite for macromolecular structure determination, Acta
Crystallogr D Biol Crystallogr 54, 905-921.

53.

Brunger, A. T. (2007) Version 1.2 of the Crystallography and NMR system, Nat
Protoc 2, 2728-2733.

54.

Schrodinger, LLC. (2010) The PyMOL Molecular Graphics System, Version
1.3r1.

55.

Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R. D., and Bairoch, A.
(2003) ExPASy: The proteomics server for in-depth protein knowledge and
analysis, Nucleic Acids Res 31, 3784-3788.

56.

Knapp, A. M., Ramsey, J. E., Wang, S. X., Strauch, A. R., and Kelm, R. J., Jr.
(2007) Structure-function analysis of mouse Pur beta II. Conformation altering
mutations disrupt single-stranded DNA and protein interactions crucial to smooth
muscle alpha-actin gene repression, J Biol Chem 282, 35899-35909.

57.

Wang, S. X., Elder, P. K., Zheng, Y., Strauch, A. R., and Kelm, R. J., Jr. (2005)
Cell cycle-mediated regulation of smooth muscle alpha-actin gene transcription in
fibroblasts and vascular smooth muscle cells involves multiple adenovirus E1Ainteracting cofactors, J Biol Chem 280, 6204-6214.

58.

Becker, N. A., Kelm, R. J., Jr., Vrana, J. A., Getz, M. J., and Maher, L. J., 3rd.
(2000) Altered sensitivity to single-strand-specific reagents associated with the
genomic vascular smooth muscle alpha-actin promoter during myofibroblast
differentiation, J Biol Chem 275, 15384-15391.

59.

White, M. K., Johnson, E. M., and Khalili, K. (2009) Multiple roles for Puralpha
in cellular and viral regulation, Cell Cycle 8, 1-7.

60.

Ronnov-Jessen, L., and Petersen, O. W. (1996) A function for filamentous alphasmooth muscle actin: retardation of motility in fibroblasts, J Cell Biol 134, 67-80.

61.

Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M., Desmouliere, A., Varga, J.,
De Wever, O., Mareel, M., and Gabbiani, G. (2012) Recent developments in
myofibroblast biology: paradigms for connective tissue remodeling, Am J Pathol
180, 1340-1355.
136

62.

Zhang, A., David, J. J., Subramanian, S. V., Liu, X., Fuerst, M. D., Zhao, X.,
Leier, C. V., Orosz, C. G., Kelm, R. J., Jr., and Strauch, A. R. (2008) Serum
response factor neutralizes Pur alpha- and Pur beta-mediated repression of the
fetal vascular smooth muscle alpha-actin gene in stressed adult cardiomyocytes,
Am J Physiol Cell Physiol 294, C702-714.

63.

Johnson, E. M., Chen, P. L., Krachmarov, C. P., Barr, S. M., Kanovsky, M., Ma,
Z. W., and Lee, W. H. (1995) Association of human Pur alpha with the
retinoblastoma protein, Rb, regulates binding to the single-stranded DNA Pur
alpha recognition element, J Biol Chem 270, 24352-24360.

64.

Barr, S. M., and Johnson, E. M. (2001) Ras-induced colony formation and
anchorage-independent growth inhibited by elevated expression of Puralpha in
NIH3T3 cells, J Cell Biochem 81, 621-638.

65.

Khalili, K., Del Valle, L., Muralidharan, V., Gault, W. J., Darbinian, N., Otte, J.,
Meier, E., Johnson, E. M., Daniel, D. C., Kinoshita, Y., Amini, S., and Gordon, J.
(2003) Puralpha is essential for postnatal brain development and developmentally
coupled cellular proliferation as revealed by genetic inactivation in the mouse,
Mol Cell Biol 23, 6857-6875.

66.

Liu, H., Barr, S. M., Chu, C., Kohtz, D. S., Kinoshita, Y., and Johnson, E. M.
(2005) Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2,
Biochem Biophys Res Commun 328, 851-857.

67.

Darbinian, N., Gallia, G. L., Kundu, M., Shcherbik, N., Tretiakova, A., Giordano,
A., and Khalili, K. (1999) Association of Pur alpha and E2F-1 suppresses
transcriptional activity of E2F-1, Oncogene 18, 6398-6402.

68.

Darbinian, N., White, M. K., Gallia, G. L., Amini, S., Rappaport, J., and Khalili,
K. (2004) Interaction between the pura and E2F-1 transcription factors,
Anticancer Res 24, 2585-2594.

69.

Zhang, Q., Pedigo, N., Shenoy, S., Khalili, K., and Kaetzel, D. M. (2005)
Puralpha activates PDGF-A gene transcription via interactions with a G-rich,
single-stranded region of the promoter, Gene 348, 25-32.

137

SUPPORTING INFORMATION

STRUCTURAL BASIS OF MULTISITE SINGLE-STRANDED
DNA RECOGNITION AND ACTA2 REPRESSION BY PURINERICH ELEMENT BINDING PROTEIN B (PUR!)†

Amy E. Rumora‡, Shu-Xia Wang§, Lauren A. Ferris‡,
Stephen J. Everse‡, and Robert J. Kelm, Jr. ‡§$*

Departments of ‡Biochemistry and §Medicine, $Cardiovascular Research Institute,
University of Vermont College of Medicine, Burlington, VT 05405

*

To whom correspondence should be addressed: Robert J. Kelm, Jr., Department of Medicine,

Cardiology/Vascular Biology Unit, University of Vermont College of Medicine, Colchester
Research Facility, 208 South Park Drive, Colchester, VT 05446, Tel: (802) 656-0329; Fax: (802)
656-8969; E-mail: robert.kelm@uvm.edu

SUPPLEMENTAL MATERIALS AND METHODS
SUPPLEMENTAL REFERENCES
SUPPLEMENTAL TABLE S1
SUPPLEMENTAL FIGURES S1-S11

138

SUPPLEMENTAL MATERIALS
METHODS

Construction of expression vectors encoding Pur! truncation proteins.
Complementary DNAs encoding amino acids 41-112 (Pur! I), 125-210 (Pur! II), 209303 (Pur! III), 41-210 (Pur! I-II), 125-303 (Pur! II-III), and 41-303 (Pur! I-II-III) were
amplified by polymerase chain reaction (PCR) from the pCI-10-1Pur! template (1) using
Pfu polymerase (Stratagene) and primers engineered to create 5) BamHI and 3) KpnI
cloning sites (Table S3-I). PCR products were gel purified, cut with restriction enzymes,
and ligated into BamHI/KpnI digested and alkaline phosphatase-treated pQE30 vector
(Qiagen). Following transformation into E. coli JM109 cells, ampicillin-resistant clones
were selected and bacterial expression plasmids were purified from 5 ml cultures using a
High Pure Plasmid Isolation Kit (Roche Applied Science). Plasmids were screened for
the presence of the correct cDNA insert by restriction enzyme digestion and DNA
sequencing. EcoRI/KpnI fragments were then isolated from sequence-validated pQE30
constructs and subcloned into EcoRI/KpnI digested and alkaline phosphatase-treated pCI
vector (Promega). The resulting mammalian expression plasmids were propagated in E.
coli DH5" cells and screened for insertion and sequence fidelity as described above.
DNA sequencing of plasmid constructs was performed by the Vermont Cancer Center
DNA Analysis Facility.
All reporter and expression plasmids used in transient transfection studies were
purified from 1 liter E. coli cultures by double CsCl gradient centrifugation. Ethidium
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bromide was extracted from isolated plasmid bands using 50% v/v CsCl-saturated
isopropanol. Plasmids were then dialyzed extensively against 7.5 mM sodium citrate, 75
mM NaCl pH 7.0, precipitated with 70% ethanol, and collected by centrifugation.
Plasmid pellets were washed with 70% ethanol and then dissolved in sterile water.
Soluble plasmids were quantified by optical density measurement and stored at #20°C.
Relative DNA purity was assessed by A260/A280 ratio in conjunction with agarose gel
electrophoresis of supercoiled and restriction enzyme cut plasmids.
Cell growth assay. AKR-2B MEF cell lines were seeded at a fixed density of 2.0%
105 cells per 60 mm dish in McCoys 5A medium with 5% FBS and 10 µg/ml blasticidin.
At selected time points, cells were trypsinized, resuspended in serum-containing growth
medium, and enumerated using a hemacytometer. Counts were typically performed on
two dishes of cells at each time point and repeated three times.
Cell migration assay. Stably-transduced AKR-2B MEF cell lines were grown to
confluence in growth medium containing 10 µg/ml blasticidin and then switched to
serum-free medium for 24 h. Cells were then trypsinized, resuspended in trypsinneutralization solution (Lonza), and counted. Cells were collected by centrifugation at
450 % g for 10 min and resuspended in serum-free MCDB-402 medium (JRH
Biosciences) to a concentration of 2.5 % 106 cells/ml. A total of 0.1 ml was loaded (in
duplicate or triplicate) into 6.5 mm diameter, 8.0 µm pore size Transwell& inserts
(Corning Costar Corp.), which were placed in wells containing 0.6 ml of MCDB-402
medium supplemented with 10% v/v FBS or 5% w/v BSA for 22 h at 37°C in a 5% CO2
incubator. Inserts were washed with PBS and transferred to wells containing 0.09% w/v
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crystal violet in 8% v/v ethanol, 1% v/v methanol, 1% v/v isopropanol for 30 min. The
cell-stained inserts were rinsed extensively in water and the inner membrane of each
insert was cleaned with a cotton fiber-tipped swab prior to air-drying for 30 min. The
inserts were then placed in wells containing 0.2 ml cell extraction solution consisting of
0.2 M acetate pH 5.0, 45% v/v ethanol, 3% v/v methanol, 3% v/v isopropanol. Cell
lysates, 0.1 ml, were transferred to 96-well plates and absorbance values at 570 nm were
obtained using a microplate reader.
Expression and purification of recombinant Pur! truncation proteins. Aminoterminal hexahistidine-tagged (NHis) fusion proteins were expressed in E. coli JM 109
cells transformed with pQE30 plasmids encoding full-length mouse Pur", mouse Pur!, or
selected Pur! truncation proteins. Terrific broth containing 100 µg/ml ampicillin
(typically 4 liters) was inoculated with a 1:50 dilution of bacterial starter culture. After 3
h growth in a 37°C shaker incubator, full-length NHis-Pur! or NHis-Pur! I-II expression
was induced by the addition of 1 mM isopropyl !-D-1-thiogalactopyranoside (IPTG) for
4 h at 37°C. Stable expression of NHis-Pur! I-II-III or NHis-Pur! III was achieved by
addition of 0.1 mM IPTG and incubating for 16 h at 25°C. Cells were collected by
centrifugation at 8000 % g for 10 min at 4°C and soluble lysate was prepared as described
previously (2). Recombinant truncation proteins were purified by metal chelate affinity
chromatography (His-Select& Nickel Affinity Gel, Sigma-Aldrich) followed by size
exclusion chromatography (SEC) using conditions previously established for full-length
NHis-Pur! with some modifications (2). Briefly, His-tagged proteins were eluted from
the Nickel Affinity Gel by application of a linear gradient of 10 to 500 mM imidazole in
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column buffer consisting of 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 10 mM !mercaptoethanol, 0.5 mM PMSF, and 1 µg/ml each of aprotinin, pepstatin A, and
leupeptin. Elution was monitored by measuring the absorbance of fractions at 280 nm.
Fractions enriched in recombinant protein as determined by SDS-PAGE were pooled and
concentrated using either a 10,000 MWCO (NHis-Pur! I-II-III) or 3,500 MWCO (NHisPur! I-II and NHis-Pur! III) Amicon& Ultra centrifugal filter unit (Millipore). SEC of
NHis-Pur! truncation proteins was performed on a calibrated 1.5 % 100 cm column
packed with Sephacryl& 200 HR resin (Sigma) at a flow rate of 0.85 ml/min. NHis-Pur!
I-II-III was subjected to an additional heparin-agarose affinity purification step prior to
SEC in a similar manner as described for the Pur! core tryptic fragment (3).
Antibody screening assays. Mouse or rat antiserum and hybridoma culture
supernatants were screened by enzyme-linked immunosorbent assay (ELISA). Bovine
serum albumin (BSA)-coupled peptides at 1.0 µM or full-length recombinant Pur" or
Pur! at 50 nM were passively absorbed to microtiter wells (Costar& EIA/RIA plates or
strips, Corning Inc.) in 100 µl coating buffer consisting of 20 mM Tris-Cl pH 7.5, 150
mM NaCl (TBS) with 5 µg/ml BSA. After overnight incubation at 4°C, coating solution
was removed and the wells were rinsed twice with wash buffer consisting of TBS with
0.05% v/v Tween& 20 (TBST) followed immediately by the addition of 300 µl of 2%
w/v BSA-TBS blocking buffer. After 1 h incubation at ambient temperature, blocking
buffer was removed and 100 µl of hybridoma culture supernatant or rodent antiserum
diluted serially in 0.2% w/v BSA-TBST was applied. Uncoated, BSA-blocked wells
served as a negative control. After 2 h incubation with primary antibody, wells were
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washed three times and 100 µl of a 1:4000 to 1:8000 dilution of horseradish peroxidase
(HRP)-conjugated goat anti-mouse IgG (Jackson Laboratories or Santa Cruz
Biotechnology, Inc.) or HRP-conjugated goat anti-rat IgG (Santa Cruz Biotechnology,
Inc.) was applied for 1 h. After removing the secondary antibody, the wells were washed
three times and 100 µl of ABTS (2,2)-AZINO-bis[3-ethylbenziazoline-6-sulfonic acid])
peroxidase substrate solution (Millipore) was applied. The reaction was quenched by the
addition of an equal volume of 1% w/v sodium dodecyl sulfate solution and absorbance
values at 405 nm were obtained using a 96-well plate reader. Color development times
typically ranged from 8 to 15 min.
Western blotting antibodies. The source and dilution of primary antibodies used for
immunoblotting were as follows: rabbit anti-Pur"/! B42-69 ((4), 1.0 µg/ml), rat antiPur"/! clone 3C3.6C1 (this report, 0.5 µg/ml), mouse anti-smooth muscle "-actin clone
1A4 (Sigma-Aldrich, 1:2000), mouse anti-!-actin clone AC-15 (Sigma-Aldrich, 1:2000),
mouse anti-GAPDH clone 6C5 (Millipore, 1.0 µg/ml), mouse anti-RGS-His (Qiagen, 1.0
µg/ml). HRP-coupled goat anti-mouse IgG, goat anti-rabbit IgG, or goat anti-rat IgG
secondary antibodies (Santa Cruz Biotechnology, Inc.) were all used at a 1:2000 dilution.
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SUPPLEMENTAL TABLE AND FIGURES
Table S3- 3 Primer sets used in the amplification of cDNAs encoding mouse Pur!
truncation proteins containing sequences corresponding to PUR repeats I, II, or III
_______________________________________________________________________
Primersa
Sequenceb
_______________________________________________________________________
Pur! I (41-112):
mPurb RI 41S 5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3)
mPurb RI 112AS 5)-CATGATGGTACCTTAGCTGGGACCCAGCTGCGCGTA- 3)
Pur! II (125-210):
mPurb RII 125S
5)-ATCATGGGATCCGGCGGGCCGCGCCGCGCGCTCAAG-3)
mPurb RII 210AS 5)-CATGATGGTACCTTAGTCCTCGTCGCCCCCGTAGTC-3)
Pur! III (209-303):
mPurb RIII 209S 5)-ATCATGGGATCCGAGGACGAGCTGGCCGGCGGCCCG-3)
mPurb RIII 303AS 5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3)
Pur! I-II (41-210):
mPurb RI 41S 5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3)
mPurb RII 210AS 5)-CATGATGGTACCTTAGTCCTCGTCGCCCCCGTAGTC-3)
Pur! II-III (125-303):
mPurb RII 125S
5)-ATCATGGGATCCGGCGGGCCGCGCCGCGCGCTCAAG-3)
mPurb RIII 303AS 5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3)
Pur! I-II-III (41-303):
mPurb RI 41S 5)-ATCATGGGATCCCAGGAGACGCAGGAGCTGGCCTCG-3)
mPurb RIII 303AS 5)-CATGATGGTACCTTAGTAAAGCTTATCCCTCTGTCG-3)
_______________________________________________________________________
a
Numbers in parentheses denote the amino acid sequence encoded by the cDNA
amplified by each primer set (not including the N-terminal His epitope tag).
Abbreviations: m, mouse; S, sense; AS, antisense.
b
Clamp, BamHI site (sense primer), KpnI site (antisense primer), TTA (stop codon)
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Figure S3- 1. Characterization of monoclonal antibodies recognizing Pur" and Pur!.
Microtiter wells coated with an equivalent concentration of NHis-Pur" (A) or NHis-Pur!
(B) were incubated with varying amounts of the indicated mouse or rat monoclonal
antibodies. Solid-phase antibody-Pur"/! complexes were detected by ELISA. Antibodies
raised against amino acids 42-69 of Pur! (PURB42, a PUR repeat I sequence conserved
in Pur") recognize both Pur" and Pur! while antibodies raised against C-terminal amino
acids 302-324 of Pur! (PURB302) only recognize Pur!. Due to its very high affinity for
both Pur" and Pur!, mAb 3C3.6C1 was chosen for use in Western blotting analyses.
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Figure S3- 2. Growth of stably-transduced AKR-2B MEF cell lines. Cells were seeded at
a fixed density of 2.0 % 105 cells per 60 mm dish in McCoys 5A medium supplemented
with 5% FBS and 10 µg/ml blasticidin. Cell counts were performed every 24 h. Bars
(mean ± SEM, n = 8) show cell counts performed on Pur! knockdown MEFs (!I-B4,
black bars), Pur" deficient MEFs (!I-F3, red bars), or scrambled RNA control cells (!SE6, green bars).
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Figure S3- 3. Morphology of Pur! knockdown MEFs at confluence. (A) Immunoblotting
of whole cell extracts (15 µg protein/lane) of the indicated MEFs cell lines was
conducted with rat anti-Pur"/! mAb 3C3.6C1. The Pur"/! blot was reprobed with a
GAPDH mAb as a protein loading control. !I-B4 and !I-G7 are cell lines stably
expressing Pur! shRNA, while !S-E6 is a control cell line expressing scrambled RNA.
!I-F3 is a serendipitously isolated cell line that exhibits markedly reduced Pur"
expression. Lines and numbers on the left side designate the relative position and size (in
kDa) of prestained protein markers. (B) Phase contrast micrographs of confluent cultures
of the indicated MEF cell lines viewed through a 10% objective.

147

Figure S3- 4. Relative migration of Pur! knockdown MEFs. The migration of the Pur!
knockdown (!I-B4 and !I-G7) and control (!S-E6) MEFs toward chemotactic agent
(10% FBS) or inert medium (5% BSA) was assessed by colorimetric Boyden chamber
assay. Bars shows the absorbance values at 570 nm (A570) of extracts made from post
migration, crystal violet-stained cells (mean ± SEM, n = 11 for 10% FBS and n = 7 for
5% BSA). **, p < 0.01, ***, p < 0.001 compared to !S-E6.
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Figure S3- 5. Hypothetical structure of PUR repeats I and II in Pur" versus Pur!. The
known structure of Dm Pur" 40-185 (A, blue) was used as a template to generate
homology models of the intramolecular domain formed by PUR repeats I and II in Mm
Pur" (B, green) and Mm Pur! (C, orange) using the SWISS-MODEL web server. (D)
Predicted structures were overlaid using PyMOL to reveal several internal loop-forming
elements that may distinguish Pur" from Pur!. The most distinctive regions within Mm
Pur! correspond to amino acids 109-131 and 162-182.
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Figure S3- 6. SDS-PAGE of purified Pur! truncation proteins. Recombinant proteins
were expressed in and purified from E. coli JM109 cells using a combination of metal
chelate affinity, heparin agarose affinity, and size exclusion chromatography. Proteins
were separated on a 4-20% gradient gel under reducing conditions and stained with
Coomassie Blue. Each lane was loaded with 40 pmoles of NHis-tagged protein. The
numbers on the left side designate the relative size (in kDa) of marker proteins in the
ladder run in lane 1. FL, full-length.
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Figure S3- 7. Analysis of Pur! truncation proteins by CD spectroscopy. (A) Baselinecorrected CD spectra of 5.0 µM solutions of the indicated purified recombinant proteins
are shown. Pur! I-II #1 and #2 refer to two distinct protein preparations. (B) The mean
residue ellipticity in deg cm2 dmol-1 of each protein at each wavelength was calculated
using the formula [!] = !obs/(c * l * n) where !obs is the observed ellipticity in millidegrees,
c is the molar protein concentration, l is the path length of the cuvette in millimeters, and
n is the number of amino acid residues. The values of n for each NHis-tagged protein are
as follows: Pur! FL (335), Pur! I-II-III (274), Pur! I-II (181), Pur! III (106). FL, fulllength.
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Figure S3- 8. ACTA2 repressor activity of Pur! truncation proteins expressed in
C57BL/6 AoSMCs. (A) Primary AoSMCs were transiently co-transfected with ACTA2
luciferase reporters (VSMP8 or VSMP4) and expression vectors encoding the indicated
Pur! proteins. After 48 h, cell lysates were prepared and assayed for luciferase activity
and total protein. Bars show total protein-corrected luciferase values normalized to the
pCI control (defined as 1) for each reporter (mean ± SEM, n = 6 to 9). ***, p < 0.001, **,
p < 0.01, *, p < 0.05 compared to pCI control for VSMP8 (black bars) or VSMP4 (gray
bars). (B) Western blotting of detergent-soluble lysates (10 µg protein/lane) of
transfected cells was performed with a mAb recognizing the N-terminal His epitope tag
present on each Pur! construct. (C) Western blotting of urea-denatured extracts (10 µg
protein/lane) of detergent-insoluble cell remnants was conducted with the His tag mAb.
(B, C) In both immunoblots, lysates were resolved on a 14% polyacrylamide gel. Lines
and numbers on the left side designate the relative position and size (in kDa) of
prestained protein markers. FL, full-length.
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Figure S3- 9. Binding of purified NHis-Pur! proteins to PE32-bF. (A) Biotinylated
ssDNA probe (PE32-bF) corresponding to the sense strand of a cis-element spanning
nucleotides #195 to #164 of mouse ACTA2 was immobilized on StreptaWells at
concentrations ranging from 60 nM to 82 pM. Solutions containing 1.0 nM of the
indicated NHis-Pur! proteins were added and the wells were incubated for 16 h. Solidphase nucleoprotein complexes were detected by ELISA using a primary His tag
antibody. Absorbance values at 405 nm were corrected for nonspecific protein binding to
wells without DNA and normalized to the maximum absorbance attained at saturation for
each protein. Data points were fit to a four parameter equation (Y = Amin + (AmaxAmin)/(1+10((LogEC50-X)*HillSlope)) to determine the midpoint (EC50) of each curve. (B)
Varying concentrations of NHis-Pur! were incubated with 5.0 nM wild type PE32-bF or
double or triple PUR element mutants (35T7 or 3I5T7) immobilized on StreptaWells.
Solid-phase nucleoprotein complexes were detected by ELISA using a primary His tag
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antibody. Absorbance values at 405 nm were corrected for nonspecific binding of NHisPur! I-II to wells without DNA. Data points were connected by a spline curve. FL, fulllength.
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Figure S3- 10. Binding of AKR-2B MEF-derived transcription factors to purified NHisPur! proteins. Microtiter wells coated with equivalent concentrations of the indicated
Pur! proteins (200 nM) were incubated with a fixed amount of nuclear protein (250
µg/ml) diluted in binding buffer containing 0.5 mM DTT. Solid-phase protein-protein
complexes were detected by ELISA using primary rabbit polyclonal antibodies directed
against Pur", MSY1, TEF1, SRF, Sp1, or Sp3. Parentheses indicate the specific antibody
designation. Absorbance values at 405 nm were corrected for nonspecific antibody
binding to Pur!-coated wells in the absence of nuclear extract. Control experiments
conducted with a His tag antibody indicated that the coating efficiency of each Pur!
construct was equivalent at protein coating concentrations in excess of 100 nM (data not
shown). FL, full-length.
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Figure S3- 11. Subcellular distribution of Pur! truncation proteins. AKR-2B MEFs were
transiently transfected with equivalent amounts of expression vector encoding either
NHis-Pur! I-II or NHis-Pur! III. After 48 h, adherent cells were harvested, washed, and
processed by sequential fractionation in cytoplasm extraction buffer (CEB), membrane
extraction buffer (MEB), nuclear extraction buffer (NEB), and nuclear extraction buffer
plus micrococcal nuclease (NEB+). Subcellular protein fractions (30 µg loaded/lane)
were analyzed by Western blotting with a His tag mAb. Lines and numbers on the left
side designate the relative position and size (in kDa) of prestained protein markers. In
contrast to the near equal distribution of Pur! I-II in cytoplasmic and nuclear fractions,
Pur! III expression is restricted almost exclusively to the cytoplasmic compartment.
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Abbreviations: Pur!, purine-rich element binding protein B; SM"A, smooth muscle "-

actin; ssDNA, single-stranded DNA; MCAT, muscle-CAT box; Sp(1/3), specificity
protein 1 and 3; Pur", purine-rich element binding protein A; Dm, Drosophila
melanogaster; Mm, Mus Musculus; YB-1, Y-box binding protein 1; MEF, mouse embryo
fibroblast; Pur/Pyr, polypurine/polypyrimidine; TGF-!1, transforming growth factor !1.

159

ABSTRACT
Fibrotic diseases are characterized by a persistent fibroblast to myofibroblast
transition marked by an increased expression of smooth muscle "-actin (SM"A). The
SM"A gene, ACTA2, is regulated by a multifaceted network of transcriptional regulatory
factors that activate or repress the promoter-enhancer. Purine-rich element binding
protein B (Pur!) is a transcriptional repressor that suppresses the expression of SM"A by
cooperatively interacting with the cryptic 5’-MCAT enhancer motif. A recent study from
our laboratory showed that the functionally relevant Pur! homodimer is made up of an
intermolecular subdomain flanked by two intramolecular subdomains that confer highaffinity multisite binding to a purine-rich sequence from the ACTA2 enhancer. In this
study, we evaluated the chemical basis of nucleoprotein complex formation between the
Pur! repressor protein and the ACTA2 promoter. Quantitative single-stranded DNA
(ssDNA)-binding assays conducted in the presence of increasing concentrations of
monovalent salt or anionic detergent suggested that high affinity nucleoprotein
interaction is driven by a combination of ionic and hydrophobic interactions. Consistent
with results of in vitro biochemical assays, site-directed mutagenesis revealed several
basic residues within the inter- and intramolecular subdomains (K82, R159, R267) of
Pur! that are essential for maximal transcriptional repressor activity in cell-based ACTA2
promoter-reporter assays. Our findings point to a combinatorial role for hydrophobic and
ionic interactions in facilitating protein self-association, ssDNA-binding, and ACTA2
repression by Pur!.
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INTRODUCTION
Myofibroblasts are contractile cells with a smooth muscle-like phenotype that
play a key role in granulation tissue formation and provide the contractile force necessary
for wound closure during tissue repair (1-4). Although this cell-type is beneficial for
wound healing, chronic activation and survival of myofibroblasts contributes to the
progression of fibrotic diseases including hypertrophic scar formation, pathological
vascular remodeling, and persistent organ fibrosis resulting in heart, liver and lung
impairment (5-7). To develop better therapeutic strategies for treating fibrotic
pathologies, it is necessary to identify and characterize the molecular pathways that
govern myofibroblast growth and differentiation.
Smooth muscle "-actin (SM"A) is a key protein biomarker of fibroblast to
myofibroblast conversion and acquisition of a contractile phenotype (2,8-10). Expression
of the SM"A gene (ACTA2) in fibroblasts is tightly regulated by a complex network of
transcriptional activators and repressors (11,12). The 5’-flanking region of ACTA2
contains a variety of positive cis-regulatory elements including an inverted muscle-CAT
(MCAT) enhancer motif, CArG boxes, and GC-rich sequences that act as cognate
binding sites for trans-activators transcription enhancer factor 1 (TEF-1), serum response
factor (SRF), and specificity proteins 1 and 3 (Sp1/3), respectively (13-17). ACTA2
transcription in fibroblasts is repressed by the coordinate interaction of purine-rich
element bind proteins A and B (Pur" and Pur!) and Y-box binding protein (YB-1) with
the opposing strands of a polypurine-polypyrimidine (Pur/Pyr) sequence surrounding the
MCAT motif (14,18-20).
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Although Pur" and Pur! both interact with purine-rich single-stranded nucleic
acids and possess the capacity to destabilize duplex DNA, they also possess distinct
functional properties (21-23). While gain-of-function/overexpression assays identified
Pur! as the dominant repressor of ACTA2 in fibroblasts and smooth muscle cells, gene
knockdown studies suggested that Pur" may function as a co-regulator of ACTA2
expression in fibroblasts (24,25). A more recent study revealed that Pur" and Pur! differ
in their protein-protein interaction properties during myofibroblast differentiation (26).
Pur" and Pur! are members of a small but highly conserved family of purine-rich
ssDNA/RNA-binding proteins (27). Each member of the Pur family (Pur", Pur!, Pur$
variant A, Pur$ variant B) contains three central sequence elements designated PUR
repeats I, II, and III (27-29). These sequences elements account for the roughly 70%
sequence homology between mammalian Pur" and Pur! (22). Recently solved x-ray
crystal structures of Drosophila melanogaster (61) Pur" (amino acids 40 to 185) and
Borrelia burgdorferi (Bb) Pur" (amino acids 8 to 105) revealed that PUR repeat
sequences fold to form a 4-standed anti-parallel !-sheet followed by an "-helix. In the
case of Dm Pur", intramolecular association of PUR repeats I and II produces a Whirlylike globular domain (dubbed the PUR domain) capable of ssDNA interaction (28). In the
case of Bb Pur", intermolecular dimerization of the single encoded PUR repeat forms a
ssDNA-binding PUR domain, which is nearly identical to the intramolecular dimer
generated by association of PUR repeats I and II of Dm Pur" (29). Because full-length
Pur proteins in metazoans contain three PUR repeats, PUR repeat III likely serves to
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mediate intermolecular interaction of Pur protein monomers as first reported in Dm Pur"
(28).
Our efforts to establish the molecular basis for ssDNA-binding and ACTA2
repression by Pur! have provided additional insight into the similarities and differences
in the structural and functional properties of members Pur protein family. For example,
hydrodynamic analyses indicated that recombinant mouse Pur! reversibly self-associates
to form a homodimer (Kd ~ 1.0 µM) in the absence of ssDNA (30). Rigorous quantitative
analyses of nucleoprotein complex formation between Pur! and the 32 nt purine-rich
strand of the ACTA2 MCAT-containing Pur/Pyr element were consistent with a
cooperative, multisite binding mechanism leading to formation of a high-affinity 2:1
Pur!:ssDNA complex (31). Results of limited tryptic digestion suggested that the
presence of all three PUR repeats was required for high affinity binding of Pur! to the
purine-rich strand of the ACTA2-derived MCAT enhancer (32). To further define the
structural elements in Pur! responsible for multisite ssDNA-binding and ACTA2
repression in fibroblasts, we recently reported that dimeric Pur! is comprised of three
distinct PUR subdomains each capable of ssDNA interaction (33). Consistent with the
cooperative nature of Pur!-ssDNA interaction, all three PUR subdomains were required
for high affinity interaction of Pur! with the ACTA2 promoter. Interestingly, when
studied in isolation, the central dimerization subdomain of Pur! formed by intermolecular
association of two PUR repeat III sequences exhibited markedly higher ssDNA-binding
affinity than the comparable subdomain formed by intramolecular association of PUR
repeats I and II (33).
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In this report, we evaluated the detergent- and salt-sensitivity of nucleoprotein
complex formation between Pur! and an ACTA2-derived ssDNA target sequence. Based
on computational homology modeling of Pur! protein structure, we identified and
empirically validated three basic amino acid residues in PUR repeats I, II, and III that are
critical for ACTA2 repression in fibroblasts. Our findings suggest that a combination of
hydrophobic and electrostatic interactions contribute to the ssDNA-binding and
transcriptional regulatory properties of Pur!.

MATERIALS AND METHODS
Computational modeling of Pur!. Hydrophobic side chains were identified in a
Mus musculus Pur! homology model using PyMOL to depict regions of Pur! with high
hydrophobic amino acid content (33,34). Additionally, electrostatic surface maps were
generated to identify solvent-exposed, charged amino acids. To select positively charged
amino acid residues of Pur! that might confer ACTA2 repression, a ClustalW multiple
pairwise sequence alignment of Mm Pur! and Dm Pur" was performed to identify Pur!
residues corresponding to the Pur" residues (R80, R180, and R226) that had been
mutated to abolish single-strand nucleic acid interaction (35-37). The lack of
conservation of Pur" R180 led us to align the crystal structure of Dm Pur" (amino acids
40-185) and the homology model of Mm Pur! I-II to identify a positionally conserved
arginine in spatial proximity to Pur" R158.
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Single-Stranded DNA-Binding Assays. Direct ssDNA-binding colorimetric
ELISAs were performed in the presence of varying levels of deoxycholate or NaCl with
pure proteins and a synthetic 3’ biotinylated single-strand oligonucleotide derived from
the ACTA2 promoter-enhancer spanning bp -195 through -164 (PE32-bF) as described
previously (32,38). These ssDNA-binding ELISAs were carried out by incubating 1 nM
Pur!, 1 nM Pur! I-II-II, or 5 nM Pur! III with 0.5 nM solid-phase PE32-bF in the
presence of varying concentrations of deoxycholate or NaCl (Sigma). Solid-phase
Pur!:PE32-bF complexes were detected with an antibody directed against amino acids
210-229, a secondary antibody conjugated to horse radish peroxidase (20), and the
addition of colorimetric substrate, ABTS (Sigma Aldrich). Data points were fit to a fourparameter variable-slope equation to obtain an IC50 value (Prism 6, Graphpad Software,
Inc.).
Construction of Expression Vectors. The mammalian expression plasmid
encoding full-length N-terminal hexahistidine-tagged mouse Pur! (pCI-NHis-Pur!) was
generated in a previous study (14,20). The QuikChange+ Primer Design Program
(Stratagene) was used to design primers for site-directed mutagenesis of the pCI-NHisPur! template. Mammalian pCI-NHis-Pur! expression vectors encoding selected point
mutations were generated using the QuikChange® XL site-directed mutagenesis kit
(Agilent). Mutated plasmids were sequence validated (Vermont Cancer Center DNA
Analysis Facility) and purified by double cesium chloride gradient centrifugation.
Quantification of purified plasmids was achieved by measuring the optical density at 260
nm. Double restriction enzyme digestion with BamHI and KpnI was used to evaluate
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plasmid purity from genomic DNA and to confirm the size of the restriction digestion
products via analytical agarose gel electrophoresis. The expression plasmids generated
encoded different combinations of single, double, and triple mutations including Pur!
K82A,

R159A,

R267A,

K82A/R159A,

K82A/R267A,

R159A/R267A,

and

K82A/R159A/R267A.
Transient Transfection Assay. AKR-2B mouse embryo fibroblasts (MEFs) were
seeded at 4.0 % 104 in McCoy’s 5A medium supplemented with 5% heat-inactivated FBS
in 6-well plates. Cells were incubated at 37°C in an incubator with 5% CO2 for 24 h to
facilitate adherence to the plate. MEFs were transiently transfected with a total of 2 µg of
DNA consisting of 0.1 µg of pSV40-!Gal, 1 µg of expression plasmid encoding single,
double, or triple point mutations, and 0.9 µg of promoter-reporter construct, pVSMP8luciferase (33). After 48 h incubation at 37°C, transfected cells were washed with PBS
and harvested by lysis in 1% Passive Lysis Buffer (Promega) containing protease
inhibitors. Luciferase activity assays (Promega) were used to evaluate luciferase reporter
expression which was normalized for total protein concentration determined by Bradford
assay. Datasets were analyzed by performing a one-way analysis of variance and
Dunnett’s multiple comparison test with significance of p <0.05 (Prism 6, Graphpad
Software, Inc.).
Immunoblotting. Total soluble protein from cell lysates was precipitated by
addition of 5 volumes of cold ethanol and incubation at –20°C for 1 h. Insoluble protein
was collected by centrifugation and dissolved in 1% SDS-PAGE loading buffer (20 mM
Tris-Cl, pH 6.8, 0.5% w/v SDS, 5% v/v glycerol, 0.005% w/v bromophenol blue, 5% v/v
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!-mercaptoethanol), heated for 3-5 minutes at 100°C, and run on a 12% w/v
acrylamide/bisacrylamide (29:1) mini-gel with molecular weight standards (BenchMark
Prestained Protein Ladder, Invitrogen). Protein (10 µg or 20 µg) was transferred to an
Immobilon-P polyvinylidene difluoride membrane (Millipore) at 125V for 90 min at 4°C
in 25 Trizma base, 192 mM glycine, 20% v/v methanol. His-tagged Pur! proteins were
detected with a mouse anti-RGS-His monoclonal antibody (Qiagen, 1.0 µg/ml) followed
by a goat anti-mouse IgG-HRP antibody. Bands were visualized via chemiluminescent
detection (Pierce® ECL Western Blotting Substrate).

RESULTS
Mapping of hydrophobic and ionic regions in the Mm Pur! homology model.
The chemical properties of amino acid residues in the Mm Pur! homology model were
displayed using hydrophobic and electrostatic maps generated in PyMOL (33). As
expected, hydrophobic amino acid residues were located at the interior of the
intramolecular (PUR repeat I-II) and intermolecular subdomains (PUR repeat III) (Figure
1A, B). Hydrophobic side chains in the !!!!" structure formed by each PUR repeat
protrude away from solvent-exposure and in toward the interface of two PUR repeats.
This model suggests that a hydrophobic core is located at the center of each PUR
subdomain.
Electrostatic maps of solvent-exposed residues in the Mm Pur! model exhibited a
negative charge localized around the "-helices of each PUR subdomain and pockets of
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positively charged residues on the !-sheet surface (Figure 1C, D). Interestingly, the PUR
I-II intramolecular domain exhibited one positively charged pocket on the surface of the
!-sheets while evidence of two positively charged channels existed at the surface of the
!-sheets in the PUR III intermolecular subdomain (Figure 1D). These results are
consistent with surface charge maps of the Dm Pur" I-II crystal structure which exhibited
moderately negative charge on the "-helix surface side and positive charges around the
!-sheets (28,29). The positively charged channels localized around the !-sheets of the
PUR subdomains point to potential binding surfaces for negatively charged nucleic acid.
Three basic amino acid residues located in !-strands of each PUR repeat were
selected for mutagenesis based on the reported ability of analogous residues to mediate
RNA-binding by Pur" (Figure 3A-F) (37). Alignment of Pur" and Pur! sequences
revealed that Pur" residues R80 and R226 were positionally conserved in Pur! and
corresponded to residues K82 and R267 located in the fourth !-sheet of the PUR I and
PUR III repeats in the Pur! homology model. The absence of a conserved basic residue
in the PUR II repeat led us to align the PUR repeat I-II subdomain of the Mm Pur!
homology model with the Dm Pur" I-II structure (28,33). This maneuver revealed a
unique R159 residue located in the 3rd !-sheet of Pur! repeat II in spatial proximity to
Pur" R158.
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Figure 4- 1. Hydrophobic and electrostatic surface maps of Mm Pur! computational
model. (A) Hydrophobic amino acid residues of the Mm Pur! dimer model. Yellow
spheres represent hydrophobic amino acids while purple represents non-hydrophobic
residues. (B) Representation of (A) rotated 180° around the horizontal axis. (C)
Electrostatic surface maps of the Mm Pur! dimer show regions of charged amino acids.
Blue areas indicate positively charged residues and red represents negatively charged
residues. (D) Representation of (C) rotated 180° around the horizontal axis.
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Effect of deoxycholate on cis-element binding by Pur!. To investigate whether
hydrophobic interactions play a role in Pur! nucleoprotein complex formation, ssDNAbinding ELISAs were conducted in binding buffer supplemented with increasing
concentrations of the anionic bile salt detergent, sodium deoxycholate (Figure 2A). The
amphiphilic properties of deoxycholate allow the detergent to interact with hydrophobic
surfaces of proteins in a non-cooperative and non-denaturing manner (39). Consequently,
deoxycholate is useful in disruption of protein-protein interaction (40,41). A 3’
biotinylated single-stranded oligonucleotide corresponding to the purine-rich sense strand
of

the

MCAT

enhancer

motif

of

ACTA2

(5’-

GGGAGCAGAACAGAGGAATGCAGTGGAAGAGA-3’, PE32-bF) was used as the
ssDNA probe. This oligonucleotide has previously been shown to form high-affinity 2:1
Pur!:PE32-F nucleoprotein complex with a macroscopic Kd of approximately 0.3 nM
(31). The binding step of the assay was executed with a limiting concentration of PE32bF (0.5 nM) and a 2-5 fold molar excess of purified recombinant Pur! proteins in the
presence of varying concentrations of sodium deoxycholate. Results show that very low
concentrations of deoxycholate (< 0.0156% or 0.38 mM) had little to no effect on Pur!
binding to ssDNA. However, at deoxycholate concentrations exceeding 1 mM, binding to
PE32-bF was markedly inhibited for full-length Pur! (IC50 = 0.098%, 2.36 mM), the core
Pur! I-II-III construct (IC50 = 0.084%, 2.03 mM), and the isolated Pur! III intermolecular
subdomain (IC50 = 0.060%, 1.45 mM). The deoxycholate-sensitivity of all three
constructs is consistent with previous findings in which the specific inhibitory effect of
deoxycholate on Pur" and Pur! interaction with ssDNA was documented by band shift
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assay in comparison to Triton X-100 (20). These results are in keeping with structural
data implicating hydrophobic interactions as the principal driver of both intramolecular
and intermolecular association of PUR repeats in Pur" (29).
Effect of increasing ionic strength on cis-element binding by Pur!. To
evaluate the involvement of electrostatic charges in Pur!-ssDNA interaction, the effects
of increasing NaCl concentration on the interaction of full-length Pur!, the core I-II-III
construct, and the isolated Pur! III subdomain with PE32-bF was monitored by ELISA
(Figure 2B). Results indicated that salt concentrations greater than ~0.5 M abolished the
binding of each Pur! construct to PE32-bF. Given the similarity of the competition
curves, these data suggest that each Pur! subdomain possesses charged amino acids
required for stable nucleoprotein complex formation.
Identification of K/R residues in PUR repeats I, II, and III that are essential
for Pur! repressor activity. To evaluate the consequence of K82A, R159A, and R267A
point mutations on the ACTA2 repressor activity of Pur!, MEFs were co-transfected with
Pur! expression vectors and an ACTA2 promoter-reporter construct (VSMP8-luciferase)
(33). All point mutations tested reduced the repressor activity of Pur! toward the VSMP8
promoter activity in MEFs. Effects of double and triple point mutations were more
pronounced than single point mutations. Immunoblotting of the cell lysates confirmed
that all Pur! point mutants were stably expressed in MEFs (Figure 4B). Interestingly,
Pur! constructs containing the PUR repeat III R267A mutation exhibited greatly
diminish Pur! repressor activity indicating that R267 plays a critical role in Pur!
nucleoprotein complex formation. In addition, the Pur! K82A/R159A/R267A triple and
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Pur! R159A/R267A double mutants were much weaker repressors than the R267A
mutant alone. These data suggest that basic residues in each Pur! subdomain are involved
in ACTA2 promoter recognition. This finding is consistent with the cooperative, multisite
binding mechanism proposed for Pur! (31). The results of transient co-transfection
assays comparing the ACTA2 repressor activity of varying concentrations of Pur!
K82A/R159A/R267A and R159A/R267A validated the near complete loss-of-function
phenotype of these mutants relative to wild-type Pur!.
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Figure 4- 2. Effect of deoxycholate and salt on Pur!-ssDNA interaction. (A) Purified,
recombinant NHis-Pur!, NHis-Pur! I-II-III and NHis-Pur! III were incubated with 0.5
nM biotinylated PE32-bF in binding buffer containing varying concentrations of
deoxycholate. Solid-phase nucleoprotein complexes were detected by ELISA. (B) The
same ELISA format was used to evaluate the effect of varying salt concentrations on the
binding of Pur!, Pur! I-II-III, and Pur! III to ssDNA.
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Figure 4- 3. Homology model of Mm Pur! highlighting basic residues implicated in
ssDNA-binding. (A) Space-filling model of the Mm Pur! dimer depicting surface
exposure of K82 (red), R159 (blue), and R267 (purple). (B) Figure (A) rotated 90°
around the horizontal axis clearly shows the location of K82 and R159. (C) A 3D ribbon
model of the Mm Pur! dimer highlighting the location of the selected basic residues. (D)
Figure (C) rotated 90° around the horizontal axis. (E) Electrostatic surface maps of the
Mm Pur! dimer showing distinct regions of charged amino acids. All selected basic
amino acids are located within positively charged clusters (blue areas). (F) Figure (E) was
rotated 90° horizontally to depict a distinct positively charged channel.
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Figure 4- 4. Mutation of selected basic amino acid residues inhibits the ACTA2 repressor
activity of Pur! in fibroblasts. (A) Subconfluent AKR-2B MEFs were transiently cotransfected with mammalian expression plasmids encoding either wild-type Pur! or the
indicated point mutants and an ACTA2 promoter-luciferase reporter plasmid, VSMP8.
After 48 h, transfected MEFs were harvested and whole cell extracts were assayed for
luciferase enzyme activity and total protein concentration. Luciferase reporter expression
measured in cells co-transfected with an empty pCI vector control was defined as 1. Bars
show the fold repression of the VSMP8 reporter by each Pur! construct (mean ± SEM, n
= 6-15). (B) Immunoblot analysis was performed to confirm the expression of single,
double, and triple NHis-Pur! point mutants in cell lysates prepared in (A). (C) A titration
assay was performed with plasmids encoding the indicated double and triple Pur! point
mutants in comparison to the wild-type protein. Symbols show the relative VSMP8
repressor activity of each Pur! construct (mean ± SEM, n = 3). (D) Immunoblot analysis
was performed to confirm the dose-dependent expression of NHis-Pur! in cell lystates
prepared in (C).
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DISCUSSION
During tissue repair, trans-differentiation of fibroblasts lead to the formation of
contractile myofibroblasts expressing SM"A. Persistent myofibroblast activation results
in pathological tissue remodeling associated with many fibrotic diseases. A better
understanding of the underlying molecular pathways that regulate ACTA2 transcription in
myofibroblasts is necessary to develop better strategies for treating aberrant fibrosis. Pur!
is a transcriptional repressor that interacts with the MCAT enhancer of ACTA2 to prevent
the binding of trans-activators which induce SM"A gene expression.
To identify the specific structural elements in Pur! that mediate protein binding to
purine-rich ssDNA, we evaluated the contribution of hydrophobic and ionic amino acids
to Pur! nucleoprotein interaction with an ACTA2 promoter-derived ssDNA probe (Figure
2). Our results indicated that the anionic detergent, deoxycholate, inhibited ssDNAbinding of Pur! proteins composed of all three PUR repeats and the PUR III
intermolecular subdomain at concentrations greater than 0.06%. Additionally, at salt
concentrations exceeding 0.6 M, protein binding to ssDNA was abolished in the case of
full-length Pur!, Pur! I-II-III, and the Pur! III intermolecular domain. These results
suggest that a combination of hydrophobic and electrostatic interactions contribute to the
assembly of Pur!-PE32-bF complex. We surmise that the hydrophobic core of each
subdomain ensures the structural stability of each ssDNA-binding module while basic
residues on the surface serve to mediate subdomain contact with nucleic acid (Figure 1).
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This explanation is consistent with the subdomain architecture of the Pur! dimer and
cooperative mechanism of nucleoprotein complex assembly (31,33).
To evaluate the effect of PUR repeat-specific K82A, R159A, and R267A point
mutations on Pur! function (Figure 3), single, double, or triple mutants were expressed in
undifferentiated MEFs and assayed for their ability to repress an ACTA2 promoterluciferase reporter gene. (Figure 4). The results showed that Pur! constructs containing
the R267A mutation were the most defective in ACTA2 repressor activity. Of the mutants
tested, Pur! R159A/R267A, K82/R159/R267, and K82A/R267A demonstrated the
greatest loss of ACTA2 repressor activity (Figure 4 A, B). These findings suggest that
residue R267 in PUR repeat III plays a critical role in mediating Pur! repressor activity
but that residues K82A and/or R159A in PUR repeats I and II contribute to ACTA2
repression as well. This interpretation was further validated by confirming that the
deficiency in repressor activity in the Pur! R159/R267 and Pur! K82A/R159A/R267A
mutants was seen over a range of expressed protein concentrations (Figure 4 C, D). It is
important to note that analogous mutations in the 4th !-strand of PUR repeats I, II, and III
of Dm Pur" have been reported to abolish RNA-binding in the absence of any effect on
Pur" dimerization (37). Consequently, the loss of ACTA2 repressor function observed
with the Pur! K82, R159, R267 mutants is most likely due to a deficiency in purine-rich
ssDNA-binding affinity although we cannot formally exclude the possibility of altered
subcellular trafficking of the expressed Pur! point mutants. Further biochemical studies
are required to empirically validate the predicted structural features and ssDNA-binding
properties of these Pur! point mutants relative to the wild-type protein. These studies will
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include the use of circular dichroism spectroscopy to assess protein folding and stability,
size exclusion chromatography to evaluate quaternary structure, and ssDNA-binding
ELISAs to test the capacity of each Pur! point mutant to bind PE32-F.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
!
The studies presented herein have established a structural basis for site-specific
ssDNA-binding of Pur! to the sense strand of the ACTA2-derived cryptic MCAT
enhancer element (PE32-F). Our findings show that the functional Pur! dimer consists of
three subdomains that interact cooperatively with PE32-F to form a repressive
nucleoprotein complex. The molecular arrangement of subdomains consists of an
intermolecular PUR domain made up of PUR III repeats from two Pur! molecules
flanked on either side by intramolecular subdomains consisting of PUR repeats I-II. The
inter- and intramolecular subdomains are structurally similar but functionally unequal in
ssDNA-binding capacity. In our most recent study, we show that specific basic amino
acids within the !-sheets are essential for full ACTA2 repression by mouse Pur!.
Specifically, mutation of R267 individually and in combination with K82 and R159
resulted in a significant reduction in ACTA2 repression.
Biochemical analysis of Pur! K82A, R159A, and R267A individually or as
double and triple point mutants is essential for elucidating the underlying molecular
mechanism of ACTA2 repression by Pur!. First, the ssDNA-binding properties of AKR2B MEF lysate-derived Pur! point mutants will be evaluated using a ssDNA-binding
ELISA. Cell lysate-derived Pur! constructs that impact ssDNA-binding will be evaluated
using biochemical techniques. Bacterial expression plasmids will be generated by
subcloning the open reading frame from the pCI mammalian expression vectors into the
bacterial competent expression plasmid, pQE30. Stable expression of Pur! constructs in
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E. coli will be assessed by immunoblotting. To evaluate the biochemical characteristics
of point mutations that impair the ACTA2 repressor activity of Pur!, we will purify
recombinant NHis-tagged Pur! proteins harboring the point mutations using affinity
column chromatography. The quaternary structure of each isolated Pur! construct will be
evaluated using calibrated SEC and the fold state of each protein will be assessed by CD.
Finally, the ssDNA-binding capacity of each Pur! point mutant will be examined using
colorimetric ssDNA-binding assays.
Future studies will focus on characterization of individual amino acids and
sequence elements that confer site-specific binding at the MCAT enhancer of the ACTA2
promoter. Crystallization trials with the Pur! I-II intramolecular subdomain and the Pur!
III intermolecular subdomain will be carried out in attempt to solve the x-ray crystal
structure of Pur!. Furthermore, amino acid sequences unique to Pur! may account for the
differences in Pur protein structure that distinguish Pur! as the dominant ACTA2
repressor in muscle cells. Site-directed mutagenesis of these unique amino acids may
provide insight into the intrinsic biochemical differences between Pur! and Pur" that
contribute to site-specific binding to purine-rich ssDNA.
Future studies will also be directed at evaluating the effect of nucleoprotein
complex formation on duplex DNA destabilization. Mammalian genetic regulation
requires transcriptional repressors and activators to access sequence elements within the
supercoiled dsDNA. The mechanism by which ssDNA-binding transcription factors, such
as Pur! and Pur", acquire access to the constrained double-stranded helix remains
unknown. Several studies have indicated that Pur" may be capable of unwinding duplex
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DNA in the absence of ATP (1, 2). Pur" and Pur! do not exhibit helicase activity
suggesting that they may possess the capacity to destabilize the dsDNA helix (2).
Another ssDNA-binding protein, phage T4 gene 32 protein (gp32), mediates ATPindependent strand unwinding similar to Pur" (3). This indicates that ATP-independent
duplex unwinding may be a mechanism carried out by various ssDNA-binding proteins.
As we have shown in the presented studies, the unique tripartite arrangement of Pur! is
optimal for interaction with the MCAT enhancer element. To evaluate whether this
arrangement also facilitates duplex DNA unwinding, we will use base modifying
chemical reactions and electrophoretic mobility shift assays to evaluate helix unwinding.
Pur! nucleoprotein complexes will be formed on radioactively labeled PE32-F
oligonucleotides in both single and double-stranded configuration. Reactive base
modifying chemical probes including dimethyl sulfate (DMS), potassium permanganate
(KMnO4), and diethyl pyrocarbonate (DEPC) will be used to modify unprotected bases.
These chemical probes will react with bases exposed in areas of localized or global
perturbation in the dsDNA. Subsequent exposure to piperidine will mediate cleavage of
the sugar-phosphate backbone and cleavage products will be evaluated using sequencing
gel electrophoresis and phosphorimage analysis. Additionally, a DNAse I footprinting
analysis may be used to evaluate DNA duplex destabilization and identify bases protected
by Pur! nucleoprotein interaction.
The studies presented in this dissertation indicate that Pur! acts as a
transcriptional repressor of ACTA2 expression by cooperatively interacting with the
MCAT enhancer motif. To evaluate the thermodynamic parameters of Pur!:PE32-F
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nucleoprotein complex formation, we propose to perform isothermal titration calorimetry
(9) and a van’t Hoff analysis. ITC experiments will be carried out by titrating full-length
Pur! into PE32-F. The binding isotherms will be fit to a single-site or multisite model
and the binding affinity, stoichiometry, and enthalpy change generated from these
experiments will establish the thermodynamic contributions involved in the cooperative
nucleoprotein interaction of Pur! with PE32-F. Different states of protein folding and
protein-ligand interaction are reflected in the difference in Gibbs free energy (!G) (4).
The standard free energy (!Gº) depends on the equilibrium between two states expressed
in an equilibrium constant:
!Gº (T) = -RT ln K(T)
where K is the equilibrium constant, R is the gas constant and T is the temperature in
Kelvin. The !Gº of association is based on enthalpy (!Hº) and entropy (!Sº) of the
system.
!Gº (T) =!Hº (T) -T!Sº (T)
The formation of protein-ligand complexes results in the formation of new bonds and
interactions such as van der Waals interactions, hydrogen bonding, electrostatic
interactions, and hydrophobic forces. These interactions directly affect the enthalpy of a
system. Changes in entropy are also observed as protein-ligand complexes form and
affect the disorder within a system. Therefore, changes in the thermodynamic parameters
will indicate the assembly of the Pur! nucleoprotein complex on PE32-F. The
cooperative assembly of Pur! on PE32-F will likely result in a decrease in entropy
indicative of nucleoprotein complex formation. In addition, the ITC experiments may be
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carried out with Pur! intra- and intermolecular subdomains to identify the structural
elements that facilitate cooperative ssDNA-binding. As an additional method for
evaluating the thermodynamic parameters of Pur! nucleoprotein interaction, we will
obtain melting curves using temperature-controlled UV-visual spectroscopic techniques.
We will determine the melting temperature or midpoint of these binding curves and plot
1/midpoint versus the natural log of the total concentration. The value of !Hº can be
determined as a function of temperature using this van’t Hoff analysis. Thermodynamic
parameters determined using ITC and the van’t Hoff analysis will aid in our
understanding of the cooperative assembly of the Pur!:PE32-F nucleoprotein complex.
Posttranslational modifications (PTMs) may also contribute to Pur! function.
Modification of ssDNA-binding transcription factors with PTMs have previously been
linked to transcription factor function. PTMs have been shown to govern transcription
factor subcellular localization, DNA-binding, structural stability, or protein-protein
interaction with other transcription factors (5). Phosphorylation of serine, threonine, or
tyrosine by the addition of a phosphate group generates a negative charge around the
modified amino acid, which may govern cellular signaling, stability, subcellular
localization, or protein-protein interaction. Methylation of arginine residues has been
shown to modulate protein-protein interaction and the regulatory switch-like activity of
transcription factors. For example, methylation of RUNX1 prevents its interaction with
co-repressor SIN3A resulting in de-repression of RUNX1 genes (6). Acetylation of
arginine and lysine residues has been implicated in the abolishment of transcription factor
nucleoprotein complex formation by neutralizing the positive charge with an uncharged
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amide group. As another example, the interaction between FOXO1 and the glucose-6phosphate promoter is abolished by acetylation (7). Lastly, ubiquitination of transcription
factors targets them for proteasomal degradation. This PTM may control the local
expression level of transcription factors by inducing their proteolytic digestion. To
evaluate posttranslational modification of Pur proteins, Pur! or Pur" constructs will be
expressed in a human embryonic kidney 293 (HEK 293) cells and evaluated by mass
spectrometry for posttranslational modifications that contribute to Pur protein function.
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